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Summary 
The ribosome constitutes the scaffold for one of the most important processes within a living 
cell; jointly with tRNAs, mRNAs and a number of assisting factors, they comprise the 
macromolecular machinery responsible for decoding of mRNAs and translation of proteins. 
This makes ribosomes and translation an attractive point of action. Under stress conditions, 
bacterial cells induce a stringent response, mediated by the alarmones (p)ppGpp, to limit a 
waste of resources. With translation being an extremely energy consuming process, it is 
targeted as well. To understand this process, we studied the effect it has on two targeted 
GTPases, namely the ribosome biogenesis co-factor RbgA, and the elongation factor EF-Tu. 
We applied cryo-EM to solve the structure of RbgA interacting with its substrate, the 50S. 
Initially a low-resolved and flexible density was interpreted as RbgA associated with rRNA 
helices. However, further cryo-EM of 50S in the absence of RbgA revealed a similar density. 
X-ray crystal structure of RbgA bound to (p)ppGpp showed that the 3’-pyrophosphate moiety 
likely inhibits RbgA from adopting a conformation allowing binding to ribosomal particles, 
thus hindering it from producing mature and translation competent 50S. In the second study, 
an X-ray crystal structure analysis of EF-Tu in the presence of pppGpp revealed a similar 
mode of inhibition, as 3’-pyrophosphate would sterically clash with switch I in an ordered 
conformation. Accordingly, switch I adopts a disordered conformation, which we suggest will 
obstruct EF-Tu from binding aminoacylated tRNAs. We conducted EMSAs and could indeed 
show that in the presence of (p)ppGpp, complex formation of EF-Tu with tRNA was inhibited. 
Besides the stringent response, also a number of antibiotics target translation. In a third study, 
we revealed that the polyketide antibiotic tetracenomycin X (TcmX) inhibits translation. 
Through stacking interactions onto a conserved U1782-U2586 base-pair and coordination of 
two Mg2+ ions, TcmX binds inside the nascent peptide exit tunnel, blocking translation 
elongation. From toe-printing experiments with different templates we suggest it has a 
sequence-specific stalling mechanism, analogous to macrolides. In a fourth project we 
conducted biochemical experiments showing that the antibiotic argyrin B inhibits bacterial 
translation by trapping the elongation factor EF-G on the ribosome. A cryo-EM structure of 
EF-G on the 70S ribosome in the presence of argyrin B confirms a previously determined 
binding site between domain III and V, and shows that the drug inhibits conformational 
changes of EF-G necessary for subsequent dissociation. 
 
Introduction 1 
1. Introduction 
One of the most accepted theories on the origin of life is that it started with RNA molecules 
(Gilbert, 1986; Noller, 2012), which were able to serve both as molecules with enzymatic 
activity and as storage of genetic information. Formation of amino acids under pre-biotic 
conditions has been achieved (Miller, 1953), and a co-evolution of ribosomes and proteins is 
conceivable (Noller, 2012). As the ribose group poses an easy point of attack, RNA is less 
stable, and life mitigated to storing information in the more reliable form of DNA, and 
evolved to what we know today. 
The essence of life is the reproduction on an organismal and cellular level. The latter is 
described in the central dogma of molecular biology (Crick, 1970): genetic information is 
stored in DNA, but it also serves as template for transcription of RNA. The RNA in return is 
employed in protein synthesis and translated into polypeptide chains consisting of amino 
acids. Translation itself is a highly complex process facilitated by a multitude of distinct 
RNAs: the transcribed messenger RNA (mRNA) contains a code, which is deciphered by 
transfer RNAs (tRNAs). tRNAs assume the role of adapters between RNA and proteins, as 
they recognise a three-nucleotide code in the mRNA and carry the corresponding amino acid. 
Macromolecular machineries termed ribosomes represent a scaffold for this decoding event 
between tRNA and mRNA. They promote a precise translation process, and act as ribozymes 
as they facilitate the peptide-bond formation between amino acids (Steitz & Moore, 2003). 
The enzymatic core of the ribosome, the peptidyl transferase centre (PTC), has been 
suggested to be the primordial part of the ribosome (Fox, 2010). Ribosomes must have existed 
in the last universal common ancestor (LUCA), as ribosomes across all domains of life share 
a common core, whereas the exposed exterior domains become increasingly diverse 
(Melnikov et al., 2012). By comparing ribosomal structures of organisms, with increasing 
organism complexity, the ribosome has been suggested to evolve via several phases of 
accretion: ancestral expansion segments (AES), tRNA-like mini-helices, attach to existing 
helices and domains, thus expanding ribosome function (Petrov et al., 2015). From an initial 
simple helix-formation to protect against degradation, the non-specific ribozyme function of 
the PTC was formed. Further increases in RNA structure not only stabilised the active centre, 
but expansion of the tunnel guiding and sheltering the created peptides facilitate the formation 
of longer oligopeptides. The oligopeptides formed in this manner can bind to the RNA, 
providing further protection against degradation. Concrete decoding employing tRNA and 
mRNA evolved only in the later phases of ribosome evolution. 
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1.1. The bacterial translation machinery 
Ribosomes comprise both RNA and proteins and consist of two subunits, termed the large and 
the small subunit (LSU and 30S, respectively; Fig 1A). In Escherichia coli, the large subunit, 
also termed 50S, consists of two ribosomal RNAs (rRNAs), namely the 5S and the 23S rRNA, 
and 33 ribosomal proteins (L1-L36). The small subunit (30S) consists of the 16S rRNA and 
21 ribosomal proteins (S1-S21; Fig. 1B). While 34 ribosomal proteins are universally 
conserved across eukarya, archaea and bacteria, 21 are unique bacterial proteins. For 
translation itself, most ribosomal proteins are expendable. However, they play an important 
role during the biogenesis, ensuring correct folding of the rRNA (Wilson & Nierhaus, 2005). 
In the process of translation, the tRNAs traverse the ribosome through three distinct binding 
sites (Fig. 1C) (Schmeing & Ramakrishnan, 2009; Opron & Burton, 2018). This process is 
referred to as elongation and is always coupled to mRNA movement.  
 
 
Figure 1: The bacterial ribosome. (A) Overview of the Escherichia coli ribosome: the large subunit (LSU) consists of 2 
rRNA strands (grey surface) and 33 proteins (grey cartoon), whereas the small subunit (30S) has one rRNA strand (yellow 
surface) and 21 proteins (yellow cartoon). (B) Composition of the overall E. coli ribosome and the respective subunits. (C) 
Transverse section through the ribosome, exposing the three distinct tRNA binding sites of A-site (orange), P-site (green) and 
E-site (blue), as well as the mRNA (D) Transverse section through the ribosome showing the decoding centre (DC) between 
tRNA and mRNA at the A-site, the peptidyl transferase centre (PTC) and a short nascent polypeptide chain in the nascent 
peptide exit tunnel (NPET). 
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In the A-site, the mRNA nucleotide triplet determining the amino acid is decoded and an 
aminoacyl-tRNA with the respective amino acid can bind. The P-site holds the tRNA with the 
peptidyl-chain, and at the E-site deacetylated tRNAs exit the ribosome (Agrawal et al., 2000; 
Yusupov et al., 2001). While the decoding centre (DC) in situated in the small subunit (Fig. 
1D), the enzymatic reaction is carried out in the PTC in the large subunit. Here, the 
polypeptide bound to the P-site tRNA is transferred to the A-site tRNA. The following 
translocation moves the A-site tRNA to the P-site, the now deacylated P-site tRNA to the E-
site, and subsequently the E-site tRNA is ejected. Coupled movement of tRNA and mRNA 
leads to a new codon presenting itself in the A-site, and the cycle begins anew. The growing 
polypeptide is guided through the nascent peptide exit tunnel (NPET; Fig. 1D), which is 
approximately 100 Å in length (Nissen et al., 2000). Once the N-terminal end of the peptide 
reaches the exit, further processing proteins like chaperones or the signal recognition particle 
(SRP), facilitating membrane insertion, can interact with the nascent peptide (Deuerling et al., 
2019). Elongation of the nascent peptide chain (NPC) continues until the ribosome encounters 
a stop-codon, which does not encode a respective tRNA. The peptide chain is released from 
the P-site tRNA to form a functional protein, and the ribosome can be recycled for a new 
round of translation. 
 
1.2. Ribosome Biogenesis 
Ribosomes exercise one of the core tasks within a living cell, and as such it is critical that 
accurate ribosome assembly is ensured. The subunits are assembled separately and only join 
for translation once they are matured. This complex process encompasses rRNA transcription, 
processing and modification of nucleotides, as well as r-protein translation, and finally joining 
of the rRNA and protein components. Some of these processes can take place simultaneously, 
and binding of r-proteins to the RNA proceeds in a hierarchical order. Furthermore, a 
multitude of biogenesis co-factors assist in the assembly and provide checkpoints during 
maturation. 
Composition and expression of ribosomal RNA. E. coli possesses seven rRNA rrn operons 
(rrnA, B, C, D, E, G, H) encoding 16S, 23S and 5S rRNA (Ellwood & Nomura, 1982), as well 
as tRNAs encoded in the intergenic spacers (Fig 2A). The operons can be divided into two 
groups; group one type operons encode tRNAAla and tRNAIle between the 16S and 23S rRNA, 
whereas group two encodes tRNAGlu (Condon et al., 1995b). All seven operons are largely 
conserved in the rRNA, however, they differ mostly in their promoter regions and still show 
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around 2% variation within the rRNA sequence (Maeda et al., 2015). Divergence can be 
found outside the catalytic regions and at the solvent surface, which define protein 
interactions. Not all operons are equally transcribed under native conditions (Maeda et al., 
2015). An upstream regulatory region (UP), containing two promoters, P1 and P2 (Young & 
Steitz, 1979)(Fig. 2A) is recognised by transcription activator Fis (Ross et al., 1990), and the 
global transcription repressor HN-S (Afflerbach et al., 1998). However, not all rRNA operons 
are regulated equivalently (Hillebrand et al., 2005). Possession of multiple rRNA operons is 
not only a means of backup in case of mutations, but has been proven to be crucial for 
adaptation to cold shock, starvation or other stress conditions (Condon et al., 1995a). 
 
 
Figure 2: rRNA operon organisation and secondary structure. (A) A typical rRNA operon organisation, consisting of two 
preceding promoters (P1, P2), the gene coding for the 16S rRNA (rrs), one or two tRNA genes, followed by the 23S rRNA 
gene (rrl) and the 5S rRNA gene (rrf), and finally transcription two terminators (T1, T2). (B) The secondary structure of the 
16S rRNA, with four distinct domains (5’, central domain (C), 3’ major (3’M) and the 3’ minor (3’m)). The central 
pseudoknot (CPK) connects all domains. (C) The secondary structure of the 23S (blue) rRNA can be divided into 7 domains 
(0-IV), where domain 0 connects all domains. The peptidyl transferase centre (PTC) is located in domain V. 5S rRNA is 
depicted in purple. Secondary structure data as provided by (Petrov et al., 2013; Petrov et al., 2014). 
 
Processing of rRNA. The operons are transcribed by the DNA dependent RNA polymerase 
(RNAP) as one transcript (Ginsburg & Steitz, 1975). A multitude of RNA polymerases are 
active on each operon, causing characteristic christmas-tree shaped Miller spreads due to 
different transcript lengths, as they proceed along the rDNA (French & Miller, 1989). With an 
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average transcription rate of 80-90nt/s (Dennis et al., 2009), transcription of one rRNA operon 
(~5 kbp) takes roughly one minute. In vivo, transcription by RNAP cannot be substituted by 
T7 polymerase at 37 °C, as it leads to translation-incompetent subunits (Lewicki et al., 1993). 
At lower temperatures, viability of T7 transcribed subunits is restored, further supporting the 
importance of transcription-coupled ribosome assembly (de Narvaez & Schaup, 1979). 
Although transcribed from one operon, the subunits are assembled separately. During on-
going transcription is the primary transcript cleaved by RNase III, separating the 16S, 23S and 
5S precursors with 3’ and 5’ overhangs (Dunn & Studier, 1973; Nikolaev et al., 1973; 
Szeberényi et al., 1984). Following, a multitude of RNases act together to mature the rRNA 
(Shajani et al., 2011; Sulthana & Deutscher, 2013; Bechhofer & Deutscher, 2019). RNase E 
further processes the 16S and 5S precursor from the 5’ end (Szeberényi et al., 1984; Li et al., 
1999b). In E. coli, 23S and 5S rRNA are cleaved at the 3’ end by RNase T (Li & Deutscher, 
1995; Li et al., 1999a). Finally, the remaining nucleotides at the 5’ ends of these rRNA 
strands are removed exonucleolytically by RNase AM (Jain, 2020). In Bacillus subtilis, the 
RNase Mini-III recognises 23S dsRNA overhangs independent of prior RNase III cleavage, 
and substitutes RNase AM and T from E. coli (Redko & Condon, 2010). Additionally, 
processing of the 5S precursor in B. subtilis is carried out by a single enzyme, RNase M5, but 
is dispensable for functional 70S formation (Condon et al., 2001). 
Modifications on the rRNA. Ribosomal RNA carries 36 modifications, mostly in the form of 
pseudouridylation, methylation at the 2’-OH of the ribose or methylation of the bases 
(Decatur & Fournier, 2002; Kaczanowska & Rydén-Aulin, 2007; Shajani et al., 2011). These 
modifications occur during ribosome assembly (Siibak & Remme, 2010), and possibly 
function as assembly checkpoints (Sergeeva et al., 2015). The majority of 16S modifications 
occur late in assembly, whereas the majority of 23S modifications are made early in assembly. 
16S modifications are dispensable for an active 70S, albeit leading to less efficient translation 
(Krzyzosiak et al., 1987). In vitro reconstitution of functional 70S using T7 transcribed 16S 
rRNA without modifying enzymes present is possible (Shimojo et al., 2020). Seven 
modifications of the 23S have been proven vital (Green & Noller, 1996) and in vitro 
reconstitution still requires purification of matured 23S (Nikolay et al., 2018). Some 
modifications appear to be important for RNA integrity and assembly (Polikanov et al., 2015; 
Wang et al., 2020), like pseudouridylation of H69 in the 50S, which is important for peptide 
release by RF2 (Kipper et al., 2011). However, the exact functions of most modifications are 
still unknown (Sergeeva et al., 2015; Stojković et al., 2020) and strains deficient in 
methylation or pseudouridylation are still viable (O'Connor et al., 2018; Pletnev et al., 2020). 
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Some modifications are optional for normal function and can be used as a means of antibiotic 
resistance through steric hindrance of binding (Maravić, 2004; Kehrenberg et al., 2005). 
Ribosomal proteins. The majority of ribosomal proteins are encoded in the str-S10-spc-α 
gene region (Jaskunas et al., 1977; Cerretti et al., 1983), which can be divided into four 
operons. The residual proteins are scattered across the genome in operons encoding at least 
one further protein, which are either other ribosomal proteins or other essential proteins like 
translation factors or the β-subunit of RNAP (Zengel & Lindahl, 1994). To avoid wasting 
resources on expression of unnecessary ribosomal proteins, expression should occur 
stoichiometrically to rRNA synthesis. This is achieved by negative autogenous regulation of 
r-protein operons: select unincorporated r-proteins can bind to their own mRNA, and in this 
way obstruct translation (Zengel & Lindahl, 1994; Aseev et al., 2016). Lack of r-proteins, 
which are important during early assembly points, causes accumulation of intermediates and 
an abundance of late binding proteins, subsequently leading to repression of tertiary binding 
proteins (Sykes et al., 2010). 
Incorporation of r-proteins. Ribosome assembly occurs co-transcriptionally, i.e. r-proteins 
are recruited while transcription is still in process (de Narvaez & Schaup, 1979; Rodgers & 
Woodson, 2019). On one hand is the construction of a ribosomal subunit a hierarchical 
process, meaning binding of certain proteins relies on prior binding of early step binding 
proteins. Nonetheless, these hierarchical strings are only partially dependent on one another, 
and many roads lead to ribosome as parallel assembly pathways exist (Gupta & Culver, 2014; 
Davis & Williamson, 2017). The first assembly maps were postulated by Nomura (Mizushima 
& Nomura, 1970) and Nierhaus (Herold & Nierhaus, 1987) for the 30S and 50S, respectively, 
after in vitro reconstitution experiments: primary r-proteins are proteins binding to the rRNA 
early in assembly, thus initiating assembly, and give a platform for other proteins down the 
pathway (secondary/mid and tertiary/late proteins) (Shajani et al., 2011). For the 30S, uS7, 
uS15 and uS4 have been identified as initiator proteins for the 5’, central and 3’ domain, 
respectively. For the 50S, uL3, uL4, bL20 and uL24 are crucial for assembly initiation, out of 
which only uL3 binds in the 3’ end and the others the 5’ end of the 23S. The postulated 
original assembly maps still stand today, with few minor corrections; in vitro reconstitutions 
often lack the co-transcriptional assembly, and to overcome resulting kinetic traps of unusual 
secondary folding, non-physiological magnesium concentrations, long incubation times or 
heat activation are necessary (Nierhaus, 1991). In vivo observations, made possible by 
innovations and advancements such as in the cryo-EM field in recent years (Razi et al., 2017), 
led to revisions of the assembly maps. Intermediate assembly stages resulting from r-protein 
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deletions could be visualised and revealed that ribosome assembly is not strictly hierarchical 
but has parallel pathways (Mulder et al., 2010; Leong et al., 2013; Davis et al., 2016). In the 
absence of early assembly proteins, particles can get stuck in kinetic traps, which, however, 
can be overcome after addition of missing proteins, similar to in vitro reconstitutions. 
Additionally, it has been shown that some initiator proteins like uS4 and uS7 bind transiently 
to help initial binding of downstream proteins and only become stably incorporated at a later 
stage (Duss et al., 2019; Rodgers & Woodson, 2019). 
Assembly of the 30S occurs in a transcription-coupled 5’ – 3’ direction (Duss et al., 2018). 
The body (Fig. 2B) is matured first (Dutca & Culver, 2008), then the platform, and the 3’ 
domain, consisting of the head and h44, is formed last (Davis & Williamson, 2017). As a 
result, maturation of each domain is independent of the other domains, and if one domain 
cannot be matured, the remaining ones will still fold correctly (Razi et al., 2019). The central 
pseudo knot (CPK) connects all domains, and if correct maturation is disrupted here, 
translation becomes inhibited (Brink et al., 1993). 
Maturation of the 50S, however, is more complex as a multitude of inter-domain interactions 
within the 23S occur, and maturation is dependent on these interactions. Depletion of bL17 
provided further evidence of parallel assembly pathways present also in the 50S (Davis et al., 
2016). While for 30S maturation, four building blocks have been identified, for the 50S six 
have been found (Davis & Williamson, 2017). The solvent face of the ribosome, consisting of 
domains I, IV and parts of domain II and III (Fig. 2C), is formed first. Many assembly 
intermediates present a lack of the central protuberance, yet it has been determined to mature 
in the second step already. In a third step, the subunit interface is advanced. Domain V, and 
the PTC within it, is matured only in the 4th building block, so rather late and in contrast to 
evolutionary development. Block five includes flexible structures, like the uL1 stalk and H68-
H71. Block six comprises further subunit interface regions. 
Ribosomal assembly co-factors. To aid in the complex process of biogenesis, a host of 
transiently interacting assembly co-factors come into play: DEAD-box proteins, chaperones 
and GTPases (Wilson & Nierhaus, 2007; Britton, 2009; Shajani et al., 2011). DEAD box 
proteins are RNA-dependent ATPases with helicase activity, and assist mostly in 50S 
assembly. Strains depleted in these proteins, like CsdA or SrmB, show either cold or heat 
sensitive phenotypes combined with disturbed ribosome profiles, but are generally 
dispensable for assembly at 37 °C (Shajani et al., 2011; Redder et al., 2015). 
Deletion of RNA chaperones is not lethal, however, lack of some proteins like RimM leads to 
an accumulation of immature 30S subunits with an unprocessed h44 (Leong et al., 2013). 
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These particles can can mature into functional 30S after an increased incubation time 
(Thurlow et al., 2016). Similarly, RbfA (Ribosome binding factor A) is a coldshock protein, 
which acts late in 16S maturation. At 37 °C, ΔrbfA cells show only a mild inhibition of 
growth and an accumulation of immature 30S, however, at lower temperatures the phenotype 
becomes more severe (Dammel & Noller, 1995; Xia et al., 2003). The conserved RNA 
chaperone Hfq, which has been known as translational regulator by guiding sRNA to its 
counterpart mRNA, was also identified as a ribosome biogenesis factor (Andrade et al., 2018). 
By contrast, most ribosome assembly associated GTPases are essential and conserved across 
the domains (Britton, 2009). For instance, the GTPase Era (E. coli ras-like) is responsible for 
folding of h23 and h24 in the 30S platform (Razi et al., 2019). For 30S in vitro reconstitution 
addition of Era alone is sufficient to achieve assembly under physiological conditions 
(Tamaru et al., 2018). Another GTPase essential for 30S maturation is YqeH. In contrast to 
other assembly co-factors, no immature 30S particles accumulate in the absence YqeH since 
the 16S precursor becomes degraded (Loh et al., 2007). The exact function of this GTPase is 
yet to be discovered. In 50S assembly, a greater number of essential GTPases participate. Der 
(double Era like GTPase in E. coli; YphC in B. subtilis) is conserved in all eubacteria (Hwang 
& Inouye, 2006; Schaefer et al., 2006) and is essential for CP maturation (Ni et al., 2016). 
Similarly, deletion of the essential GTPases YsxC and RbgA (Ribosome Biogenesis GTPase 
A; formerly YlqF) in B. subtilis (but not E. coli) leads to accumulation of 50S precursor 
particles, sedimenting at 44.5S and 45S, respectively (Schaefer et al., 2006; Uicker et al., 
2006). The three GTPases appear to function during late stage assembly (Matsuo et al., 2006; 
Schaefer et al., 2006), and precursor particles all lack uL16, bL28, bL35 and bL36, and to a 
lesser extent bL27 and bL33 (Uicker et al., 2006; Ni et al., 2016). Each of the GTPases can 
bind to the precursor particle of the other GTPases (Ni et al., 2016), but the order or whether 
they bind simultaneously remains to be determined. 
RbgA is a widely conserved biogenesis co-factor, and its yeast homologue Lsg1 targets late 
assembly 60S precursors at the subunit interface (Ma et al., 2017; Malyutin et al., 2017). 
Likewise, the mitochondrial homologue Mtg1 aids in intersubunit bridge formation (Kim & 
Barrientos, 2018; Jaskolowski et al., 2020). RbgA belongs to the family of circular 
permutated GTPases (cpGTPases), meaning that the G-domain motives G1-G5 have changed 
order and are now in the G4-G5-G1-G2-G3 order (Anand et al., 2006), and requires potassium 
for GTPase activity (Achila et al., 2012). Solving the crystal structure of RbgA (Kim et al., 
2008) allowed the identification of a structurally conserved ANTAR (AmiR–NasR 
Transcription Anti-termination Regulator) RNA interacting motif in the C-terminal domain 
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(Gulati et al., 2013). The N-terminal domain comprises the G-domain and, in addition to G1-
G5, conserved regions CR1-3 (Gulati et al., 2013). G3 holds the switch II motif, which 
normally contains the catalytically active histidine residue. In RbgA, however, it is connected 
with the CR3 and forms a loop, linking the G- and ANTAR domain and possible conveying 
secondary structure rearrangements upon GTP hydrolysis. Furthermore, the catalytically 
active histidine His9 (His84 in EF-Tu; His92 in EF-G) is in fact found in CR1, explaining 
why deletion of ten N-terminal residues results in a loss of function (Matsuo et al., 2007). 
RbgA GTPase activity is stimulated by binding to the ribosome, and addition of GDPNP 
leads to stable interaction with the mature 50S (Matsuo et al., 2006; Achila et al., 2012). 
Mutations in uL6 at the H97 interaction site partially relieve the growth defect caused by 
absence of RbgA (Gulati et al., 2014). Together with cryo-EM studies of immature 45SRbgA 
particles, which showed lack of the CP (Li et al., 2013; Jomaa et al., 2014), this gave a first 
indication of RbgA function: stabilisation of H97 to facilitate uL16 and further protein 
binding to stabilise the CP. A recent cryo-EM structure of 45SRbgA bound to RbgA showed 
stabilisation of uL6, and also H91-93 in the A and P site (Seffouh et al., 2019). The ANTAR 
domain interacts with H62 and H4, while the G-domain occupies the space H69 and H71 
would reside in in a mature 50S particle. The catalytic H9 is still 8 Å away from the γ-
phosphate, indicating that GTP hydrolysis could not have been triggered in this conformation. 
Possibly, further conformational changes occur when the 50S is matured, ultimately 
permitting GTP hydrolysis and dissociation of RbgA. 
1.3. The Prokaryotic Translation Cycle 
After completing the maturation process, the ribosome is ready to continue to the translation 
cycle. It consists of four phases: initiation, elongation, termination and recycling (Fig. 3). Like 
for assembly, each phase of the translation cycle is guided by co-factors as well. For initiation 
of the bacterial translation cycle, three initiation factors IF1-3 are necessary. They recruit the 
initiator fMet-tRNAfMet to the P-site and ensure correct positioning of the start-codon and 
interaction between the two. In E. coli, AUG is the most abundant start codon with ~83%, 
followed by GUG (~14%) and UUG (~3%) (Rocha et al., 1999). These class I start codons are 
favoured by IF3, whereas class II codons (<1%) are discriminated against, and lead to poor 
expression levels of the downstream gene (Sussman et al., 1996). Notably, infC, the gene 
encoding for IF3, utilizes AUU, one of five class II start codons, and thus convey an 
autoregulatory mechanism of IF3. 
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Figure 3: The bacterial translation cycle. A translation cycle starts with the initiation (left upper corner; green arrows), 
when mRNA and initiation factors associate with the 30S and recruit the initiator tRNA. After accommodation of the tRNA, 
the 50S can bind to the 30S to progress from an initiation to an elongation complex (right side; blue arrows). EF-Tu delivers 
charged tRNA to decode the codon presenting in the A-site. After peptide-bond formation, the tRNAs adopt a hybrid state, 
and translocation is facilitated by EF-G. The ribosome continues in the elongation cycle until a stop codon presents itself in 
the A-site, which entails termination (left bottom corner; red arrows). RF1 or RF2 bind the stop codon and release the 
produced peptide from the P-site tRNA. Subsequently, RRF and EF-G bind and disassemble the 70S into 30S and 50S. A 
new translation cycle can begin. Figure on the basis of (Sohmen et al., 2009). 
 
Following the initiation, elongation factors (EF) Tu and G deliver the successive tRNAs to the 
ribosome and aid in the translocation of the tRNAs, respectively. Once a stop-codon presents 
itself in the A-site, the elongation cycle ends and the ribosome enters the process of 
translation termination. During regular translation termination, class I release factors (RF) 
recognise the stop-codon and subsequently mediate release of the finished polypeptide. There 
are three stop codons most commonly used in bacteria: UAA, UAG and UGA, also known as 
ochre, amber and opal, respectively. Conversely to the start codon, stop codon usage is 
correlated to the genomic GC content, with UAA being favoured by low-GC and UGA by 
high GC content bacteria (Rocha et al., 1999; Povolotskaya et al., 2012). Accordingly, in 
E. coli UAA makes up 63% of all stop codons, followed by UGA with 29%. UAG represents 
merely 8% of all stop codons and has, in a minority of archaea and bacteria, even been 
remodelled to code for a novel amino acid, pyrrolysine (Ambrogelly et al., 2007; Tharp et al., 
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2018). As such, the amber stop codon has been alienated and exploited to encode non-
standard or non-canonical amino acids in both bacteria and eukaryotes (Wang, 2017; Kato, 
2019). This has opened the field to practical applications, such as fluorescent tagging of target 
proteins, stabilising proteins and interactions for subsequent structure analysis by native 
cross-linking, or improving recombinant expression of eukaryotic proteins in E. coli by 
encoding eukaryotic specific post-translational modifications (Liu & Schultz, 2010). 
After translation termination, EF-G, in interplay with the ribosome recycling factor (RRF), 
split the 70S ribosome into its subunits, and IF3 disengages the remaining tRNA and mRNA 
from the 30S. A new translation cycle can then commence. 
Like ribosome assembly, translation takes place co-transcriptionally in bacteria. This is partly 
facilitated by interaction between a ribosome and RNAP, either by direct 30S and RNAP 
interaction (Kohler et al., 2017) or indirect via uS10 and NusG, which binds to RNAP 
(Burmann et al., 2010). This complex of ribosome and RNAP has been named expressome. 
Analysis of cryo Electron Tomography (cryo-ET) of Mycoplasma pneumoniae cells estimates 
that 2.8% of all ribosomes reside within an expressome and shows NusA forming a bridge 
between RNAP and 30S (O'Reilly et al., 2020). It has been suggested that interaction between 
the ribosome and RNAP decreases drop-off rates of RNAP and ensures transcription of the 
entire reading frame (Conn et al., 2019). However, this interaction has been challenged to 
occur only stochastically (Chen & Fredrick, 2020), for instance when RNAP is transcribing 
slowly and the ribosomes reach the end of the transcript. 
Translation speed in bacteria generally ranges from 4-20 amino acids per second (Sørensen & 
Pedersen, 1991; Proshkin et al., 2010; Zhu et al., 2016). Translation velocity is impacted by 
the encoded gene, either through rare codon usage or positively charged amino acids like 
arginine or lysine, which can interact with the ribosomal exit tunnel (Lu & Deutsch, 2008; 
Dimitrova et al., 2009; Requião et al., 2016). Occasionally the ribosome can encounter amino 
acid sequences, which form secondary structures within the tunnel and lead to ribosome 
stalling (Sohmen et al., 2015; Su et al., 2017). For the specific poly-proline staller sequence 
PPP, elongation factor P (EF-P) can rescue translation by stabilising the P-site tRNA to allow 
peptide bond formation and ribosomes to resume elongation (Ude et al., 2013; Huter et al., 
2017a). 
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1.3.1. Initiation 
Translation initiation describes the process of recruitment of mRNA and the fMet-tRNAfMet to 
the 30S. It marks the assembly of a 30S initiation complex (30SIC), which progresses to a 
70SIC and ultimately forms an elongation competent complex. 
At a last maturation checkpoint, the ribosome biogenesis factor RbfA can be displaced from 
mature 30S subunits by IF3, predominantly in the stationary phase and under starvation 
conditions (Sharma & Woodson, 2020). Release does not take place from immature 30S 
particles, ensuring only functional particle proceed to the translation cycle. IF3 binds in the 
E−site of the 30S with its C-terminal domain (CTD), and upon initial binding probes the P-
site for mRNA with its N-terminal domain (NTD) (Hussain et al., 2016) (Fig. 4A), to 
safeguard correct positioning of the start codon in the P-site (La Teana et al., 1995). Joining of 
the mRNA is independent of initiation factor or tRNA binding (Milon & Rodnina, 2012). A 
rotation and upward movement of the head opens the mRNA channel, possibly to facilitating 
mRNA binding and positioning (Hussain et al., 2016). Subsequent positioning of the start 
codon in the P-site is assisted by helix formation between the Shine-Dalgarno contained in the 
mRNA and anti-Shine-Dalgarno sequence in the 3’ of the 16S rRNA (Shine & Dalgarno, 
1974). Initiation can occur at correct sites in the absence of the anti-SD, albeit significantly 
less efficiently (Sussman et al., 1996; Saito et al., 2020). 
IF2 is a GTPase and comprises a G-domain within its N-terminal domain (NTD) and recruits 
formlyated initiator fMet-tRNAfMet to the P-site with domain IV in its CTD (Milon et al., 
2010). fMet-tRNAfMet is not only discernible by IF2 because of the formyl modification, but 
also due to an exceptionally GC-rich anticodon stem (Roy et al., 2018). In vitro, binding of 
IF3 and IF2 occur independently of one another and without hierarchical restrictions (Milon 
& Rodnina, 2012). The last and smallest factor, IF1, only joins after IF2 or IF3 binding. It 
binds in the A-site (Fig. 4B) and stabilises IF2 and increases initiation fidelity (Hartz et al., 
1989; Antoun et al., 2006; Milon & Rodnina, 2012). 
After fMet-tRNAfMet recruitment, IF3 samples correct codon–anticodon interaction (Meinnel 
et al., 1999). It undergoes conformational changes throughout the initiation complex 
formation in order to fulfil multiple functions (Hussain et al., 2016) (Fig. 4A-C). The NTD 
moves upon tRNA binding to interact with the tRNA elbow (Fig. 4B). Once the codon-
anticodon pairing is stable, the complex progresses from the 30SPIC (pre-initiation complex) 
to the 30SIC. Accommodation of the tRNA leads to conformational changes and displacement 
of the IF3 CTD (Fig. 4C), weakening IF3 binding to the 30S (Hussain et al., 2016).  
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Figure 4: The translation initiation process in bacteria. (A-C) View onto the 30S (yellow) subunit interface. (A) The CTD 
of IF3 (purple) interacts with the mRNA (red) in the P-site and ensures correct positioning of the start codon. (B) IF1 (cyan) 
binds in the A-site. Upon tRNA (limegreen) binding, the NTD of IF3 moves substantially to interact with the elbow region of 
the tRNA. (C) IF2 (blue) binds on the body, close to the A-site and recognises the fMet with its CTD. Correct codon–
anticodon interaction disengages the CTD of IF3. (D) Transitioning from the 30SIC to the 70SIC, domain IV of IF2 moves 
10 Å (blue vs. light blue) and slight movement in the tRNA (green vs. dark green) can be observed. Figures (A-C) based on 
PDBs from Hussain et al., 2016, and (D) on Kaledhonkar et al., 2019. 
 
Subsequent dissociation of IF3 allows 50S subunit joining for 70SIC formation. IF1 
dissociates early during SU joining and allows formation of the critical B2a intersubunit 
bridge (Kaledhonkar et al., 2019). fMet-tRNAfMet adopts different conformations throughout 
the initiation complex formation, and upon 50S binding, the elbow moves 11 Å to switch 
from interactions with uL1 to interactions with the CP (Sprink et al., 2016). The IF2 CTD 
moves 10 Å to enable accommodation of the 50S (Fig. 4D). Through subunit joining, IF2 
comes in contact with the Sarcin-Ricin-Loop (SRL) in the 23S rRNA and the GTPase-
associated centre (GAC) including bL12, which triggers GTP hydrolysis (Qin et al., 2009). 
Subsequent conformational changes and Pi release lead to IF2 dissociation and allow the 
initiator tRNA to accommodate from the P/I to the P/P state. The 70S elongation complex 
(70SEC) is thus formed (Kaledhonkar et al., 2019). 
1.3.2. Elongation 
After IF1 and IF2 release from the 70S initiation complex, the A-site becomes available for a 
new tRNA. Divergent to the initiator tRNA being recruited by already bound IF2 (Milon et al., 
2010), during the elongation phase the aminoacylated tRNA is delivered to the ribosome in a 
tertiary complex with the EF-Tu (elongation factor thermo-unstable) and GTP, or in a 
quaternary complex including the EF-Tu guanine exchange factor (GEF) EF-Ts (Burnett et al., 
2014). Recruitment of the EF-Tu–tRNA complex is facilitated by the bL12 stalk (Dey et al., 
1995; Savelsbergh et al., 2000b; Kothe et al., 2004; Diaconu et al., 2005; Helgstrand et al., 
2007). The majority of EF-Tu co-localizes with ribosomes as shown by single molecule 
fluorescent microscopy (Mustafi & Weisshaar, 2018). Upon binding of the ternary complex, 
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the A-site is sampled by the tRNA. The delivered tRNA anti-codon can either be cognate (all 
three bases match), near-cognate (one base does not match) or non-cognate (only one or no 
bases match). Incorporation of the amino acid corresponding to the codon is critical for 
correct protein composition. Accordingly, several checkpoints are applied during decoding: 
the first safety measure for a continuous elongation cycle is the discrimination against 
deacylated tRNA by EF-Tu. EF-Tu forms several hydrogen bonds with the 3’-aminoacyl bond 
through residues in its domain II, which accommodates the CCA-end (Nissen et al., 1996). 
Once EF-Tu delivers a charged tRNA to the ribosome two further checkpoints have to be 
passed, which are initial selection and proofreading (Ieong et al., 2016). The initial selection 
discriminates between non- and near-/cognate tRNAs, and non-cognate are quickly rejected 
(Rodnina et al., 2017; Kavaliauskas et al., 2018). Already in this step, the ratio of selection of 
a near-cognate versus a cognate tRNA is 1:6, and proofreading increases specificity again, 
permitting only one in 24 (Blanchard et al., 2004). After accommodation of the correct tRNA, 
the growing peptide chain is transferred from the P-site tRNA to the A-site tRNA and thus the 
nascent peptide chain elongated by one amino acid. Following peptide bond formation, EF-G 
binds to the ribosome to accelerate translocation of the tRNAs from the A- and P- to the P- 
and E-site, respectively (Ling & Ermolenko, 2016; Noller et al., 2017). While E-site tRNA 
dissociates, only the P-site tRNA remains and the A-site is unoccupied. It can be sampled for 
a new round of decoding. 
 
Decoding. When EF-Tu delivers a tRNA to the A-site, the tRNA adopts an A/T-state; its anti-
codon stem-loop (ASL) is placed in the A-site to interact with the mRNA, whereas the 
acceptor stem is tilted and interacting with EF-Tu. The decoding centre in the 16S rRNA, 
comprising G530, A1492 and A1493, monitors base-pairing between the anticodon of the 
tRNA and the codon in the mRNA (Ogle et al., 2001; Loveland et al., 2020). If no interactions 
develop, near- or non-cognate tRNAs are discarded in the initial screening and the ternary 
complex dissociates (Morse et al., 2020). This process repeats until a cognate tRNA is 
delivered, and base-pairing between mRNA and tRNA takes place. A1493 interacts with the 
minor groove of the codon-anticodon helix to screen base-pairing of the first nucleotide in the 
triplet (Loveland et al., 2017). G530 flips into an anti-position and first stabilises the 
backbone of the helix at the second nucleotide. This omits screening of the third base-pair, 
thus permitting wobble base-pairing. In case of cognate and near-cognate tRNAs, G530 shifts 
deeper into the tRNA-mRNA helix, A1492 flips out and establishes hydrogen bonds with 
G530. This brings the shoulder (G530) and body (A1492) into closer contact, and the 30S 
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accommodates a closed conformation (Ogle et al., 2002; Schmeing et al., 2009). This shift in 
the shoulder causes the GTPase domain of EF-Tu to dock onto the SRL, which triggers GTP 
hydrolysis (Loveland et al., 2017; Loveland et al., 2020). Docking to the SRL is essential for 
GTP hydrolysis, as mutation of the SRL has adverse effects on accommodation and EF-Tu 
release (Hausner et al., 1987; Bilgin & Ehrenberg, 1994; Blanchard et al., 2004; García-
Ortega et al., 2010). Hydrolysis inducing domain closure occurs significantly faster for 
cognate than for near-cognate, and not at all for non-cognate tRNAs (Pape et al., 1999; 
Blanchard et al., 2004; Morse et al., 2020). 
Upon GTP hydrolysis, switch I in domain I of EF-Tu undergoes substantial conformational 
changes. Switch I transforms from an α-helical structure to a β-sheet, guiding the CCA-end 
away from EF-Tu (Girodat et al., 2020). Consequently, switch I no longer interacts with the 
tRNA, and can adopt a conformation incompatible with tRNA interaction. Additionally, 
domain I rotates by 90° away from domain II, as shown by recent cryo-EM data (Loveland et 
al., 2020). Destabilisation of domain I leads to the release of the CCA-end of the tRNA from 
domain II, prompting accommodation of the A/T-tRNA. Domain III is the last to dissociate 
from the ribosome during the process of accommodation, indicating that an EF-Tu 
independent proof-reading step takes place (Loveland et al., 2020). This is consistent with 
smFRET data showing that EF-Tu dissociates before the tRNA is fully accommodated in the 
PTC (Morse et al., 2020). The A-site tRNA has to move through an accommodation corridor 
to position its CCA end in the PTC. However, the corridor does not allow free movement and 
is occluded by 23S rRNA (Whitford et al., 2010; Loveland et al., 2020). Therefore, to enable 
movement, the accommodation of the tRNA elbow takes place first, and in combination with 
minor rotation of the 30S allows the acceptor stem to bypass the obstacles (Loveland et al., 
2020; Morse et al., 2020). Consequently, EF-Tu dissociation is delayed when accommodation 
of the elbow is obstructed (Morse et al., 2020). Interestingly, if accommodation into the PTC 
is blocked by antibiotics, or because a near-cognate tRNA fails the last steps of proofreading, 
EF-Tu can repeatedly bind and form a ternary complex on the ribosome to retrieve tRNAs 
(Morse et al., 2020). 
EF-Tu dissociates in a GDP-conformation from the ribosome and relies on EF-Ts (Elongation 
factor thermo-stable) as a GEF to be recharged with GTP (Gromadski et al., 2002; Thirup et 
al., 2015). Accommodation of the A-site tRNA on the ribosome permits the next step: transfer 
of the P-site tRNA peptide chain to the A-site. 
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Peptide bond formation. Stable accommodation of the tRNAs is ensured via interactions 
with the 23S rRNA located at the PTC. G2251 in the P-loop and G2553 in the A-loop base-
pairing with the C75 of the P- and A-site tRNAs, respectively (Samaha et al., 1995; Kim & 
Green, 1999). Once the new tRNA has fully accommodated in the A-site, and the 
aminoacylated CAA-end localises to the PTC, peptide bond formation can take place. The 
accommodation of A-site tRNA leads to conformational changes of the ribosomal RNA in the 
PTC. Nucleotides U2585 and A2505 move to an induced state, and position the P-site tRNA 
for the following peptide bond formation (Schmeing et al., 2005b). Failure to accommodate 
the A-site accurately leaves the nucleotides in an uninduced state, simultaneously preventing 
peptide bond formation and protecting the peptidyl tRNA from spontaneous hydrolysis. 
The α-amine of the A-site amino acid catalyses a nucleophilic attack on the carbonyl carbon 
of the P-site amino acid (Fig. 5A), consequently breaking the ester bond between the amino 
acid and A76 of the P-site tRNA and attaching the carbonyl carbon to the α-amine of the A-
site; therefore, the growing peptide chain is transferred to the A-site and leaves the P-site 
deacetylated (Fig. 5B). As the 3’-O of the P-site tRNA is too far away from the attacking α-
amine, a direct proton transfer is not possible. The precise mechanism of proton transfer is yet 
to be determined; nevertheless, some important components have been identified (Fig. 5C). 
The 2’-OH of the P-site tRNA A76 is crucial for peptide bond formation, as substitution of 
the oxygen with hydrogen or fluorine substantially stunts the reaction (Weinger et al., 2004; 
Zaher et al., 2011). Structure analysis showed hydrogen bonding between the attacking α-
amine and 2’-OH (Schmeing et al., 2005a; Polikanov et al., 2014). Additionally, the 2’-OH 
group of A2541 of it is crucial for peptide bond formation (Erlacher et al., 2006; Lang et al., 
2008). Accordingly, mutation of the nucleobase at this position does not affect peptide bond 
formation, which long concealed the function of its contribution. During peptide bond 
formation, a concerted movement of protons takes place and a tetrahedral intermediate is 
formed (Fig. 5C). However, the exact process is still unknown, and two mechanisms have 
been proposed: the proton-wire and a proton-shuttle (Fig. 5D, E). The proton wire suggests 
that the proton movement starts at the N-terminal end of bL27, which is about 10 Å from the 
attacking α-amino group (Polikanov et al., 2014). Deprotonation of this N-terminus, in 
combination with the negative charge of the phosphate backbone of A76 in the A-site, 
exercises attraction on the protons of a water molecule (W1) in their proximity (Fig. 5D). This 
water forms a proton-wire with the 2’-OH of both the P-site A76 and A2451, inducing 
deprotonation of the attacking α-amine. While a second water molecule (W2) stabilises the 
temporarily negatively charged tetrahedral intermediate at the carbonyl oxygen, another water 
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molecule (W3) (Fig. 5D) assists in protonation of the 3’-O of the P-site tRNA, and finally 
facilitating transfer of the peptidyl chain onto the A-site tRNA. In the eight-membered proton-
shuttle mechanism (Fig. 5E), on the other hand, only W3 contributes to the peptide bond 
formation (Schmeing et al., 2005a; Wallin & Aqvist, 2010). Calculation of activation energies, 
consistent with biochemical experiments, have suggested the proton shuttle could be 
supported by an additional magnesium (Świderek et al., 2015), or an additional water leading 
to a ten-membered proton shuttle (Kazemi et al., 2018). 
 
 
Figure 5: Structural analysis of peptide bond formation. (A, B, D, E) Chemical 2D structures of the peptide bond 
formation process (A) Peptide bond formation is initiated via a nucleophilic attack of the A-site tRNA α-amine on the P-site 
carbonyl carbon (B) After successful reaction, the methionine is transferred to the A-site, and the P-site tRNA is deacylated. 
(C) 3D crystal structure (based on PDB 1VYA from Polikanov et al., 2014) of a pre-attack complex: both proton shuttle and 
proton wire rely on a water molecule (W3) aiding in the proton transfer. A tetrahedral intermediate (presented by dashes) is 
formed during the attack of the A-site tRNA (orange) α-amine on the P-site (lime). (C, D) In the proton wire mechanism, 
another water molecule (W1, olive green) is coordinated by bL27 and the 2’OH of A2451. (D) The proton wire (blue arrows) 
suggests the N-terminus of bL27 and the phosphate backbone of A76 of the P-site tRNA promote a partially negatively 
charged water molecule W1 (olive). After nucleophilic attack, the proton is guided back via W3 (green) and 2’-OH to W1. 
(E) The proton shuttle suggests a similar path, however the proton is transferred back to the attacking amine. 
 
The role of bL27 in the peptide bond formation is still controversial; some researchers have 
determined it dispensable for peptide bond formation, consistent with the proton shuttle 
mechanism (Maracci et al., 2015), while others found the absence of it to have an adverse 
effect, albeit a limited one (Wower et al., 1998; Maguire et al., 2005; Trobro & Aqvist, 2008; 
Voorhees et al., 2009). 
Further research is required to determine if either one of these mechanisms is accurate, as 
neither one is fully consistent with the existing literature. Additionally, neither proposed 
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mechanism resolves the question of initial deprotonation of the A-site NH3+, which is 
necessary for the nucleophilic attack. Conceivably, the precise mechanism can only be 
elucidated if this crucial step is taken into account. 
 
Translocation. After transfer of the peptidyl-moiety to the A-site tRNA, the deacetylated P-
site tRNA enhances formation of tRNA hybrid states (Moazed & Noller, 1989; Julián et al., 
2008). The deacetylated P-site tRNA adopts a P/E hybrid state, in which the ASL stays stably 
bound to the mRNA codon in the P-site, whereas the CCA-end on the large subunit tilts 
towards the E-site. The uL1 stalk adopts a closed conformation to interact with the P/E-tRNA 
and stabilises the hybrid state (Munro et al., 2007). Likewise, the A-site tRNA adopts an A/P 
hybrid state. The majority of this initial shift in the tRNAs is coupled (Munro et al., 2007), 
and leads to an unlocking of the 70S ribosome, meaning movement of the large and the small 
subunit are no longer coupled to one another (Valle et al., 2003). The 30S body and platform 
rotate 7° counter clockwise (CCW) relative to the 50S, from a classical non-rotated to a 
rotated hybrid state (Frank & Agrawal, 2000; Ratje et al., 2010). Like the tRNA hybrid state, 
subunit rotation is essential for translocation (Horan & Noller, 2007). This movement occurs 
spontaneously and is also described to be ratchet-like as the ribosome repeatedly rotates back 
and forth. This rotation facilitates binding of EF-G, which has a high affinity to the rotated 
state. Binding of EF-G both promotes and stabilises the small subunit in the rotated state 
(Spiegel et al., 2007; Cornish et al., 2008; Belardinelli et al., 2016). Translocation can occur 
in the absence of EF-G, however, it proceeds up to 100 times slower (Bergemann & Nierhaus, 
1983; Katunin et al., 2002; Munro et al., 2010). EF-G is suggested to couple tRNA and 
mRNA movement (Zhou et al., 2019), as translocation in its absence is more prone to frame 
shifting (Peng et al., 2019). Additionally, EF-G can facilitate sliding along stretches of 
noncoding mRNA using multiple rounds of GTP-hydrolysis (Klimova et al., 2019). Aside 
from translocation, EF-G is also necessary for ribosome splitting at the end of the translation 
cycle. 
EF-G establishes multiple interactions with the ribosome upon binding (Fig. 6A). Domain I 
(G-domain) contacts the GAC, involving bL12 as well as the SRL (Helgstrand et al., 2007; 
Pulk & Cate, 2013; Carlson et al., 2017). Both interactions are important for GTP-hydrolysis 
of EF-G (Savelsbergh et al., 2005; García-Ortega et al., 2010; Carlson et al., 2017). A2662 in 
the SRL positions the catalytically active H92 in switch II to coordinate the water for GTP 
hydrolysis. Domain II establishes stacking interactions with the 16S of the body, whereas 
domain III predominantly interacts with uS12 (Fig. 6A). Domain IV is flexible, and inserts 
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itself into the decoding centre on the small subunit, mimicking a tRNA in the A/T state and 
(Fig. 6) (Gao et al., 2009; Ratje et al., 2010; Pulk & Cate, 2013; Ramrath et al., 2013). 
Furthermore is domain IV crucial for translocation (Savelsbergh et al., 2000a; Holtkamp et al., 
2014a; Liu et al., 2014b), and restricting its freedom of movement impairs translocation 
(Peske et al., 2000). Loop I and II in the tip of domain IV establish contacts with the decoding 
centre, as well as the A-site tRNA (Zhou et al., 2014; Zhou et al., 2019). Consequently, EF-G 
promotes a head swivel, a rotation 18° relative to the body, and stabilises this conformation 
(Ratje et al., 2010; Belardinelli et al., 2016). 
 
 
Figure 6: EF-G mimics the ternary complex of EF-Tu and tRNA. (A) During translocation, EF-G (blue) establishes 
contacts with the SRL in the 23S rRNA, uS12 ins the body (green, only soluble surface shown), as well as the DC and A/P 
tRNA (orange) with domain IV (Zhou et al., 2014). (B) EF-Tu (teal) delivers a tRNA (orange) to an elongating ribosome 
with a P-site tRNA (limegreen) for decoding (Loveland et al., 2020). 
 
GTP-hydrolysis takes place shortly after EF-G binding. Conversely, Pi release from EF-G 
does not happen directly after hydrolysis (Savelsbergh et al., 2003). It does, however, induce 
major conformational changes in EF-G. Switch I locks the GTP in its binding pocket, and 
upon hydrolysis, switch I changes from an ordered to disordered conformation (Gao et al., 
2009; Ticu et al., 2009). This leads to disruption of a hydrophobic pocket created by a 
multitude of interactions between switch I/II, domain II and III (Pulk & Cate, 2013). Domain 
II and III move apart and subsequently destabilise EF-G on the ribosome (Gao et al., 2009). 
Conformational changes in EF-G are coupled to the ribosome and cause a back-rotation of the 
body (Gao et al., 2009; Munro et al., 2010).  
Translocation of the tRNAs is guided by interactions of the ASLs with the head and during 
translocation, intermediate chimeric hybrid states constituting ap/P- and pe/E-tRNA are 
formed (Ramrath et al., 2013; Zhou et al., 2013; Zhou et al., 2014). In particular, the ASLs 
form interactions with the head corresponding to the A- or P-site, and simultaneously interacts 
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with the P- or E-site on the body, as denoted by the first letter (a or p) and the second letter (p 
or e), respectively. These rigid interactions between ASL and 16S rRNA couple movement of 
the head to that of the tRNAs (Ramrath et al., 2013). The opposed head swivel and back-
ratcheting of the body (Belardinelli et al., 2016) allow translocation of the mRNA by one 
codon and the tRNAs to adopt a classic E/E and P/P state. Only after translocation is 
completed will EF-G dissociate from the ribosome, concomitantly with further back rotation 
of head and body, and followed by dissociation of E-site tRNA (Spiegel et al., 2007; 
Belardinelli et al., 2016). Once off the ribosome, cytosolic EF-G exchanges GDP to GTP, and 
is ready for a new round of translocation. The 30S adopts a classic non-rotated POST-
translocational state with only a peptidyl-tRNA in the P-site. A new codon presents itself in 
the A-site for a new cycle of elongation.  
The exact mechanism by which translocation occurs is still debated. Early research suggested 
that EF-G breaks interactions of the DC and the codon-anticodon duplex (Ratje et al., 2010). 
Subsequently the latch formed by h34 in the head and the G530 region is opened, thus 
unlocking the movement of the 30S head and body and facilitating Brownian motion driven 
translocation uncoupled from the ribosome, while guiding the A-site tRNA by constant 
contact. Another proposed mechanism is that EF-G actively pushes the tRNA-mRNA 
complex through the ribosome. During GTP hydrolysis, a measurable mechanical force is 
released (Yao et al., 2013; Chen et al., 2016; Yin et al., 2019). This active movement has been 
termed a power-stroke and depends on the free movement of domain IV (Yin et al., 2019). 
This is consistent with X-ray structures showing EF-G in a compacted conformation, 
suggesting that domain IV moves by 100 Å and rotates 90° for performance (Lin et al., 2015; 
Zhou et al., 2020). However, these structures were achieved by linking EF-G to bL9 and thus 
during crystal formation was forced to bind to the neighbouring ribosome, thus raising the 
question as to whether this conformation occurs on the ribosome under more physiological 
conditions. 
Likely, EF-G-facilitates translocation in a combination of Brownian movement and power 
stroke (Holtkamp et al., 2014b). Time resolved cryo-EM has become an increasingly more 
reliable method for differentiating the many individual states of each step in the translation, 
such as initiation (Kaledhonkar et al., 2019), decoding (Loveland et al., 2020) and recycling 
(Fu et al., 2019). Application of this method to translocation could give valuable insights and 
further understanding to the exact mechanism, which is utilized by EF−G to facilitate 
translocation. 
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1.3.3. Termination 
When the ribosome has successfully translated a given mRNA, a stop codon in the A-site 
marks the end of the open reading frame (ORF). This codon is not recognised by tRNAs, but 
rather by the class I release factors RF1 and RF2. They differ in stop codon recognition, 
which makes both essential to a functioning translation cycle. UAA presents the most 
commonly used stop codon in E. coli (Rocha et al., 1999), and is accordingly recognised by 
both release factors, whereas UAG is only recognised by RF1 and UGA by RF2 (Scolnick et 
al., 1968). Remarkably, substituting all UAG codons in E. coli for UAA, has rendered RF1 
dispensable for cell survival (Amiram et al., 2015). The codon discrimination between the two 
factors originates in conserved but divergent recognition sequences, PVT and SPF for RF1 
and RF2, respectively (Ito et al., 2000; Zhou et al., 2012). Both factors interact with U1 of the 
stop codon via the adjacent backbone of the α5 helix in domain II, and interact with the third 
nucleotide via a threonine. The threonine in the RF1 PVT motif interacts with both U1 and A2, 
thus discriminating against G2 (Laurberg et al., 2008). Conversely, the serine in the SPF motif 
likely interacts solely with the nucleotide at the second position, allowing either A2 or G2. 
Additionally, a glutamine facilitating G3 binding in RF1 is substituted with a hydrophobic 
valine in RF2, which aids in active discrimination against G3 (Korostelev et al., 2008). 
RF1/2 initially bind to the ribosome in a compacted conformation, and upon accommodation, 
i.e. stable interaction with the stop codon, domain III extends to the PTC (Petry et al., 2005). 
Domain III holds the conserved and for peptide release essential GGQ motif (Zavialov et al., 
2002; Mora et al., 2003), and the conformational change accommodates the GGQ motif in the 
PTC. The two glycines are crucial for forming the loop inserting into the PTC, as a GAQ 
mutation slows the reaction by a few orders of magnitude (Zavialov et al., 2002). Furthermore, 
the glutamine residue carries a conserved methylation, which increases peptide release 
efficiency (Dincbas-Renqvist et al., 2000; Mora et al., 2007). Surprisingly, substitution of the 
glutamine side chain has a marginal effect on peptide release (Mora et al., 2003): the 
backbone amide, rather than the side chain amide, is in hydrogen bond distance with the 3’ 
ester bond of the A76 and stabilises reaction intermediates. Similarly to peptide bond 
formation, a nucleophilic attack is carried out by a water molecule. Again, a tetrahedral 
intermediate is formed, in which the 2’OH of the A76 of the tRNA functions once more as a 
proton shuttle (Trobro & Aqvist, 2009; Jin et al., 2010; Kuhlenkoetter et al., 2011). 
After peptide release has been completed by RF1/2, the class II release factor RF3 facilitates 
release of RF1/2 (Freistroffer et al., 1997; Koutmou et al., 2014). Recent findings suggest it 
does so by inducing a rotated state of the ribosome, which leads to RF1/2 release (Graf et al., 
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2018). While the ribosome can adopt a rotated state spontaneously in the absence of RF3, 70S 
bound to RF2 are more likely to be rotated than those bound to RF1 (Adio et al., 2018). Albeit 
the difference and ratio of rotated to non-rotated is minimal, this leads to a decreased 
dependency of RF2 on RF3-mediated release. 
Divergent to initial findings, does binding of RF3 to the ribosome not depend on a deacylated 
P-site tRNA (Peske et al., 2014), it was suggested that its GTPase activity is not necessary for 
RF release (Adio et al., 2018). Rather, GTP hydrolysis appears to be a mechanism to 
disengage RF3 from the ribosome. After the release factors dissociate, a deacylated P/E-site 
tRNA and the mRNA remain bound to the post termination complex (PoTC).  
1.3.4. Recycling 
The last phase in a translation cycle is the dissociation of ribosomal subunits and dislodging 
of the remaining tRNA and mRNA. This step is called recycling, as the ribosome can 
consequently be reused for a new round of translation. Recycling is carried out by three 
factors: EF-G, the ribosome recycling factor RRF, and IF3 (Karimi et al., 1999). Concerted 
action of EF-G and RRF split the ribosome into its subunits (Ito et al., 2002; Zavialov et al., 
2005), whereas IF3 dissociates the remaining tRNA (Karimi et al., 1999; Prabhakar et al., 
2017). 
RRF plays an indispensable part in ribosome recycling. Depletion in the exponential phase 
shows a bacteriostatic effect, as it leads to re-initiation at downstream ORFs and consequently 
ribosomes are incapable of initiating at new mRNAs (Janosi et al., 1998). RRF consists of 
only two domains, a three-helix bundle and a small globular like domain, which are connected 
by extremely flexible hinges (Toyoda et al., 2000). Initial theories for the splitting mechanism 
suggested that RRF acts as a tRNA mimic and is translocated to the P-site, which in turn 
translocates the P/E-tRNA into the E-site, where it finally dissociates (Hirokawa et al., 2002). 
In contrast, X-ray crystallography and cryo-EM studies on the RRF-70S/50S complex showed 
that RRF does not act a tRNA mimic (Wilson et al., 2005; Gao et al., 2007; Fu et al., 2016). 
Rather, domain I extends toward the PTC and interacts with the 23S rRNA at the P-loop, 
whereas domain II interacts with uS12 and, together with the hinge region, with domain IV of 
EF-G. Furthermore, while GTP hydrolysis is necessary for splitting (Hirokawa et al., 2008; 
Savelsbergh et al., 2009; Prabhakar et al., 2017), EF-G mutants deficient in translocation were 
still functional in ribosome recycling (Fujiwara et al., 2004). 
Binding of RRF to the PoTC at the A-site stabilises the ribosome in a rotated state (Prabhakar 
et al., 2017). Only binding of RRF prior to EF-G association can lead to successful 
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disassembly, as EF-G alone will simply dissociate after GTP-hydrolysis. Conversely, the 
disassembly is rate-limited by EF-G, as even high RRF concentrations cannot increase 
disassembly speed at low EF-G concentrations (Borg et al., 2016a; Prabhakar et al., 2017). 
Currently, the proposed mechanism is that domain IV of EF-G induces a rotation of RRF 
domain II, which pushes it, like a wedge, between H69 and h44, disrupting the central B2a 
intersubunit bridge (Wilson et al., 2005; Pai et al., 2008; Fu et al., 2016; Zhou et al., 2020). 
Consequently, the interactions between the subunits are destabilised, ultimately leading to 
dissociation into 50S and a 30S-tRNA-mRNA complex and release of RRF and EF-G. 
Subsequently, IF3 binds to the 30S and dissociates the tRNA (Karimi et al., 1999; Prabhakar 
et al., 2017). Binding of IF3 is necessary for this last step in ribosome recycling, as in its 
absence, the ribosome will reassemble (Hirokawa et al., 2005; Prabhakar et al., 2017). 
Although the exact mechanism by which the mRNA disengages from the 30S remains to be 
elucidated, the mRNA dissociates only after the tRNA. Ultimately, the subunits are ready for 
a new round of translation. 
 
1.4.  The stringent response 
In order to adapt to environmental changes, bacteria have developed the so-called stringent 
response (Cashel & Gallant, 1969; Hauryliuk et al., 2015; Irving & Corrigan, 2018). It is 
triggered by increased amounts of uncharged tRNAs and is promoted by two secondary 
metabolites, pppGpp and ppGpp (Haseltine & Block, 1973; Sprinzl & Richter, 1976). Also 
known as alarmones, these metabolites are produced by RSH (RelA/SpoT homologue) type 
proteins. They impact and modulate a multitude of processes within the cell, like transcription, 
translation and DNA replication. Furthermore, increasing evidence reveals that the stringent 
response is also involved for antibiotic resistance, for instance by inducing formation of so 
called persister cells (Maisonneuve & Gerdes, 2014). 
Alarmone-producing proteins are conserved across all bacteria and also plants (Atkinson et al., 
2011; Jimmy et al., 2020). Alarmones are generated by transfer of a pyrophosphate from ATP 
to the 3’-OH of either GTP or GDP. Notably, the 2’-OH of the accepting nucleotide plays a 
pivotal role during this process (Patil et al., 2020). Upon induced amino acid starvation, GTP 
and GDP concentrations drop from 755 µM and 306 µM to about half their concentrations 
under optimal conditions, whereas their alarmone counterparts rise to ~800 and 500 µM 
(Varik et al., 2017; Zborníková et al., 2019). 
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RSH-type proteins are ~70 kDa multi-domain proteins, comprising both a SYN (Synthetase) 
as well as a HD (Hydrolase) domain in the N-terminus. Additionally, the C-terminal domain 
interacts with the deacylated tRNA (Jain et al., 2006; Arenz et al., 2016). Most bacteria 
possess a bifunctional Rel, whereas β- and γ proteobacteria possess a monofunctional RelA, 
which lacks hydrolysis activity despite an existing HD domain. Instead, in these bacteria 
SpoT compensates this deficiency. Inversely to RelA, it possesses only weak synthetase 
activity (Xiao et al., 1991). RSH-type proteins act in an autoregulatory manner by adopting an 
open or closed conformation, which brings the HD and SYN domain into contact and induces 
steric obstruction (Hogg et al., 2004; Tamman et al., 2020). 
Additionally to the long alarmone producing and degrading RSH-type proteins, in some 
bacteria also short variants exist (Atkinson et al., 2011; Jimmy et al., 2020). Depending if they 
consist of a hydrolase or a synthetase domain, they are called SAH or SAS (small alarmone 
hydrolase/synthetase), and they function in homo-multimer forms (Steinchen et al., 2015; 
Manav et al., 2018). 
While the principle of the stringent response is conserved in all bacteria, not all targets are. 
RNAP is directly targeted in E. coli (Zuo et al., 2013), while in the majority of other bacteria, 
the respective binding site is not present (Krásný & Gourse, 2004; Hauryliuk et al., 2015). 
Instead, according to current theory, alarmones inhibit GTP-dependent processes by depletion 
of the GTP/GDP pool. Furthermore, in Bacillus, a heat shock is also responsible for triggering 
stringent response (Schäfer et al., 2020). 
When nutrients and charged tRNAs become scarce, abundant protein production becomes 
counterproductive, and transcription is predominantly inhibited directly by restriction of 
RNAP activity (Sanchez-Vazquez et al., 2019). On the other hand, genes associated with 
biosynthesis, like amino acid or fatty acid, are upregulated. The stringent response further 
addresses protein synthesis by targeting various points in the translation cycle. First off, rRNA 
transcription from P1 is inhibited, although the different operons appear to be affected to 
varying degrees (Barker et al., 2001; Kolmsee et al., 2011). Simultaneously, ribosomal 
proteins are down-regulated, this however originates from the previously mentioned auto-
regulation (Burgos et al., 2017). Next to rRNA transcription, ribosome assembly becomes 
inhibited by binding of (p)ppGpp to assembly GTPases, like Era, Obg(E) or RbgA (Buglino et 
al., 2002; Feng et al., 2014; Corrigan et al., 2016). Binding of alarmones to the active site of 
RbgA inhibits conformational rearrangement necessary for hydrolysis (Pausch et al., 2018). 
This likely prevents RbgA dissociation after 50S maturation and inhibits subunit joining 
during the initiation step, similarly to Obg (Feng et al., 2014). Moreover, translation itself is 
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also obstructed by (p)ppGpp, by inhibiting the translation associated GTPases, namely IF2, 
EF-Tu, EF-G and RF3 (Kanjee et al., 2012). 
While alarmones are commonly addressed as (p)ppGpp, differentiating between the tetra- and 
penta-phosphate form is pivotal. pppGpp has been shown to still allow IF2 and EF-Tu to 
function in their respective purposes (Hamel & Cashel, 1974; Milon et al., 2006; Vinogradova 
et al., 2020), whereas ppGpp exhibits inhibitory effects similar to GDP (Rojas et al., 1984; 
Diez et al., 2020) and also inhibits RF3 function (Kihira et al., 2012). Conversely, EF-G 
function is inhibited by either the tetra- and penta-phosphate form (Hamel & Cashel, 1973). 
Importantly, select GTPases, like EF-Tu and IF2, are capable of hydrolysing pppGpp to 
ppGpp. Structural studies for these GTPases can give further insights into the mechanism by 
which alarmones inhibit one but not the other. 
1.5.  Antibiotics 
While human-kind has made great advances in the medical field in the last century, antibiotic 
resistances and especially resistance against last resort antibiotics is becoming more prevalent 
each day. The need for new antimicrobial agents has not decreased since the discovery and 
introduction of penicillin 80 years ago. In 2017, the World Health Organisation (WHO) 
released a list of priority pathogens, primarily consisting of Gram-negative bacteria, with A. 
baumanii, P. aeruginosa and Enterobacteriacea classified as critical (WHO, 2017); due to 
their outer membrane, Gram-negative bacteria possess a naturally increased resistance against 
antibiotics. M. tuberculosis was given the highest priority, as it leads to 1.8 million deaths 
annually. It possesses an additional outer layer consisting of mycolic acid, which enhances 
antibiotic resistance even more. Special antibiotics like ethambutol, inhibiting mycobacteria-
specific cell wall synthesis, are necessary for treatment (Schubert et al., 2017). 
Researchers are using different methods to tackle the increasingly difficult problem of 
antibiotic resistance (Vila et al., 2019). The most straightforward approach is to modify 
previously approved antibiotics in order to counteract resistance mechanisms, e.g. make them 
resistant against inactivating chemical modifications by the pathogens (Marschall et al., 2019). 
About 40% of currently investigated antibiotics are modified β-lactam antibiotics, and two of 
the most recent FDA (US Food and Drug Administration) approved Gram-negative targeting 
antibiotics – omadacycline and eravacycline – are tetracycline-derivatives (WHO, 2019a). 
Besides modification of known antibiotics, investigation of new compounds with novel and 
distinct targets to circumvent cross-resistance is a central aspect in combating antitbiotic 
resistance (Durand et al., 2019). Antimicrobial peptides (AMPs) are one class of such 
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compounds, that are being rediscovered and optimised. They originate from the innate 
immune and host defence system, and can be found mostly in higher eurkaryotic organisms, 
although they are in some form present in all domains (Ageitos et al., 2017). Currently, 27 
AMPs are in the pre-clinical pipeline (WHO, 2019b). The most prevalent mechanism of 
AMPs is membrane permeabilisation (Epand & Vogel, 1999; Brogden, 2005), and therefore 
also exerts an undesireable cytotoxic effects on humans. However, in recent years, advances 
have been made in the field, proline-rich AMPs (PrAMPs) which target the translation 
machinery, have been characterised (Scocchi et al., 2011; Graf et al., 2017) and shown 
promising results as improved AMPs with less cytotoxicity (Mardirossian et al., 2019). 
Moreover, many antimicrobial drugs have been originally discovered as secondary 
metabolites in bacteria, mainly the class of Gram-positive Actinobacteria, especially the order 
of Actinomycetales (Genilloud, 2017; Hutchings et al., 2019), and the order of Gram-negative 
Myxobacteria (Schaberle et al., 2014; Landwehr et al., 2016). As genome sequencing 
becomes more affordable and a standard approach, combined with bioinformatics tools and 
high-throughput screening assays to asses cytotoxicity or translation inhibition, a plethora of 
novel compounds are being discovered (Steele et al., 2019). Furthermore, assays screening for 
active molecules could in the future become less extensive, as algorithms are being trained to 
evaluate chemical properties and predict potential antimicrobial activity (Stokes et al., 2020). 
Additional to modification and discovery of novel compounds, understanding bacterial 
resistance mechanisms can give valuable insight and further points of action. For instance, 
resistance against β-lactam antibiotics is facilitated through degradation by β-lactamases. 
Indeed, it has become common to administer β-lactamase inhibitors like clavulanic acid in 
combination with β-lactam antibiotics (Huttner et al., 2020).  
1.5.1. Argyrins 
The family of argyrins has first been isolated from an Actinoplanes strain as antibiotics 
A21459 A and B (Ferrari et al., 1996; Selva et al., 1996). A few years later they were 
rediscovered in myxobacteria, Archangium gephyra Ar8082 and Cystobacter sp. SBCb004 
(Sasse et al., 2002; Vollbrecht et al., 2002). They were renamed argyrins A-H, where argyrin 
A and B correspond to antibiotics A21459 B and A, respectively, and represent the most 
dominant products (Pogorevc et al., 2019). The structures of argyrin A-H were solved by X-
ray and NMR and revealed a cyclic octa-peptide antibiotic (Fig. 7), consisting of D-alanine, 
glycine, one modified and one unmodified tryptophan, 2-(1'- aminoethyl)-thiazole-4-
carboxylic acid, sarcosine and dehydroalanine. In argyrin B, D and G the alanine is replaced 
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by D-α-aminobutyrate (Vollbrecht et al., 2002). The originally reported structure of argyrin A 
and B (Ferrari et al., 1996) had to be corrected as the methoxy modification in the second 
tryptophan moiety (R4) resides at the C4 and not at the C5. 
  
Figure 7: Chemical structure of the Argyrin family. The circular octapeptide antibiotics consist of one modified (Trp2) 
and one unmodified Tryptophane (Trp1), Aminoethyl-Thiazolecarboxylic acid (Thiaz), Sarcosine (Sarc), Dehydroalanine 
(Dha), and Alanine (Ala; R1 = H; Argyrin A, C, E, F and H) or α-aminobutyrate (Abu; R2 = CH3;  Argyrin B, D and G). 
 
As the argyrins consist of non-proteinogenic amino acids like D-amino acids and a thiazole-
ring, a non-ribosomal synthetic pathway had been presumed. While the chemical synthesis of 
several argyrins has been published (Ley et al., 2002; Bulow et al., 2010; Chen et al., 2014), 
the biosynthetic cluster from the producer strain was only discovered recently (Pogorevc et al., 
2019). Through scanning of the Cystobacter genome for homologues of previously identified 
non-ribosomal peptide synthetase (NRPS) genes, the argyrin biosynthetic gene cluster (arg 
BGC) was determined with a size of 33kbp and consisting of five genes, arg1-5. Arg2 and 
Arg3 represent the octamodular NRPS subunits 1 and 2, respectively. Together they generate 
the circular octapeptide, Arg2 starts synthesis with either an alanine or α-aminobutyrate 
determining R1, and Arg3 determines R2 by incorporating either alanine or serine. Arg1, 4 and 
5 have been identified as a SAM-dependent-methyltransferase, an O−methyltransferase and a 
tryptophan-dioxygenase, resulting in the methyl- (R3) and methoxy-modifications (R4) on the 
Trp2 moiety. 
Intriguingly, the argyrins show a high antimicrobial activity against a number of Gram-
negative bacteria (Selva et al., 1996; Sasse et al., 2002). Argyrin A and B showed high 
activity against Clostridium, Proteus, and an intermediate activity against Staphylococcus 
aureus as well as Pseudomonas aeruginosa and a hyperpermeable Salmonella strain (Selva et 
al., 1996). No activity could be detected against yeast. Specifically, argyrin A-E and H 
showed activity against Staphyloccocus and an Escherichia coli ΔtolC as well as 
Argyrin R1 R2 R3 R4 
A H CH3 H OCH3 
B CH3 CH3 H OCH3 
C H CH3 CH3 OCH3 
D CH3 CH3 CH3 OCH3 
E H CH3 H H 
F H CH2OH H OCH3 
G CH3 CH2OH H OCH3 
H H H H OCH3 
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Pseudomonas with IC50 values ranging from 0.08-1.4 µM (Sasse et al., 2002). Argyrin F and 
G carry a hydroxymethylgroup at R2 and have a substantially lower IC50 of 5 and 4 µM, 
respectively. 
Initial investigations into the mode of action showed that in vitro neither RNA nor DNA 
synthesis were affected by the antibiotics, but rather that bacterial poly-Phe synthesis was 
inhibited (Selva et al., 1996). Additionally, argyrin B was found to be a strong inhibitor of the 
autoimmune response and displayed a cytotoxic effect (Sasse et al., 2002). Due to the 
cytotoxic effect the possibility to use the argyrins as anti-cancer drugs was pursued in further 
research. Argyrin A was identified as a strong proteasome inhibitor, leading to stabilisation of 
the tumor-suppressor protein p27kip1 (Nickeleit et al., 2008). Further investigation showed that 
argyrin F is another potent candidate with anti-tumor activity, likewise inhibiting the 
proteasome (Bulow et al., 2010; Chen et al., 2017), as well as Argyrin B (Allardyce et al., 
2019). Computational analysis showed, however, that the different compounds have different 
proteasome subunit-specificities due different modifications (Stauch et al., 2010; Loizidou & 
Zeinalipour-Yazdi, 2014; Allardyce et al., 2019). 
Resistance mutation studies in P. aeruginosa lead to the identification of EF-G1 as the target 
for both argyrin A and B (Bielecki et al., 2012; Nyfeler et al., 2012). Resistance mutations 
identified a novel binding site in EF-G between domain III and V. Interacting residues are 
extremely conserved, and indeed also yeast and mammalian mitochondrial EF-G is targeted 
by argyrin B (Nyfeler et al., 2012). A crystal-structure of P. aeruginosa EF-G1 in complex 
with argyrin B showed that hydrogen bonds and van der Waals interactions are important for 
binding of the drug. EF-G adopts an elongated and previously not reported conformation, 
which is not compatible with binding to ribosomes. Concluding, it has been suggested that 
inhibition of binding of EF-G to the ribosome is the mechanism by which argyrins inhibit 
translation (Nyfeler et al., 2012). 
1.5.2. Tetracenomycins 
Similar to the argyrins, tetracenomycin C (TcmC) was first isolated 40 years ago from a strain 
belonging to the Actinomycetales, Streptomyces glaucescens GLA.0 (Weber et al., 1979). It 
showed activity mostly against other Streptomyces strains, as well as some other 
Actinobacteria like Corynebacterium and Brevibacterium. NMR analysis revealed a 
tetracyclic structure with two neighbouring benzene rings. The X-ray structure of TcmC was 
solved in 1992, giving the final stereochemistry of the A-ring (Fig. 8) (Egert et al., 1992).  
Introduction 29 
The biosynthetic cluster was identified, involving 12 genes (Motamedi et al., 1986). Extensive 
studies were undertaken to identify the role of each gene. The Polyketide synthase (PKS) 
genes tcmKLM were the first to be characterised as two keto-synthases and an acyl-carrier 
protein, respectively (Bibb et al., 1989; Gramajo et al., 1991). TcmN belongs to the PKS as 
well and is a bifunctional protein with a cyclase and an aromatase domain (Summers et al., 
1992). TcmI is the D-ring cyclase (Summers et al., 1993). TcmJ has a still unknown function, 
however in its absence there is drastic decrease in production of the PKS intermediate TcmF2 
(Bao et al., 1998). Concluding, TcmIJKLMN generate the tetracyclic scaffold, and 
TcmGHOP are responsible for modifications. Both TcmO and TcmP are O-
methyltransferases (Summers et al., 1992; Decker et al., 1993). TcmG hydroxylyses the 
scaffold at three positions (Shen & Hutchinson, 1994), and TcmH is a monooxygenase (Shen 
& Hutchinson, 1993). Expression of the tcm cluster occurs only in the stationary phase, likely 
to combat competing Streptomyces for scarce nutrients (Gramajo et al., 1991). 
tcmGHJKLMNO appears to be transcribed as polycistronic mRNA under control of the tcmG 
promoter, while tcmP is monocistronic and interestingly has the same start side for 
transcription and translation, meaning it is missing a RBS which might influence and regulate 
tetracenomycin production (Decker & Hutchinson, 1993). 
 
Figure 8: Structure of TcmX. (A) Chemical 2D structure of TcmX and rings labelled D-A from left to right. (B) 3D 
structure of TcmX in the same ring orientation as (A) 
Tcm producer strains gain resistance through utilisation of an efflux pump, TcmA. TcmA 
expression is negatively regulated by the transcriptional repressor TcmR. In the absence of 
tetracenomycins, it is stably bound to an intergenic region between the neighbouring although 
oppositely oriented genes tcmA and tcmR. Binding of tetracenomycins to TcmR in the 
stationary phase leads to dissociation, subsequent transcription and expression of TcmA and 
TcmR. As a result, tetracenomycin is exported, leading to a decrease in intracellular 
concentration. Eventually, the concentration will become insufficient to inhibit TcmR 
sufficiently, and transcription will be repressed again (Guilfoile & Hutchinson, 1992a; 
Guilfoile & Hutchinson, 1992b). Leaky expression of TcmR from a second promotor 
downstream of the TcmR-binding site leads to sufficient repression during the exponential 
phase. 
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Despite similarity to tetracycline antibiotics, in vitro poly-Phe synthesis was not affected by 
tetracenomycin C (Weber et al., 1979). TcmC was screened for anti-herpes virus activity in 
HeLa cells, and showed protection with an IC50 of 32 µM, while the IC50 for cytotoxicity was 
at 212 µM (Alarcon et al., 1984). Interestingly, cytotoxicity was measured via inhibition of 
[35S]-methionine incorporation. 
TcmX, a 12a-O-methylether of TcmC, was later isolated from Nocardia mediterranea, also 
belonging to the order of Actinomycetales (Khoo, 1988; Anderson et al., 1989). It showed the 
same activity spectrum as tetracenomycins C. Together with the structurally related 
elloramycins, which carry a rhamnose moiety at the C-8, TcmX and TcmC were shown to be 
active against murine leukaemia cells with IC50s of 3.3 µM, 1.2 µM and 0.6 µM, respectively 
(Lazar et al., 1981; Rohr & Zeeck, 1990). Intriguingly, a structural intermediate (TcmD3), 
which is still missing methylation and hydroxylations, was found to have some activity 
against B. subtilis, however was not active against Streptomyces (Rohr et al., 1988) Recently, 
TcmX was isolated from the marine Actinomycete Saccharothrix sp. 10-10 (Liu et al., 2014a). 
Surprisingly, in this study TcmX showed activity against both methicillin resistant S. aureus 
(MRSA) and vancomycin resistant Enterococcus (VRE) with MIC values of 32-64µg/ml. 
Moreover, novel tetracenomycin-related metabolites, the Saccharothrixones and Seco-
tetracenomycins, were identified from the same strain, however they were either inactive or 
only moderately active against both cancer cell lines and bacteria (Gan et al., 2015; Liu et al., 
2018). 
Due to structural similarity to the DNA intercalator doxorubicin, the planar structure given by 
the neighbouring aromatic rings, as well as preliminary results indicating binding to DNA and 
inhibition of uracil incorporation, intercalation with DNA has been suggested to be the 
inhibitory mechanism for the tetracenomycins (Hutchinson, 1997), however, no studies were 
undertaken to illuminate the actual mechanism of this antibiotic family. A recently published 
study suggests TcmX leads to cell cycle arrest exclusively in lung cancer cells by down 
regulating Cyclin D1 and does not affect healthy cells (Qiao et al., 2019). The study, however, 
shows inconsistencies in the data and lacks appropriate negative controls. Indeed it has been 
determined that TcmX inhibits protein synthesis by binding in the ribosomal nascent peptide 
exit tunnel (Osterman et al., 2020). Structural comparison with doxorubicin suggests that 
tetracenomycins universally cannot intercalate with dsDNA, nor bind to the tetracycline 
binding site on the 30S, due to the stereochemistry of the characteristic A-ring. The binding 
site in the NPET is conserved between E. coli and human ribosomes, making tetracenomycins 
also an attractive agent for cancer treatment.  
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2. Objectives  
 
Stringent response (Publication 1 and 2) 
During the stringent response, the secondary messengers (p)ppGpp target a multitude of 
processes and proteins within the bacterial cell. However, the exact mechanism by which 
some targets, especially ribosome-associated GTPases, are inhibited by the alarmones is still 
not well understood. Inhibition had been reported but not explored further of ribosome-
biogenesis co-factor RbgA and EF-Tu (Rojas et al., 1984; Corrigan et al., 2016). Moreover, 
while interactions between RbgA and the 45S or 50S had been analysed biochemically 
(Achila et al., 2012), no structure of the complex was available. To address this, we employed 
cryo-EM to solve a structure of the RbgA-50S complex, as well as aimed to obtain a structure 
of (p)ppGpp stalled EF-Tu on the translating ribosome. Both studies were accompanied by 
affinity measurements, hydrolysis activity and X-ray analysis of the GTPases in complex with 
the alarmone. 
 
Tetracenomycin X (Publication 3) 
With antibiotic resistance on the rise, investigation of novel compounds with distinct target 
binding sites is indispensable. One such novel compound is the antibiotic tetracenomycin X 
(TcmX) (Weber et al., 1979; Anderson et al., 1989). TcmX had been suggested to be a DNA 
intercalator (Hutchinson, 1997), and was recently reported to be active against MRSA and 
VRE (Liu et al., 2014a). Conversely our data indicated that ribosomes are targeted. We aimed 
to gain insight into the mechanism of this antibiotic by monitoring translation in the presence 
of the antibiotic, obtaining a cryo-EM structure as well as toe-printing to examine which 
phase of translation is inhibited. 
 
Argyrin B (unpublished results) 
The argyrin family of circular peptide antibiotics were first reported to inhibit bacterial 
translation (Sasse et al., 2002) and resistance mutations identified EF-G as the target (Bielecki 
et al., 2012; Nyfeler et al., 2012). A crystal structure of EF-G bound to argyrin B suggested it 
induces conformational changes incompatible with ribosome binding. To verify this 
hypothesis, we applied binding-assays, monitored GTPase activity and obtained a cryo-EM of 
a 70S ribosome with EF-G in the presence of argyrin B. 
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3. Cumulative Thesis: Summary of publications 
3.1.  Paper 1 - Structural basis for (p)ppGpp-mediated ribosomal large subunit 
arrest by RbgA  
Patrick Pausch, Maximiliane Wieland, Thomas Klaus, Sven-Andreas Freibert, Wieland 
Steinchen, Daniel N. Wilson and Gert Bange  
 
J Biol Chem 293: 19699-709 (2018) 
 
Under unfavourable conditions, a stringent response is provoked in bacteria (Cashel & Gallant, 
1969). Production of the secondary messengers (p)ppGpp, also termed alarmones, is induced. 
These molecules lead to a decrease in multiple essential cellular processes, like DNA 
replication and protein synthesis, in order to conserve resources and partially divert them to 
for survival necessary processes. One of the targeted processes within the bacterial cell is 
ribosome biogenesis. Besides rRNA transcription, several assembly co-factors are also 
inhibited by ppGpp (Corrigan et al., 2016). One of these targeted proteins is RbgA, a factor 
conserved across all domains of life. RbgA assists in the late-stage assembly of the 50S and 
associates with an immature 45S particle. While presumably the majority of the targets of 
alarmones have been identified at this point, the mechanism of action is not well explained for 
most of them. 
To characterise the mode of inhibition of RbgA by alarmones, we analysed biochemical and 
structural data. Kd measurements revealed that (p)ppGpp affinity to RbgA was similar to that 
of GDP/GTP, with values between 5.04 µM (GTP) and 3.26 µM (ppGpp). High-resolution X-
ray crystallography of S. aureus RbgA revealed that binding of alarmones, when compared to 
GDP/GMPPNP, does not induce major conformational changes off the ribosome, which 
would hinder association with a 45S particle. However, positioning of the δ- and ε-phosphates 
likely prevents RbgA from adopting a hydrolysis competent state: both the G2 (switch I) and 
G3 (switch II) motif are displaced and incapable of coordination of for hydrolysis essential 
Mg2+ or K+. This is further supported by GTPase assays showing RbgA is not able to 
hydrolyse (p)ppGpp, neither in the absence nor in the presence of ribosomes. We set out to 
obtain a RbgA-50S-GMPPNP complex by cryo-EM, as no structural data on a native RbgA-
45S or RbgA-50S complex had been published at this point. Reconstruction of the B. subtilis 
complex revealed a class (34%) of 50S with missing densities for H68-H71. This 
conformation was termed 50SInt. Low-pass filtering disclosed an undefined density in 
proximity to where the helices are in the mature particle. No defined density for RbgA could 
Cumulative Thesis: Summary of publications 33 
be discovered, and we concluded, since its binding site is at the displaced helices, it was likely 
part of the undefined density. 
3.2.  Paper 2 - Structural basis for the (p)ppGpp-dependent control of the 
translation elongation factor EF-Tu  
Wieland Steinchen, Mohamad Majkini, Maximiliane Wieland, Anita Dornes, Pietro I. 
Giammarinaro, Alex Lepak, Benjamin Burnett, Scott C. Blanchard, Daniel N. Wilson 
and Gert Bange  
 
unpublished 
 
Late in the bacterial life cycle, when nutrients become scarce and uncharged tRNAs become 
abundant, the stringent response is triggered. Uncharged tRNAs binding to an elongating 
ribosome stall translation. This complex is recognised by RSH-type proteins, which become 
activated and produce the secondary messengers (p)ppGpp. These molecules are also known 
as alarmones have multiple targets within the cell, and besides RNAP, also inhibit GTPases 
associated with translation. Due to a lack of charged tRNAs, translation is impaired, and thus 
a waste of GTP resources can be prevented. One of the targeted GTPases is EF-Tu (Hamel & 
Cashel, 1974). 
To examine the impact of the tetra- and penta-phosphate guanosine, we determined the 
structure of an EF-Tu–pppGpp complex at 2 Å employing X-ray crystallography. Surprisingly, 
the structure revealed an electron density for ppGpp and an Mg2+, not pppGpp. Positioning of 
the 3’-phosphates is not only incompatible with rearrangement of the switch I motif of EF-Tu, 
but also consequently with interactions with aa-tRNA. To underline the structural analysis, we 
performed electrophoretic mobility shift assays (EMSA) as well as fluorescence spectroscopy 
to monitor ternary complex formation. Indeed, (p)ppGpp was able to out-compete GTP once 
ratios of alarmone to GTP were >1, and inhibit ternary complex formation. As the structure 
showed density for ppGpp instead of the originally added pppGpp, we investigated whether 
this was due to active hydrolysis by EF-Tu or possible cross-contamination with ppGpp. Our 
results indicate that EF-Tu indeed is able to hydrolyse pppGpp. Moreover, we show that EF-
Ts, the guanosine exchange factor of EF-Tu, can displace (p)ppGpp from EF-Tu, facilitating 
translation recovery after resolution of the SR. 
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3.3.  Paper 3 - Tetracenomycin X inhibits translation by binding within the 
ribosomal exit tunnel  
Ilya A. Osterman, Maximiliane Wieland, Tinashe P. Maviza, Kseniya A. Lashkevich, 
Dmitrii A. Lukianov, Ekaterina S. Komarov, Yuliya V. Zakalyukina, Robert 
Buschauer, Dmitrii I. Shiriaev, Semen A. Leyn, Jaime E. Zlamal, Mikhail V. Biryukov, 
Dmitry A. Skvortsov, Vadim N. Tashlitsky, Vladimir I. Polshakov, Jingdong Cheng, 
Yury S. Polikanov, Alexey A. Bogdanov, Andrei L. Osterman, Sergey E. Dmitriev, 
Roland Beckmann, Olga A. Dontsova, Daniel N. Wilson and Petr V. Sergiev 
 
Nat Chem Biol (2020) 
 
The tetracenomycins are molecules belonging to the group of the aromatic polyketides first 
identified in 1979 (Weber et al., 1979). They are planar tetracyclic naphthacenequinone 
derivatives, with structural similarities to the DNA intercalating compound doxorubicin (Dox) 
and the translation inhibiting compound tetracycline (Tet). They were first identified in 
actinomycetales, and as such have been found to be mostly active against other 
actinomycetales, but also against multiple cancer cell lines (Lazar et al., 1981; Rohr & Zeeck, 
1990). However, no activity against bacteria could be detected. Recently, they were 
rediscovered in a marine actinomycete, Saccharothrix sp. 10-10, and showed activity against 
multi-resistant bacteria (Liu et al., 2014a). Due to initial experiments showing no inhibition of 
in vitro Poly-Phe synthesis and structural similarity to Doxorubicin, it has been assumed to 
function as a DNA intercalator as well. 
Conversely, we found its mechanism of action is inhibition of translation. We identified 
Tetracenomycin X (TcmX) from Amycolatopsis sp. 23, and through extensive biochemical 
analysis and comparison with Dox and Tet, we could show that in vitro TcmX inhibits 
incorporation of valine, and not that of thymidine, and translation of a Fluc reporter construct 
with an IC50 of 1.5 µM. Analysis of resistance mutations revealed mutations in the 23S rRNA, 
but not in the 16S, where Tet binds. Cryo-EM analysis of E. coli 70S ribosomes confirmed 
the TcmX binding site within the nascent peptide exit tunnel, close to the PTC. The drug 
stacks onto the non-canonical base-pair of U1782-U2586 and coordinates two Mg2+ for 
further interactions. Strikingly, the non-canonical base-pair is conserved in the eukaryotic 
ribosome. Consequently, cryo-EM analysis of a human 80S ribosome revealed the same 
binding site, stacking upon the corresponding U3644-U4352 base-pair. Further experiments 
on HEK293T cells showed that the cytotoxicity concentration at which TcmX permits only 
50% cell survival (CC50) was at 2.5 µM. The IC50 for in vivo translation inhibition of a Fluc 
reporter coincided with 2.5 µM. Intriguingly, translation of a Fluc reporter in a whole cell 
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extract showed an increased IC50 of 10 µM. This suggests additional targets in human cells 
besides translation. 
The binding site of TcmX lies at the beginning of the NPET, opposing to the macrolide 
erythromycin (Ery) binding site. To prove a similar mode of action, i.e. inhibition of 
translation elongation, we conducted toe-printing assays. The use of two different templates, 
TrpL-2Ala and ErmBL, established that neither initiation nor termination was inhibited, but 
translation elongation. Comparison to Ery showed a similar amino acid preference for stalling 
for the TrpL-2Ala template, but not for ErmBL. Therefore, the mechanism by which TcmX 
inhibits elongation occurs in a sequence-specific manner. 
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4. Unpublished results 
The argyrins represent a family of circular octa-peptides, with modifications present at 
multiple residues (Ferrari et al., 1996; Sasse et al., 2002; Vollbrecht et al., 2002) (Fig. 9A). 
They exhibited activity in translation inhibition as well as cytotoxicity (Sasse et al., 2002). 
Because of their cytotoxic effect the argyrins were further investigated as anti-cancer drugs 
(Nickeleit et al., 2008; Bülow et al., 2010; Chen et al., 2017); argyrin A, B and F were shown 
to target the proteasome, however, all with differing subunit specificities (Bülow et al., 2010; 
Allardyce et al., 2019). 
 
Argyrins inhibit bacterial translation 
In bacteria, the target of argyrin A and B has been identified as the prokaryotic elongation-
factor G (Nyfeler et al., 2012; Bielecki et al., 2012). Structural determination of EF-G 
complexed with argyrin B led to the hypothesis that argyrin arrests EF-G in a conformation 
incompatible with ribosome binding. Poly-Phe synthesis was indeed inhibited (Sasse et al., 
2002). To confirm this under more physiological conditions, coupled transcription-translation 
assays employing Firefly Luciferase (Fluc) were carried out (Fig. 9B). All tested argyrins A-D 
inhibited translation, with IC50 values of 2-3 µM, with the exception of argyrin C, which 
showed delayed inhibition with an IC50 of 10.5 µM. 
 
 
Figure 9: Argyrins inhibit translation (A) Chemical structure of Argyrins A-D showing the circular nature and differences 
in R1-R3 (B) In vitro Firefly luciferase assay were performed in the presence of varying concentrations of argyrins. 
 
Argyrins inhibit the ribosome-dependent GTPase activity of EF-G 
EF-G is targeted by another antibiotic, fusidic acid (FA), which inhibits its function (Tanaka 
et al., 1968), but allows for one round of hydrolysis (Bodley et al., 1970). To test whether 
argyrins function similarly, GTP-hydrolysis activity of EF-G in the presence of argyrins was 
evaluated. For this purpose malachite green assays were conducted. In the process of GTP 
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hydrolysis, EF-G releases an inorganic phosphate (Pi). Malachite green in combination with 
molybdate will form a complex with Pi, which can be measured spectrophotometrically. EF-G 
activity is stimulated by interactions with the ribosome, thus the assays were performed in the 
presence of purified E. coli 70S ribosomes. A time course of EF-G in the absence of any 
inhibitors showed that within a 90 min window EF-G hydrolysed the added GTP (20 µM) 
almost entirely (Fig. 10A). In the absence of ribosomes GTP hydrolysis after 90 min showed 
only marginal activity (1.4 µM Pi). Plotting time against GTP hydrolysed per ribosome 
revealed the majority of hydrolysis occurred within the first 30 min. Between 60 and 90 min 
the slope declined drastically and plateaued around 530 GTP/ribosome at 90 min (Fig. 10B). 
Thus, for the following assays an incubation time of 60 min was chosen. The impact of 
argyrins on GTP-hydrolysis was examined in the presence of varying concentrations (0, 0.1, 1, 
10, 50, and 100 µM). Figure 10C shows one representative experiment. At 1 µM, all argyrins 
displayed 40-50% inhibition. Argyrin B and D were most active at 50 µM (20%), whereas 
argyrin A and C had reduced activity at concentrations higher than 10 µM. Pi release in the 
presence of fusidic acid (FA) was monitored as a positive control and showed a slightly 
higher IC50 of ~3 µM. However, FA also displayed a greater degree of inhibition than any 
argyrin with only 10% residual activity at 100 µM. 
 
 
Figure 10: Phosphatase assays of EF-G. (A) Time course of EF-G (60 nM), ribosomes (30 nM) and GTP (20 µM) up to 90 
minutes of incubation at room temperature. (B) Time course data plotted against GTP hydrolysed per ribosome fits a 
logarithmic curve. The steep slope begins to flatten after 30 minutes and appears to plateau after 90 minutes. (C) GTP-
Hydrolysis inhibition of EF-G in the presence of argyrins A-D and Fusidic acid as a control. Mean values and standard 
deviations are calculated from two independent experiments. 
 
Argyrin B stabilizes EF-G on the ribosome 
Some translation-targeting antibiotics lock their target protein on the ribosome, preventing 
access to the following factor. FA indeed traps EF-G on the ribosome (Bodley et al., 1969), as 
kirromycin does with EF-Tu (Vogeley et al., 2001). To test if argyrin bound EF-G is indeed 
incapable of ribosome-interaction as proposed (Nyfeler et al., 2012), or rather functions 
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similarly and traps EF-G on the ribosome, co-sedimentation assays of EF-G and 70S 
ribosomal particles were performed (Fig. 11). The comparison of free protein in the sucrose-
cushion supernatant (SN) to the pellet (P), which consists of ribosomes and any protein bound 
to it, indicates whether the protein is stably bound to the ribosome or not. In the reaction with 
only GTP, EF-G can be found in the pellet only at sub-stoichiometric concentrations, and 
mostly in the supernatant. Conversely, in both the reaction with ArgB and the positive control 
of FA, it is stably bound to the ribosome at stoichiometric concentrations. As EF-G was added 
in 3-fold excess over ribosomes, it can still be found in the supernatant of all three reactions. 
In the absence of ribosomes EF-G does not pellet, confirming that pelleting is ribosome-
dependent. 
 
Figure 11: Argyrins traps EF-G on the ribosome. Co-Sedimentation assay of EF-G with 70S particles in the presence of 
FA or argyrin B; comparison of whole reaction (R) before subjecting it to a sucrose gradient, the remaining particles in the 
sucrose supernatant after centrifugation (SN) and in the pellet (P). 
 
Cryo-EM structure of a 70S−EF-G−Argyrin B complex 
In order to understand how argyrin B traps EF-G on the ribosome, 4.5 OD/mL of the 70S−EF-
G−GTP−ArgB from the co-sedimentation assay reaction were applied to grids and the 
structure was determined by cryo-EM. 
Processing of the high-resolution complex. The dataset was initially processed with 
RELION2. However, this yielded mediocre resolution of the argyrin binding site. Therefore, 
the dataset was reprocessed with RELION3, which holds novel polishing and multibody-
refinement tools to increase resolution. 7,891 micrographs were subjected to a resolution cut-
off of 3.5 Å and a defocus cut-off of 30,000. Residual 3,629 micrographs were manually 
inspected for thon-rings and ice quality. From the remaining 3,466 micrographs 610,946 
particles were picked using GAUTOMATCH. After 2D-classification, focus-sorting was 
performed on 557,434 particles with a soft mask around EF-G, using four classes (Fig. 12A). 
All but class IV (~20%) showed extra density for EF-G, as well as argyrin B. 
Unpublished results 39 
 
Figure 12: Processing of the E. coli 70S – EF-G Argyrin B complex. (A) From 610,946 2D classified particles, 557,434 
were used for initial reconstruction. Subsequently, a focus mask of EF-G was applied for sorting into four classes. ClassI-III 
contained EF-G, whereas Class IV (19.85%) was an empty 70S. Following undecimated refinement were classes containing 
EF-G subjected to two rounds of CTF-refinement and Bayesian polishing. Multibody refinement of class I using masks for 
50S+EF-G, 30S body+ platform, and 30S head significantly improved final resolution. (B) FSC curves of refined classes I-
IV: EF-G containing classes CTF-refined and subjected to Bayesian polishing (blue curves), whereas the empty 70S class 
was only subjected to undecimated refinement (red curve) (C) FSC curves for multibody refined bodies of class I (green 
curves). (D) Decimated EF-G density in the A-site of class I-III and lack thereof in class IV. 
Closer analysis of class I of the EF-G−Argyrin−70S complex showed a ribosome in the 
rotated state. Likewise, class II contained rotated ribosomes, however a slightly different 
rotation, and domain IV adopted an unreported conformation with lacking density for α1 (Fig. 
12D). Contrary to class I and II, class III contained non-rotated ribosomes. Domain II of EF-G 
formed varying interactions with the 30S in all classes. Class IV contained only empty 
ribosomes and was not further pursued after reconstruction of the undecimated volume. The 
final gold standard FSC0.143 value for class IV indicated a resolution of 3.5 Å (Fig. 12B). 
Class I-III were further CTF-refined and polished, and showed FSC0.143 value of 3.0 Å 
(Fig. 12B). All classes were subjected to multi-body refinement for a better resolution. 
Several approaches were tried for the best outcome. First trials of multibody-refinement with 
four soft masks (EF-G, 50S, 30S body/platform and 30S head) resulted in a significantly 
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decreased resolution of EF-G. Since EF-G has multiple contacts with the ribosome, both 
attaching it to the 30S body and platform mask, as well as splitting and refining it with the 
respective interaction partners (30S head with domain IV, 30S body and platform with 
domain II-III, and 50S with domain I and V) was attempted. However, the only approach, 
which resulted in a better resolution, was applying three masks, for 50S with EF-G, the 30S 
head, and the 30S body and platform in class I (Fig. 12C). It was not possible to visualise the 
missing helix in class II, and class III did not represent a native state; hence class I was 
selected for further evaluation. 
Resolution. Resolution estimation and locally filtered maps of post-processed polished and 
multibody volumes were calculated using SPHIRE1.3, as the built-in RELION resolution 
estimation did not seem accurate. Prior to multibody-refinement overall complex resolution 
was at 3 Å, yet resolution of the 30S was at 4-7 Å (Fig. 13A). After multibody-refinement a 
resolution of 2.8 Å for 50S and 30S body and platform, and  3 Å for the head was achieved 
(Fig. 13C). Resolution of EF-G could not be improved during multibody-refinement, and 
ranged between 3-4.5 Å after polishing (Fig. 13D). 
 
Figure 13: Resolution of the E. coli 70S – EF-G Argyrin B Class I (A) local resolution of locally filtered refined class 1 
(B) resolution colour key for all resolution maps (C) local resolution of locally filtered multibody refined maps (D) local 
resolution of EF-G from polished class I. 
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Overall complex conformation. Class I comprises a rotated 70S with substoichiometric 
density for E-site tRNA, and EF-G in the A-site (Fig. 14A). As previously observed (Nyfeler 
et al., 2012), a density for Argyrin B was detected between domain III and V of EF-G (Fig. 
14B). The resolution of EF-G was sufficient to see side-chain densities in parts of the protein. 
The density for Argyrin B is well resolved and covered all residues (Fig. 14C). bS1 was 
present in co-sedimentation assays, however, in the final reconstruction only helix 1 at the 
interface with uS2 was visible (Beckert et al., 2018). 
 
 
Figure 14: Cryo-EM structure of class I: E. coli 70S in complex with EF-G and Argyrin B. (A) Cryo-EM map of the 
70S ribosome (30S, yellow; 50S, grey) and EF-G (blue). (B) Atomic model of EF-G and Argyrin fit into the cryo-EM density 
map. (C) Zoom in of Argyrin B density between domains III and V of EF-G. 
 
The complex was formed with GTP, yet the density in the binding complies with GDP and a 
coordinated Mg2+-ion, which is coordinated with T24 (Fig. 15A). Apart from switch I (aa 38-
64), domain I was well resolved, displaying side chain densities (Fig. 15A). Alignment with 
an EF-G complexed with the non-hydrolysable GTP analogue GMPPCP (Fig. 15B) showed 
that density for the γ-phosphate was missing. A comparison of the binding site to other GDP-
bound EF-Gs further confirms GDP (Fig. 15C, D), whereas in a hydrolysis-deficient EF-G, 
GTP extends further (Fig. 15E). 
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Figure 15: The GDP binding site and comparison to other GTP-analogues and conformations. (A) Cryo-EM density for 
GDP shown in mesh in the argyrin B bound EF-G complex. Comparison of conformations to (B) EF-G bound to non-
hydrolysable GMPPCP (silver, PDB 4v9p), showing GTP does not fit the density (C) GDP-bound T. thermophilus EFG 
(cyan; PDB 2bm0) (D) fusidic acid bound T. thermophilus (PDB 4v5f) (E) hydrolysis-deficient H91A E. coli EF-G (PDB 
3ja1). 
 
Interactions between argyrin B and EF-G 
A single density for argyrin B was found between domains III and V, forming interactions 
with both. The unmodified W1 moiety of argyrin B formed van der Waals interactions with 
the backbone of M682 in domain V as well as M617 and Y684 (Fig. 16A, C), and toward 
W448 in domain III. The modified W2 moiety of argyrin B was found to interact with P414 
(Fig. 16A, B). A hydrogen bond was formed between the drug and the backbone of A489 and 
further van der Waals interactions were formed with the backbone in the linker between 
domain III and IV (Fig 16B, D). S417 was in hydrogen-bonding distance the backbone 
oxygen between W1 and the thiazole ring of argyrin B, and at a lower threshold connecting 
density could be observed (not shown). Furthermore, density suggests that the W2 forms van 
der Waals interactions with P414 and that the methoxy group of W2 in argyrin B forms a 
hydrogen-bond with the backbone of P414. 
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Figure 16: Interactions between Argyrin B and E. coli EF-G. (A, B) Cryo-EM densities displayed in mesh for the argyrin 
B (purple) binding site in EF-G between domain III (green) and V (red). For less noise, a Gauss filter of 0.8 was applied to 
the post-processed map. (C) Interactions or Argyrin with domain III (green) and V (red) are formed with Y687, M617 and 
M682 and weakly with L660. Y680 mutations can confer resistance in pae, but no interactions could be detected. (D) 
Hydrogen bonding with A489 and van der Waals interactions with V488, Q487, P486 occur but no density can be detected 
for interactions with S417. 
 
 
EF-G trapped on the ribosome by Argyrin represents a GTP-like state 
The complex was formed with GTP, but missing density for switch I (aa 38-64) and density 
matching to GDP indicated that GTP-hydrolysis and Pi release had occurred. Interestingly, 
alignment with an EF-G bound to a non-hydrolysable GMPPCP (Pulk & Cate, 2013) showed 
a remarkable similarity with a R.M.S.D of 0.8 (Fig. 17A), and alignment with a FA-bound 
state (Gao et al., 2009) had a R.M.S.D of 1.6 (Fig. 17B). Comparison of the EF-G–Argyrin 
complex to the GMPPCP and FA structure displayed only marginal differences. Although 
domain IV is generally flexible, it is similar in these three structures. Comparison to an EF-G-
GDP complex in the absence of the ribosome showed a drastic movement in domains III-V 
(Fig. 17C). Furthermore, the Pseudomonas aeruginosa EF-G in complex with argyrin B 
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exhibited an elongated conformation (Fig. 17D), which had led to the assumption it was 
incompatible with ribosome binding. 
 
 
Figure 17: Alignment of EF-G structure on domain I to (A) E.coli EF-G bound to non-hydrolysable GMPPCP (silver, 
PDB 4v9p) R.M.S.D.: 0.8 (B) fusidic acid bound T. thermophilus (pink; PDB 4v5f) R.M.S.D.: 1.6 (C) GDP-bound T. 
thermophilus EFG in the absence of ribosomes (cyan; PDB 2bm0) R.M.S.D.: 5.7 (D) P. aeruginosa EF-G bound to Argyrin 
B (limegreen; PDB 4fn5) 
 
Not only switch I beomes disordered upon Pi release, also switch II exhibits minor 
conformation changes. This movement became only apparent in an EF-G structure off the 
ribosome (Fig. 18A, cyan), whereas compared to EF-G−FA trapped on the ribosome or EF-
G−GMPPCP, no changes were observed (Fig. 18A, pink, silver). 
The major divergence between these structures can be found in domains II and III (Fig. 18B-
D). Disordering of switch I leads to a loss of intramolecular interactions with switsch II and 
domain III. As a result, domain II and III move apart by 7 Å (Pulk & Cate, 2013; Gao et al., 
2009), ultimately leading to the release of EF-G. In the argyrin B trapped EF-G, no distancing 
of domain II and III could be observed. 
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Figure 18: Comparison of switch II, as well as domain II and III conformations across the translocation cycle (A) 
Switch II remains stable in compared structures bound to fusidic acid (pink; PDB 4v5f) or non-hydrolysable GMPPCP 
(silver; PDB 4v9p), but moves in the GDP-bound EF-G (cyan; PDB 2bm0). Comparison of domain II and III conformations 
to (B) EF-G bound to non-hydrolysable GMPPCP (silver, PDB 4v9p) (C) fusidic acid bound T. thermophilus (pink; PDB 
4v5f) and (D) T. thermophilus EF-G without ribosome binding (cyan; PDB 2bm0). 
 
Interactions with the ribosome 
EF-G displayed numerous contacts with the ribosome (Fig. 19). Domain II contacted the 16S 
rRNA by stacking interactions between F329 and A55 in h5 and R362 and U368 in h15 (Fig. 
19A). H76 in S12 inserted between the β-sheets and α1 in domain III and formed a hydrogen 
bond with Q428 (Fig. 19B). Domain IV contacted the backbone of C1209-1210 in the head 
region of the 16S rRNA (Fig. 19C). Densities for the two loops in domain IV reaching 
towards the A-site were not well resolved and hence contacts with h44 could not be 
determined. In the large subunit, domain V contacted the 23S rRNA with interactions between 
the backbone of L642 and A1067 and hydrogen bonds between R637 and U2473 (Fig. 19D). 
An interaction of H92 with the phosphate of A2662 in the SRL was detected at a higher 
threshold than depicted in Fig. 15A, as well as other interactions of the backbone of domain V 
with A2660. 
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Figure 19: Interactions of the Argyrin B inhibited EF-G with the 70S Ribosome (A) Domain II contacts the 16S rRNA 
by stacking interactions between R362 and U368 in h15 and F329 and A55 in h5 (B) H76 in S12 forms a hydrogen bond with 
Q428 in domain III. (C) Domain IV contacts the 16S rRNA at the head, by G542 interacting with the phosphate backbone of 
C1209 and C1210 in h34 (D) Domain V interacts with the 23S rRNA at A1067 and U2437. 
 
Intramolecular interactions 
While the conformation was similar to the GMPPCP-bound EF-G, switch I was disordered 
and interactions between it and domain III could no longer be established. Other interactions 
within the molecule were still present. As in the GMPPCP reference structure, K323 
contacted the backbone of A66, while amino acids in switch II, namely R101 and I97, 
established contacts with domain III, E441 and P443, respectively (Fig. 20A). Stacking 
interactions between residues R491 and P570 from domain IV with Y687 in domain V could 
lead to stabilisation of domain IV (Fig. 20B). Contrary to the GMPPCP bound EF-G, no 
interaction between R639 and E614 could be detected. Rather, R639 established contacts with 
P659 ad P691 (Fig. 20C). 
 
 
Figure 20: Intramolecular interactions of EF-G (A) interactions between domain I (blue), II (sand) and III (green) (B) 
stacking interactions between domain IV (teal) and V (red) could lead to stabilisation of domain IV. Y687 is also contacted 
by argyrin B. (C) interactions within domain V (red). 
 
Argyrin binding obstructs hydrolysis induced domain movement of EF-G 
Comparison with the GDP-bound EF-G off the ribosome and alignment on the G-domain 
showed large movements within domain III-V (Fig. 17C). To detect possible movement of 
domain III in relation to domain V, and vice versa, the structures were aligned on either 
domain III (Fig. 21A, C) or domain V (Fig. 21B, D). Alignment on domain III showed some 
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residual similarities in domains I and II. Domain V, however, showed a movement by about 
20 Å towards domain I. Conversely, alignment on domain V only showed similarities in 
domain IV. A closer look at the argyrin-binding site of the domain III aligned structures (Fig. 
21C) again displayed the movement of domain V away from the binding site. Conversely, in 
the domain V aligned structures, domain III moved towards the binding site. 
 
 
Figure 21: Comparison to the off-ribosome EF-G−GDP state. Overview of the complete EF-G, aligned on (A) domain III 
or (B) domain V. Zoom in on the argyrin binding site of (C) alignment on domain III shows the movement of domain V 
away from the binding site (domain I, II and IV not displayed for clarity), whereas (D) the domain V aligned structure shows 
the drastic movement of domain III into the binding site (domain I and II not displayed for clarity). 
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5. Discussion 
5.1. Exploration of the alarmone mediated stringent response effect on ribosome-
associated GTPases 
For survival under stressful conditions like nutrient deprivation, bacteria deploy the stringent 
response. Secondary messengers are produced by RSH-type proteins (Atkinson et al., 2011), 
which utilise ATP to transfer a pyrophosphate moiety onto the 3’-OH of either GDP or GTP, 
resulting in (p)ppGpp. One of the main targets of these so-called alarmones is RNAP, leading 
to transcription inhibition, while simultaneously allowing selective transcription of vital genes. 
Naturally, it stands to reason that these GDP/GTP derivatives can bind to and inhibit GTPases 
as well. Indeed, a number of studies have shown that GTPases associated with ribosome 
assembly and translation are targeted by the stringent response (Bennison et al., 2019). A 
number of structures for (p)ppGpp targets exist to elucidate the respective mechanism of 
inhibition (Steinchen & Bange, 2016), however, there are only a few regarding GTPases, like 
assembly co-factor ObgE (Buglino et al., 2002), RF3 (Kihira et al., 2012) or the ribosome-
associated GTPase BipA (Fan et al., 2015; Kumar et al., 2015). Nevertheless, neither the 
mechanism of action is well explained for most of them, nor why some are able to hydrolyse 
pppGpp, whereas others are not. We set out to further characterise and structurally analyse the 
mode of inhibition of alarmones for RbgA and EF-Tu.  
5.1.1. RbgA 
For cryo-EM reconstruction of a RbgA-50S complex, 0.4 µM B. subtilis 50S were incubated 
with 1 µM B. subtilis RbgA and 500 µM of GMPPNP. Although RbgA functions on immature 
45S particles, its GTP hydrolysis is stimulated only by mature 50S (Achila et al., 2012).  
Consequently, GMPPNP stabilises it on the 50S, and co-sedimentation assays showed stable 
binding of RbgA to the ribosomal particle following centrifugation. Cryo-EM reconstruction 
of this complex using FREALIGN resulted in 4 distinct classes, two of which were of low 
resolution and showed bias, owing to the natural predisposition of 50S particles to be 
positioned flat on the subunit interspace. Two higher resolved classes constituting a mature 
50S and a 50S with missing densities for H68-H71 were resolved to 3.58 Å and 3.65 Å, 
respectively. The lack of H68-H71 resembled immature 45SRbgA particles (Li et al., 2013). 
Higher threshold and low-pass filtering of the map visualised H71 to be only slightly distorted 
and an extra density was present in its proximity. As it coincided partially with the RbgA 
binding site, we speculated that binding of RbgA lead to a destabilisation of this region, and 
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that the additional density contained both RbgA and H67-H69 in a highly flexible state. 
Reconstruction utilizing Relion2.0 did not result in improved maps. Reviewer requested 
negative controls for the cryo-EM with B. subtilis 50S revealed that H67-H71 are unstable in 
both reconstructions, independent of RbgA binding (Fig. 22A). This indicated that RbgA 
likely dissociated during grid making. To counteract dissociation and get a functional 50S-
RbgA complex, we cross-linked the components prior to grid making. However, electron 
densities were poorly resolved and did not yield any detectable 50S-RbgA complex. 
Recently, the structure of a B. subtilis 45SRbgA-RbgA complex was solved (Seffouh et al., 
2019) (Fig 22B, C). 45SRbgA were purified from a ΔrbgA background and mixed with 
heterologously expressed RbgA at a ratio of 1:40 (0.5 µm 45S to 20 µM RbgA) under the 
addition of 2 mM of the non hydrolysable GTP analogue GMPPNP. This is in stark contrast 
to our ratio of 1:2.5, and could indicate that for successful reconstitution higher concentrations 
of RbgA and nucleotide are necessary. 
Comparing our observed affinity to GTP and (p)ppGpp to previous findings (Corrigan et al., 
2016), indicated that they are similar for GTP (5.56 ± 1.88 µM vs. 5.04 µM), and comparable 
for pppGpp (2.65 ± 0.45 µM vs. 4.31 µM). For ppGpp, however, there is a difference of one 
order of magnitude (0.49 ± 0.06 µM vs. 3.26 µM). The experimental setup was different, as in 
our case we varied the nucleotide concentration from 10 nM to 100 µM, and kept RbgA 
concentration stable at 200 nM. Corrigan and colleagues, however, applied 2.78 nM of α-32-
ppGpp and added 100 µM of competing nucleotide and varied the RbgA concentration from 
10 nM to 100 µM. Possibly this setup is more suitable for measurement of high affinities. 
Where Corrigan and colleagues saw a drop in GTP hydrolysis activity in the presence of 70S 
and 1 mM (p)ppGpp to 20% residual activity, we observed maximum inhibition at a ratio of 
GTP:(p)ppGpp of 1:4 (0.25 mM and 1 mM), and then only to around 50%. This two-fold 
difference likely originates in contrasting experimental setups. Firstly, incubation time in our 
setup was 30 min at 37 °C, thus only half of what Corrigan et al. used. More importantly, they 
mixed 10 µM of RbgA with only 118 nM 70S and 2.78 nM of α-32-P-GTP, whereas we used 
equimolar concentrations of RbgA and 70S at 1 µM. 
We set out to solve crystal structures of Staphylococcus aureus RbgA in complex with GDP, 
GMPPNP as well as (p)ppGpp. None of the structures could show an ordered G2 domain, 
indicative of an inactive conformation of RbgA, likely because the δ-phosphate would clash 
with the G2 domain (Fig. 22D). However, a structural rearrangement of G2 to coordinate a 
Mg2+ is necessary for GTPase activation. Comparison of our structure with the ribosome-
bound RbgA indicates that the ε-phosphate would also clash with the phosphate backbone of 
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G1779 (Bsu numbering; Eco: G1770) (Fig. 22D). This is in agreement with our preliminary 
co-sedimentation assays of 50S and RbgA, which showed an increase in unbound fraction 
upon addition of (p)ppGpp, albeit minimal. However, the 3’-OH added pyrophosphate could 
adopt a different conformation on the ribosome as the GTP-binding pocket faces toward the 
C-terminal RNA interacting domain, which is 8 Å away and cannot constrict the movement of 
the pyrophosphate. 
 
Figure 22: RbgA on the large subunit. 
(A) Spirit reconstruction of a B. subtilis 
50S in the absence of any ligands. 
Fitting of the 3J9W 50S shows missing 
H68-H71, like the reconstruction of our 
50S-RbgA-GMPPNP complex. (B) 
Cryo-EM density of a B. subtilis 45S 
(grey) complexed with RbgA-GMPPNP 
(red) (C) Alignment of our S. aureus 
RbgA-pppGpp structure (blue) to the 
RbgA-45S complex. The GTP binding 
pocket (white box) is localised in the 
middle of the protein on the side facing 
the ribosome. (D) Zoom in to the GTP-
binding site of RbgA in proximity to 
H64. The switch I containing G2 motif 
becomes ordered upon binding to the 
ribosome. The 3’-OH added 
pyrophosphate of alarmones would 
likely clash with G2 and H64. 
 
 
 
 
 
 
 
Although the structure of the B. subtilis 45SRbgA-RbgA complex was solved, and G2 adopts a 
structured conformation upon binding to the ribosomal particle, the exact mechanism of how 
hydrolysis is induced in RbgA still cannot be explained entirely. Its GTPase activity is 
stimulated primarily by matured 50S particles. In contrast to most other ribosome-associated 
GTPases, RbgA is not dependent on the SRL to position the catalytically active Histidine for 
hydrolysis. In the 45SRbgA-RbgA complex, His9 is with a distance of 8 Å not positioned close 
enough to induce hydrolysis. It stands to reason that maturation of the 23S rRNA is 
accompanied by a restructuring of H92, followed by the rearrangement of CR1 to position 
His9. Comparison to a B. subtilis 70S structure (Sohmen et al., 2015) (PDB 3jw9) indeed 
shows a difference of 2-4 Å upon accommodation of the neighbouring H71, however away 
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from CR1. Conceivably, this will lead to the re-structuring of CR1 and positioning of His9 for 
hydrolysis. 
Recently, the mitochondrial homolog Mtg1 has been solved in complex with mtEngA on a 
mitochondrial ribosome biogenesis intermediate (Jaskolowski et al., 2020). A comparison of 
the complexes to gain further insight into the possible GTPase mechanism is not possible, as 
the deposited structures have not been published yet. Similarly to Mtg1, the yeast homologue 
of RbgA, Lsg1, was not observed in the absence of the co-factor Nmd3 (Malyutin et al., 2017). 
Hence, a similar approach might be necessary for a bacterial complex to assess the exact 
GTPase mechanism: RbgA-GMPPNP mixed with purified 45SRbgA, assembly co-factors like 
YphC and YsxC, which operate on the same intermediate (Ni et al., 2016), and r-proteins to 
give an authentic 50S-RbgA complex. 
Concluding, contradicting data about whether (p)ppGpp will allow RbgA binding to the 45S 
exists. Contrary to EF-Tu (Wieland et al., 2020, unpublished)(Hamel & Cashel, 1974), RbgA 
cannot hydrolyse pppGpp. This is in agreement with our structural analysis, which shows that 
binding of (p)ppGpp prevents G2 from adopting a conformation permitting Mg2+ coordination 
and correspondingly GTP hydrolysis. Although binding of (p)ppGpp could obstruct 
interaction with the 50S subunit, it has been shown that pppGpp can lead to stabilisation of 
RbgA on the 50S (Achila et al., 2012). Screening for complex formation with similar 
concentrations as used for the 45SRbgA-RbgA (Seffouh et al., 2019) could be conducted, i.e. 
20 µM RbgA, 2 mM (p)ppGpp and 0.5 µM 45S or 50S. Consequently the complete 
mechanism of RbgA inhibition by alarmones still remains unsolved and further studies need 
to be conducted. 
5.1.2. EF-Tu 
All translation-associated GTPases (IF2, EF-Tu, EF-G, RF3, BipA) have been implicated to 
be targeted by (p)ppGpp (Bennison et al., 2019). To ascertain inhibition of translation by 
(p)ppGpp, we used a transcription-translation coupled system overexpressing GFP with 
concentrations of 0, 10, 100, and 1000 µM. We saw an inverse correlation between expression 
and increasing alarmone concentration, with only 30% and 40% of residual expression levels 
at 1000 µM. Although transcription is also targeted by (p)ppGpp, an effect in this coupled 
system is unlikely. For E. coli and other α-, β-, γ-, δ-proteobacteria a conserved MAR 
sequence at the RNAP N-terminus has been determined to be the target for (p)ppGpp (Ross et 
al., 2013; Hauryliuk et al., 2015). Like the T. thermophilus or B. subtilis RNAPs, T7 does not 
possess this sequence, and for these bacteria it has been suggested that alarmones inhibit 
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transcription by depleting the GTP pool rather than by direct binding. Consequently, a 
transcription-translation coupled system deploying T7 for transcription is likely not inhibited 
by (p)ppGpp at the level of transcription, so that the inhibition we observed is indeed 
inhibition of translation. Our translation inhibition levels are also in accordance with early 
translation assays showing ~65% inhibition of translation from pre-transcribed mRNAs 
(Legault et al., 1972). However, since (p)ppGpp inhibits other translation-associated GTPases, 
a direct correlation of translation inhibition to EF-Tu inhibition cannot be deduced. 
Early data indicates that EF-Tu can form a ternary complex in the presence of pppGpp and 
deliver tRNA to the ribosome (Hamel & Cashel, 1974; Pingoud et al., 1983). Thus, we 
initially attempted to form a native 70S–EF-Tu–tRNA–(p)ppGpp complex. To this end we 
employed the ErmBL construct, which stalls translation in the presence of erythromycin, due 
to an interaction of Val9 and Asp10 with the PTC (Arenz et al., 2014b). The stalled complex 
still allows binding of the downstream encoded Lys11 in the A-site tRNA, which could trap 
EF-Tu on the ribosome. Transcription-translation in the presence of Ery was allowed to go on 
for 25 min before alarmones were added to the reaction to trap EF-Tu during delivery to the 
stalled ribosome. Sucrose gradients were fractioned to analyse the ribosome profile, and 
addition of Ery compared to the negative control showed a prominent disome peak, indicating 
that stalling was successful. One reaction was carried out in the absence of Ery but in the 
presence of pppGpp, and did not show an increased disome peak. Sucrose gradient fractions 
were precipitated and analysed by Western Blotting to confirm the presence of EF-Tu on 
stalled 70S ribosomes. However, EF-Tu could only be detected in the cytosolic fraction in all 
samples. We concluded that after allowing the reaction for 25 min all complexes were already 
stalled with an accommodated tRNA occupying the A-site, making trapping of EF-Tu on the 
stalled complex impossible. The experiments could be repeated with the addition of 
alarmones from the beginning for higher chances of trapping EF-Tu on the stalled ribosome. 
Alternatively, the ErmBL-SRC could be purified and mixed with EF-Tu, Lys-tRNALys and 
alarmones for complex formation. 
In order to get structural insights, we analysed a crystal structure of EF-Tu complexed with 
pppGpp. The overall structure was comparable to an inactive GDP-bound state. Additionally, 
switch I could not be modelled due to adopting an unstructured conformation. Interaction of 
alarmones with the same binding site as GTP/GDP had been shown by a low-resolution 
crystal structure (Suck & Kabsch, 1981), and concordantly we identified a density in the GTP 
domain. Surprisingly, despite the complex being formed with pppGpp, the density matched a 
ppGpp and Mg2+ density. Ribosome-independent pppGpp hydrolysis to ppGpp had been 
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described before (Hamel & Cashel, 1974) and we verified that hydrolysis was indeed EF-Tu 
dependent; in the absence of EF-Tu no hydrolysis was observed, and hydrolysis showed a 
strong correlation with EF-Tu concentration. As EF-Tu depends on EF-Ts as a GEF in vivo, 
we examined whether it also has the capacity to exchange alarmones. In our fluorescent 
screen, we found that the exchange of GTP for ppGpp or GDP is accelerated by EF-Ts, as has 
been reported previously (Arai et al., 1972). Furthermore, we show that EF-Ts able to 
displace any bound alarmone from EF-Tu, in concordance with earlier studies (Miller et al., 
1973). 
For ternary complex formation of EF-Tu−GTP−tRNA, switch I and II adopt a specific 
conformation to allow aa-tRNA binding. Upon further examination of the crystal structure 
and comparing it to both the inactive GDP and the active GTP (GMPPNP) bound state, we 
found that the 3’-OH pyrophosphate moiety would sterically hinder switch I from adopting 
either the α-helical (GTP) or the β-sheet (GDP) ordered conformation. This would render EF-
Tu incapable to accommodate and interact with tRNA. This prompted us to carry out 
electrophoretic mobility shift assays (EMSAs) to monitor native ternary complex formation. 
In the presence of GTP, a ternary complex could be formed with EF-Tu and Lys-tRNALys. At 
equimolar concentrations of GTP and (p)ppGpp, the guanosine-tetraphosphate already 
showed near-complete inhibition of ternary complex formation, and the pentaphosphate had 
only a minor effect. At a four-fold excess of (p)ppGpp, ternary complex formation was 
completely abolished. Moreover, we screened ternary complex formation via fluorescent 
spectroscopy with Cy5Q labelled EF-Tu and Cy3B Phe-tRNAPhe. In this combination, Cy3B 
functions as a donor and Cy5Q as a quencher, so that upon ternary complex formation the 
fluorescent signal is low, and is increased upon complex dissociation. Correspondingly, only 
very low levels of fluorescence could be measured in the presence of only GTP, EF-Tu, and 
tRNA. Upon addition of ppGpp, an increase in fluorescence of 50% could be observed, and 
additional supplementation of GDP lead to a recovery of 80% of the fluorescent signal. 
Notably, the ratio of GTP to ppGpp/GDP in the fluorescent assay was 1:10. Displacement of 
GTP by ppGpp is in agreement with the EMSA, which also showed inhibition of ternary 
complex formation and our affinity assays, which show that both ppGpp and GDP can 
disengage GTP from EF-Tu. Hence, we concluded that (p)ppGpp inhibits EF-Tu by 
obstructing ternary complex-formation. 
However, this study of alarmone mediated inhibition of EF-Tu shows multiple disparities and 
contradictions to earlier studies (Hamel & Cashel, 1973; Miller et al., 1973; Hamel & Cashel, 
1974; Pingoud & Block, 1981). 
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Our affinity measurements of alarmones to EF-Tu and dissociation constants differ vastly 
from other studies. For reference we calculated a Mant-GTP Kd of 1.6 ± 0.4 µM. This is in 
stark contrast to the previously reported Mant-GTP Kd of 60 nM (Gromadski et al., 2002). 
Likewise, our Kd for GDP (0.4 ± 1.3 µM) differed considerably from previously reported 
values. Indeed the Kd for GDP has been indicated to be in the single-digit nanomolar range 
multiple times (Arai et al., 1974; Maracci & Rodnina, 2016), which results in a difference of 
two orders of magnitude. EF-Tu has a substantially lower affinity for GTP, reported to be in 
the 60-500 nM range (Arai et al., 1974; Fasano et al., 1978; Maracci & Rodnina, 2016). This 
is somewhat closer to our calculated values of 1.4 ± 1.1 µM, but still shows a discrepancy. 
Similarly, the Kd value for ppGpp was previously reported to be at 8 nM (Miller et al., 1973), 
whereas our calculated value lies at 0.5 ± 1.2 µM. Since ppGpp has been reported to be able 
to displace even GDP from EF-Tu both in the presence as well as in the absence of EF-Ts 
(Arai et al., 1972; Miller et al., 1973), it must have a higher affinity than GDP, which our 
values do not comply with. Nevertheless, it should be mentioned that in an earlier study a KI 
value of 600 nM has been calculated for ppGpp, which is comparable to our value (Rojas et 
al., 1984); however, this was tested in a competition assay of ppGpp and GDP, rather than 
ppGpp and GTP, and their Kd for GDP was 60 nM. As our reference value for Mant-GTP is 
already higher than past research documented, it could indicate that the majority of purified 
EF-Tu is not present in a nucleotide binding compatible conformation. Another explanation is 
that the setup, like for RbgA-(p)ppGpp affinity measurements, is unsuitable to detect low-
molecular affinities. 
Similarly, the validity of the EMSA is unclear, as only a minority of tRNA displayed a shift. 
A variety of factors could account for this. For one is the EF-Tu substrate for ternary complex 
formation aminoacylated tRNA, so applied tRNA could have been insufficiently charged. 
Furthermore, considering the aforementioned discrepancy in affinity measurements, a fraction 
of purified protein could be misfolded or after purification slightly denatured EF-Tu incapable 
of nucleotide and/or tRNA interaction. 
In contrast to RbgA, EF-Tu, along with other GTPases like IF2, has been reported to be 
capable of using pppGpp as a substrate to carry out tRNA delivery (Hamel & Cashel, 1973; 
Hamel & Cashel, 1974; Milon et al., 2006). ppGpp on the other hand inhibits function by 
preventing ternary complex formation (Legault et al., 1972; Miller et al., 1973; Pingoud & 
Block, 1981). This is in contrast to our EMSA results. Observed inhibition could be due to 
ppGpp contamination of the pppGpp preparation. If one quarter of the prepared compound 
was indeed ppGpp, at 1 mM supposed pppGpp, the ppGpp would be equimolar to added GTP, 
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hence leading to disassembly of the ternary complex as seen for the ppGpp containing 
reaction. 
In our structure of ppGpp–EF-Tu–Mg2+ we observed switch I in a disordered conformation. 
We reason that this is the result of steric clash with the 3’-OH pyrophosphate. However, we 
cannot make any statements about structural arrangements prior to hydrolysis. Recent time-
resolved cryo-EM shows that after hydrolysis and Pi release, switch I temporarily becomes 
disordered before it adopts the GDP-associated β-sheet conformation (Loveland et al., 2020). 
Structural analysis of RbgA also lead to the assumption that the 3’-OH pyrophosphate would 
inhibit G2 ordering. G2 becomes ordered upon interaction with the 50S or immature 50S 
particles (Seffouh et al., 2019). Conversely, biochemical data suggests pppGpp traps RbgA on 
the 50S (Achila et al., 2012), which indicates that in RbgA, there is no steric clash caused by 
alarmones. In EF-Tu, like in RbgA, the pyrophosphates are not coordinated by any protein 
residues, and could likewise adopt a different conformation to allow switch I ordering. Taken 
together, it seems likely that we caught an EF-Tu intermediate as otherwise it remains 
enigmatic how EF-Tu can hydrolyse pppGpp if it were incompatible with switch I ordering. 
To elucidate this concern, complex formation with hydrolysis deficient EF-Tu (e.g. His84Ala 
(Daviter et al., 2003)) could be undertaken. 
Lastly, the physiological relevance of (p)ppGpp mediated inhibition of EF-Tu in vivo has 
always been disputed (Miller et al., 1973; Pingoud et al., 1983; Rojas et al., 1984). In Poly-
Phe assays a ratio of 1:5 showed a reduction of 78% (Miller et al., 1973). Under stringent 
response inducing amino acid starvation conditions the ratio of GTP to ppGpp is close to 1:3 
(280:800 µM) (Zborníková et al., 2019). From this we can infer that only about 40% of 
translation would be inhibited in vivo – that is if all present (p)ppGpp interacts only with the 
translational GTPases. Additionally, EF-Ts can readily displace (p)ppGpp and exchange it for 
GTP, and in vivo concentrations of EF-Ts are greater than used in the cited assay. GTP-bound 
EF-Tu then forms a ternary complex, which is directly transported to the ribosome. To verify 
physiological relevance of translation inhibition, one could induce (p)ppGpp over production 
of a cloned SAS protein, while simultaneously expressing a fluorescent reporter like GFP or 
β-galactosidase for subsequent assays. Prerequisite for such an assay would be that 
transcription of both loci is under the control of an alarmone-independent RNAP, possibly T7, 
which should be confirmed beforehand by measuring transcript levels in the presence of 
alarmones. 
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5.2.  Investigation of novel translation inhibiting antibiotics 
A steady increase of antibiotic resistant microbes has boosted the search for novel antibiotics. 
A group with a concerning resistance profile are classified together as the ESKAPE organisms, 
where each letter stands for the initial of the species. Only two of these organisms 
(Enteroccocus faecium and Staphylococcus aureus) are Gram-positive. The others (Klebsiella 
pneumonia, Acinetobacter baumanii, Pseudomonas aeruginosa and Enterobacter spp.) are 
Gram-negative bacteria and thus possess an additional outer layer, which gives an advantage 
toward antimicrobial compounds targeting and crossing the cell wall. 
To contribute to the fight against antibiotic resistance, we routinely investigate novel 
compounds for antibacterial activity and check for translation inhibition. Additionally, we 
identify targets and resistance mutations and attempt to describe the mechanism through 
which the compound exerts its function. Part of our investigations were the drugs 
Tetracenomycin X and the family of argyrins. 
5.2.1. TcmX 
Gram-positive bacteria have been an invaluable source for the identification of novel 
antibiotics. The tetracenomycin family has first been described in 1979 as a metabolite 
purified from Streptomyces glaucescens (Weber et al., 1979). Crystal structure analysis 
revealed a tetracyclic aromatic polyketide containing a naphthacenequinone chromophore. A 
structural resemblance to the DNA intercalator doxorubicin and preliminary, yet never 
published data, suggested that tetracenomycins exert their activity by disrupting DNA 
replication (Hutchinson, 1997). Growth inhibition assays showed activity against 
Streptomyces and other Actinomycetes, however, none against other Gram−positive or 
−negative bacteria, so only against strains similar to the producer. Additionally, TcmC and 
TcmX showed a strong inhibition of murine leukaemia cells (Rohr & Zeeck, 1990). Like 
other compounds from that time, this family of antibiotics was not further pursued and re-
discovered multiple times in other organsims, including by us. Continuous testing for new 
antimicrobial compounds in a collaborating lab first revealed that TcmX indeed inhibits 
translation, rather than DNA replication (Osterman et al., 2020). This was unexpected as 
TcmC had previously not shown any inhibition of Poly-Phe synthesis (Weber et al., 1979). 
Resistance mutation analysis revealed a binding site on the 50S, rather than on the 30S, where 
another similar compound, tetracycline, binds in the decoding centre, obstructing A-site tRNA 
binding. More specifically, we found resistance mutations found at the beginning of the 
nascent peptide exit tunnel, in proximity to the PTC. 
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While mutation analysis can indicate the binding site, the exact position was determined by 
cryo-EM. Processing of a 70S-TcmX complex with RELION3 revealed one viable class of 
70S particles with 29% (161,195 particles). The class was resolved to a resolution of 2.9 Å. 
The search for additional densities confirmed the binding site to be at the beginning of the 
NPET, close to the PTC, consistent with resistance mutations. The drug stacks upon the non-
canonical U1782-U2586 base-pair with its naphthalene rings C and D. Additionally, two 
magnesium ions are coordinated by oxygens on the B- and C, and the A-ring, respectively. 
One magnesium is in hydrogen-bonding distance to the phosphate backbone of U2441. The 
second magnesium is in hydrogen-bonding distance to N3 of A2587. Besides stacking onto 
the U1782-U2586 base-pair, the C4-hydroxy group in ring A of TcmX forms a strong 
interaction with O4 of the uracil base of U1782. A2062 is in proximity to the TcmX binding 
site and has been shown to play an important role in macrolide mediated stalling by 
protruding into the peptide exit tunnel (Hansen et al., 2002; Vazquez-Laslop et al., 2008). In 
the presence of TcmX, A2062 is not well resolved, however it appears to adopt an outward 
conformation, perpendicular to TcmX, effectively narrowing the path of the nascent chain by 
several angstrom. The C9-carbomethoxy moiety is in proximity to U2585 (3.3 Å to the U2585 
2’-OH), which adopts an activated, induced conformation for peptide-bond formation. 
Density for the base is badly resolved, which makes an exact determination of the 
conformation impossible. The complex was formed with a non-translating 70S ribosome, so it 
remains undetermined if during translation in the presence of TcmX U2585 could become 
stuck in an un-induced conformation, as is the case for the ErmBL staller in the presence of 
erythromycin (Arenz et al., 2014b).  
Moreover, we employed toe-print experiments to confirm whether the drug inhibits 
translation at the initiation, elongation or termination phase. As the TcmX binding site is 
situated a mere 8 Å (2-3 amino acids) from the C76 of the P-site tRNA, we speculated 
elongation could be inhibited after a few cycles of elongation. Toe-printing of a tryptophan 
staller template revealed stalling after seven amino acids at the IFVL sequence, with valine in 
the P-site. This sequence is reminiscent of the ErmCL-staller (IFVI), and accordingly, 
erythromycin (Ery) induced stalling at the same site. On the ErmBL template, TcmX lead to 
stalling only at the penultimate (16th) codon (STIL, with isoleucine in the P-site), behaving 
differently than Ery, which stalled at VDK (7th codon), with aspartate in the P-site. This hints 
at a sequence-specific stalling mechanism of the drug rather than inhibition of translation 
altogether, and explains why initial attempts to screen for translation inhibition with Poly-Phe 
were unsuccessful. Intriguingly, the binding site of tetracenomycin X is on the opposite side 
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of the tunnel wall to erythromycin, thus not sharing identical interaction partners or resistance 
mutations. Binding of both antibiotics simultaneously leaves a distance of only 4.5-5 Å at the 
narrowest point between both antibiotics. Combination therapy using both antibiotics could 
inhibit translation by obstructing the tunnel completely, simultaneously decreasing the 
probability of viable resistance mutations. Unexpectedly, an attempt of disome formation with 
a di-cistronic construct using the TrpL-2Ala staller sequence did not show disome formation, 
in the presence of neither Ery, nor TcmX. An ErmCL_S10K template (Arenz et al., 2014a) 
showed disome formation in the presence of Ery, but not of TcmX. One possible explanation 
is that TcmX induced stalling on these sequences is not strong enough to persist 
centrifugation after the translation reaction. Considering the likelihood of sequence-specific 
translation inhibition, screening of translation of randomised amino acid sequences could be 
conducted. Stalling could be visualised using toe-print assays. Subsequently, cryo-EM 
analysis of identified stalled complexes can elucidate interactions between amino acids, 
TcmX and the tunnel. Due to unsuccessful disome experiments, sucrose gradient mediated 
purification of stalled complexes should be omitted, and saturation of stalled complexes 
reinforced by substoichiometric concentrations of ribosomes compared to the drug. 
Commonly, Gram-negative bacteria possess an efflux pump in the outer membrane (TolC), 
which facilitates the export of detrimental compounds (Zgurskaya et al., 2011), leading to 
increased resistance and tolerance against antibiotics. Notably, an E. coli wild-type strain was 
not inhibited by TcmX. Only upon deletion of TolC did cells become sensitive. Comparing 
resistance mutations to the binding site showed, that the greatest increase in MIC (from 1 µM 
to 16 µM) occurred when the non-canonical base-pair U1782-U2586 was disrupted. Notably, 
only mutations at U2586 to G or A were observed upon natural selection, but not that of 
U1782. Possibly, a mutation in this region perturbs the 23S rRNA and results in a growth-
deficient phenotype. However, artificially introduced U1782C was a viable mutation and 
displayed the same MIC. Mutation of both U1782 and U2586 to cytosine allows the 
formation of another non-canonical base-pair and indeed showed only a minor increase of the 
MIC to 4 µM. This illustrates that the maintenance of a base-pair in the TcmX binding site is 
crucial for activity. 
Strikingly, the U1782-U2586 base-pair is conserved across the eukaryotic domain. A cryo-
EM reconstruction of a H. sapiens 60S-TcmX complex confirmed the same binding site, and 
we postulated the mechanism of action to be translation inhibition in eukaryotic cell lines, as 
well. Accordingly, TcmX inhibited translation of a Fluc-reporter construct both in a 
HEK293T cell-extract and on intact cells. However, there is a 4-fold increase of IC50 between 
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the in vitro (2.5 µM) and in vivo experiments (10 µM), which indicates that TcmX might have 
additional targets within the cell or exerts its function mainly via disruption of the cell 
membrane. 
The cytotoxicity of tetracenomycins (CC50 of 2.5 µM) and related compounds makes them 
unfitting for internal application against bacterial infection in humans, however, topical 
applications could be investigated. Nevertheless, modifications are necessary to decrease 
cytotoxicity. Due to a high degree of conservation of the binding-site, attempting to increase 
bacteria-specificity could prove difficult. Rather, the apoptotic effect could be reduced and 
uptake increased by conjugation with nanoparticles, as done for doxorubicin, for cancer 
treatment (Ahn et al., 2013). Another possibility is decreasing the hydrophobicity. A 
tetracenomycin related group of antibiotics are the elloramycins, in which the C8 of the 
tetracenomycin backbone is rhamnosylated. Thus, it can be inferred that they employ the 
same mechanism and binding site. In elloramycin A, the rhamnose is permethylated and 
exhibits a 5-fold higher reported IC50 of 3.3 µM against leukemia cells, compared to TcmX 
(Rohr & Zeeck, 1990). Elloarmycin B on the other hand shows moderate activity against B. 
brevis, M. luteus and an increased activity against S. aureus, with MICs of 30 and 10 µg/ml, 
respectively (Fiedler et al., 1986). Notably, it lacks one methyl-group on the rhamnose and 
additionally there is a 12a-O-methylation in TcmX. Similarly, the tetracenomycin synthesis 
intermediate TcmD3 shows minimal activity against B. subtilis, contrary to TcmX. It holds 
hydroxyl-side chains, which only later in the synthesis become methylated (Rohr et al., 1988). 
Taken together, a decrease in hydrophobicity could alleviate the cytotoxic effect of TcmX on 
eukaryotic cells increase solubility and increase bacterial-specificity, making it an attractive 
target for future studies. 
5.2.2. Argyrins 
Argyrins displayed great expression inhibition of a Fluc-reporter with an IC50 of 2 µM, and 
near-complete inhibition at 10 µM, exception for argyrin C, which showed an IC50 of 10 µM 
and complete inhibition only at 100 µM. This is in agreement with early translation inhibition 
assays employing [3H]-Phenylalanine, which showed complete inhibition at 60 µM (Selva et 
al., 1996). In the GTPase assay, argyrins showed a lower IC50 than FA, and argyrin B and D 
were as effective as FA (20% residual activity). For FA, the IC50 regarding tripeptide 
formation has been reported to be at 1 µM (Borg et al., 2015), and a GTPase assay on 
P. aeruginosa EF-G showed a similar curve to our results (Palmer et al., 2013). Interestingly, 
argyrin A and C showed a decrease in inhibition at concentrations higher than 50 µM. This 
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could be due to different affinities for EF-G and increased argyrin-dimer formation or 
aggregation, as in the reported crystal structure interaction of the NH in the W2 moiety to a 
neighbouring argyrin have been mentioned (Vollbrecht et al., 2002). 
The inhibition mechanism of argyrin on EF-G had been suggested to induce an elongated 
conformation incompatible with ribosome binding, based on a crystal structure of 
P. aeruginosa EF-G1 (Nyfeler et al., 2012). For verification we performed co-sedimentation 
assays to monitor binding of EF-G to 70S ribosomes in the presence of argyrin B and found 
that EF-G gets trapped on the 70S in the presence of argyrin B. The previously reported 
structure was prepared in the absence of ribosomes, so we analysed the cryo-EM structure of 
our EF-G−Argyrin−70S complex to elucidate whether this reported elongated conformation 
was present in our sample. Reconstruction with RELION3.0 showed three classes containing 
EF-G and argyrin densities, whereas one class (19.85%) comprised empty ribosomes. Thus, 
argyrin traps EF-G on the ribosome, forming a stable complex. Class III presented non-rotated 
particles and worse density for EF-G, thus it was not pursued further. Class II contained 
ribosomes in a rotated state; however domain IV showed hitherto unreported flexibility, 
which resulted in the loss of the α-helix in domain IV. Class I comprised ribosomes in a 
rotated state, i.e. the substrate for EF-G, with all domains of EF-G showing good density. 
Only domain II showed in all classes significantly lower resolution compared to the other 
domains. Class I was subjected to multibody refinement and resulted in an average resolution 
of 2.85 Å across the complex, and EF-G ranging from 3 to 5 Å. Domain II and IV both were 
rather flexible and did not show good resolution. While the L7/12 stalk showed a low 
resolved density, modelling of bL12 and interactions with EF-G was not possible. 
The 30S rotation in class I was similar to that of a translocation intermediate of EF-G−FA 
with ap/P- and pe/E-tRNA, which showed an extensive head swivel of 18° and a rotation of 
the body by 2.5° (Ramrath et al., 2013). Moreover, EF-G conformation did seem comparable 
(R.M.S.D = 1), however, at an average resolution of 6.8 Å, it did not allow for accurate 
comparison. A multitude of EF-G−70S complexes exist, and for analysis of EF-G the 
structure in the presence of the non-hydrolysable GMPPCP with an average resolution of 2.9 
Å (Pulk & Cate, 2013) was chosen as it was extremely similar to the argyrin B bound EF-G 
presented here. This demonstrates that argyrin B bound EF-G does not adopt an elongated 
conformation on the ribosome, as seen by Nyfeler and colleagues. Additionally, despite an 
unambiguous density for GDP, the complex solved here displays a GTP-like conformation 
rather than GDP-like. Whether Pi was released actively from EF-G or diffused during 
complex formation or grid-making cannot be established from this complex. His92 in FA-
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GDP complexes has been reported to flip 90-140° after GTP hydrolysis. This flip cannot be 
observed in our structure, suggesting passive diffusion. Furthermore, the malachite green 
assay indicated that Pi release is indeed hindered. This assay is not suitable for a time 
sensitive analysis, as colour development occurs over a time window of 15-30 minutes. Real-
time and highly sensitive kinetic analysis of single-round Pi release by monitoring 
fluorescently MDCC-labelled phosphate binding protein (MDCC-PBP) as previously reported 
(Savelsbergh et al., 2005; Koripella et al., 2015) can further expand and verify results from 
malachite green assays. 
Further examination of the complex revealed that the interactions with the ribosome and those 
within EF-G itself resembled that of the GMPPCP-stalled EF-G, with exceptions. Naturally, 
interactions between domain III and switch I can no longer be formed. However, interactions 
between domain II, III and switch II are still in place, suggesting this network of salt bridges 
does not become unstable when switch I no longer provides a shield, but are only broken upon 
movement of domain II and III. Notable was the interaction between S12 and domain III, as it 
was different from the GMPPCP structure; it did not interact through residues from the 
domain III β-sheets, but with Q428 in the domain III α-helix. This distinction is likely due to 
different rotation degrees of the 30S. A structure of EF−G trapped by GDPNP (PDB 4v9j) 
(Zhou et al., 2013) shows a more comparable rotation and indeed the interaction is similar to 
the one in our structure. Analogous to our structure, the backbone of C1209 and C1210 in h34 
contacts the conserved Gly531 loop II in domain IV, as seen in the GDPNP-II and Ramrath 
complex, whereas the GMPPCP complex does not show any interactions, due to different 
rotations of the head. Overall, this shows that binding of argyrin likely traps EF-G in a 
translocation intermediate comparable to the Ramrath EF-G−FA structure and GDPNP-II. 
Rotation of the head as seen in our structure likely allows for translocation of tRNAs. 
Conversely, contacts with A1067 as observed here were also reported for cross-linked EF-G, 
which was deficient in translocation (Peske et al., 2000). smFRET or translocation assays 
similar to toe-prints, but allowing only for translocation of one amino acid, need to be 
conducted in order to determine whether argyrin inhibits translocation. 
The eukaryotic homologue of EF-G, eEF2, is targeted by the antibiotic Sordarin, leading to 
inhibition of translocation (Domínguez et al., 1999). Sordarins bind similarly to argyrins 
between domain III and V and its mechanism is suggested to be two-fold: it induces 
conformational changes in the for eukaryotic translocation crucial diphtamide-modified 
histidine in the tip of domain IV, thus preventing translocation; additionally, it blocks 
movement of domain III to and thus hinders the release of eEF2 (Pellegrino et al., 2018). 
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Although bacteria do not possess such a modified residue, a similar mechanism of hindering 
release is conceivable for argyrins. Sordarin binding to eEF2 is increased in the presence of 
ribosomes (Domínguez & Martín, 1998), and a same effect could be applicable to argyrin B. 
While a structure of EF-G and argyrin B in the absence of ribosomes (and nucleotide) has 
been described (Nyfeler et al., 2012), comparison to a GDP-bound EF-G off the ribosome 
reveals it is generally not compatible with argyrin binding (Fig. 21). By forming strong 
interactions with domain III, its movement away from domain II, as seen to a certain extent in 
the FA-stalled complex, is likely inhibited. 
An additional interest for future research is the question whether argyrins effect both 
translocation and recycling. FA has been reported to have different effects on both processes, 
however, with conflicting results (Savelsbergh et al., 2009; Borg et al., 2016b). Contrary to 
translocation, recycling is dependent on GTP hydrolysis and subsequent conformation 
changes. Logically, recycling should be affected to a greater extent than translocation, which 
can also occur in the absence of EF-G. Nevertheless, trapping of EF-G on the ribosome will 
inhibit elongation regardless, whereas recycling is an event that takes place significantly less 
often than translocation. Easily executed pelleting assays, which will pellet only 50S or70S 
but not 30S, or sucrose gradients can be conducted to check for splitting activity. 
Alternatively, stop-flow light scattering approaches as for FA could be conducted to monitor 
recycling in the presence of argyrins. 
Examination of the Pae EF-G1 interactions with argyrin B (Fig. 23A, B) reveal analogous 
interactions compared to our structure; more specifically, van der Waals interactions with 
residues the β-sheet of domain V (M620, M685, F687) as well as contacting the backbone of 
A489. Furthermore, structure alignment shows that relation of domain III and V to one 
another are comparable (Fig. 23C). Curiously, despite the binding site similarities 
Pseudomonas is more susceptible to argyrins (Sasse et al., 2002; Jones et al., 2017), whereas 
E. coli is resistant. Both bacteria are Gram-negative, so the discrepancy cannot be explained 
solely based on membrane composition. WT P. aeruginosa was more sensitive to argyrin B 
than A, and shows an MIC of 16 and 8 µg/ml, respectively (Jones et al., 2017). Deletion of 
efflux pumps in P. aeruginosa halves the MIC values to 8 and 4 µg/ml, respectively. 
Conversely, E. coli becomes only upon deletion of TolC sensitive, but regardless shows a 
higher MIC of 16 µg/ml (Jones et al., 2017). As deletion of TolC and other efflux pumps 
drastically increased susceptibility (Jones et al., 2017), it can be assumed that argyrins are 
indeed capable of passing membranes without difficulty, however, they are neutralised by 
efflux pumps. As this is a common obstacle found in Gram-negative bacteria, researchers 
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have started investigations into TolC inhibiting compounds (Green et al., 2020). A 
combination therapy of both drugs to promote antibiotic efficacy even against Gram-negative 
bacteria could alleviate this problem. 
A protein sequence alignment of EF-G1 of S. aureus, P. aeruginosa and E. coli shows that the 
interaction site is extremely conserved between these bacteria, the latter two are even almost 
entirely identical (Fig. 23D). Additionally amino acids, which displayed resistance mutations 
in P. aeruginosa, are conserved in these bacteria, too. The most striking divergence is located 
in the domain III β-sheet beneath the argyrin, as the Pae Lys448 (Fig. 23A) is not conserved. 
In E. coli this residue is Trp448 (Fig. 9A), whereas in S. aureus, it is His440. Argyrins are still 
able to bind to all these EF-Gs, however affinities might differ. 
 
 
Figure 23: Interactions between Argyrin B and EF-G and comparison to P. aeruginosa EF-G (A) In complex with P. 
aeruginosa EF-G argyrin B forms hydrogen bonds with the backbone of Ala489 (pae numbering), and van der Waals 
interactions with the backbone of Gln487 and Val488 in the linker domain between domain III and IV (B) hydrogen bonds 
are formed with Lys488 and Ser417 in Domain III and several van der Waals interactions occur with Phe687, Met685 and 
Met 620 in domain V. (C, D) Alignment of argyrin B of both models structures. (C) Overall EF-G conformation shows the 
interaction site is similar, but leads to major discrepancy in the G-domain (D) the interactions site in domain III is conserved 
in both P. aeruginosa and E. coli EF-G 
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While only minor differences can be found between argyrin A-D (Fig. 24), they still seem to 
impact the efficiency of EF-G binding. Argyrin A has been proven to target EF-G (Bielecki et 
al., 2012). Argyrin A and C have an alanine at R1and not an α-aminobutyrate residue like 
argyrin B (Fig. 24 B, C). This appears to be important for stable binding to EF-G, as indicated 
by decreased activity in the GTP-hydrolysis assays. Methylation of R3 in Trp2 in ArgC and 
ArgD (Fig. 17C, D) does not face towards EF-G, and does not seem to have any impact on 
interactions, as ArgD does not show less inhibition of hydrolase activity than ArgB. In 
combination with the Ala instead of Abu at R1, however, it seems to have a negative impact. 
Argyrin E, which lacks the methoxy-group on W2, has been shown to have a slightly 
increased IC50 compared to argyrin A-D (Sasse et al., 2002), which stresses the importance of 
hydrogen bonding capacity of this moiety. Argyrin G and H show a hydroxyl-group added to 
the methyl-group next to the thiazole ring, and simultaneous drastically decreased activity 
against P. aeruginosa. It is feasible that the extension towards the beta-sheet in domain III 
could lead to minor clashes and thus reduce affinity to EF-G. 
 
 
Figure 24: Fitting of other Argyrins in the binding site. (A) Argyrin B in the binding site of EF-G between domain III and 
V. R1 is extending towards the β-sheets in domain III and forms interactions (compare S.fig3). (B) Argyrin A is lacking the 
extra methyl-group at R1 (C) Argyrin C is lacking the methyl-group at R1, however is methylated in the Trp2 moiety at R3. 
(D) Argyrin D possesses both the methyl-group at R1 as well as the R3 methylation in Trp2. 
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Notably, eEF2 has been reported not to be targeted by argyrins (Nyfeler et al., 2012). Yeast 
cells were resistant against argyrin B and only became sensitive when the medium was 
supplemented with ethanol/glycerol. The authors concluded that metabolising of these carbon 
sources was mitochondrion-dependent and showed mEF-G1 to be the target for argyrins in 
these cells. Furthermore, they reported that under hypoxic conditions, metabolism becomes 
independent of mitochondrial oxidation and sensitive cancer cell lines became resistant again. 
Due to rapid cell growth, most tumors experience hypoxic conditions, stimulating the growth 
of nearby blood vessels for increased oxygen supply. This is in agreement with only 18 of 512 
tested cancer cell lines sensitive to argyrin B with an IC50 < 1 µM (Nyfeler et al., 2012). 
Nevertheless, it is also possible that the addition of ethanol facilitated argyrin uptake and 
target-interaction, and sensitive cell lines were more permissive for uptake. Although 
mEF−G1 mutations gave some resistance against argyrin B, other, more plausible cellular 
targets are conceivable. In fact, numerous publications demonstrated that argyrins target the 
proteasome (Bulow et al., 2010; Allardyce et al., 2019). New research shows that argyrin B 
selectively binds to the immunoproteasome, which is present only in unhealthy cells 
(Allardyce et al., 2019). This would make argyrin B an ideal compound for antibiotic 
development, as it can target pathogenic bacteria and under normal conditions, it will likely 
not affect healthy cells. 
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6. Methods 
6.1. Buffers and solutions 
Buffer/Solution Composition 
Buffer A 25mM HEPES-KOH, pH 7.4 
20 mM MgOAc 
100mM KOAc 
store at 4 °C 
SDS-PAGE (volumes for two small gels) 
4% stacking gel 
 
 
 
 
 
 
18% separating gel 
 
6.1 mL H2O 
1.3 mL Bis-Acrylamid (30 %; 37.5:1) 
2.5 mL Tris-HCl (0.5 M, pH 6.8) 
100 µL SDS (10 %) 
10 µL TEMED 
100 µL APS (10 %) 
 
1.95 mL H2O 
9 mL Bis-Acrylamid (30 %; 37.5:1) 
3.9 mL Tris-HCl (1.5 M, pH 8.8) 
150 µL SDS (10 %) 
15 µL TEMED 
150 µL APS (10 %) 
10X SDS-PAGE running buffer  
 
250 mM Tris-HCl  
1.92 M Glycin 
1 % (w/v) SDS  
ad 1L with H2O 
4X SDS sample buffer 200 mM Tris-HCl, pH 6.8 
8 % (w/v) SDS 
0.4 % (w/v) bromphenolblue 
40 % (v/v) glycerol 
200 mM DTT 
 
6.2. Ribosome Purification 
6.2.1. Crude Ribosomal pelleting 
Ribosomes were purified as previously described (Nierhaus, 1990). A 4L LB culture of E. coli 
BL21 was incubated at 37 °C and harvested in the exponential phase at an OD600 ≈1.5, by 
centrifugation at 5,000g and 4 °C for 25 min. Pelleted cells were flash frozen in liquid 
nitrogen and stored at -80 ° C, or directly processed further. After resuspension in 20 mL of 
Buffer A, disrupted utilising a microfluidizer. The crude cell lysate was centrifuged at 21,000 
g for 20 min at 4 °C in a JLA-25.5 rotor. Membrane debris was discarded and the cleared 
lysate was layered on a high salt (800 mM KCl) 25% sucrose cushion in buffer A and 
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centrifuged for 17.5 h at 39,000 rpm and 4 °C in a Ti45 rotor. The obtained transparent 
ribosome pellet was resuspended in 4 mL buffer A and A260 was measured. 
6.2.2. Sucrose gradient centrifugation 
For separation of ribosomal particles, a 10-40% sucrose density gradient in buffer A was 
carried out. A total of 120 OD of the purified ribosomes was layered onto the gradient and 
centrifuged for 3.5 h at 30,000 rpm and 4 °C in a SW32 rotor. Ribosome profiles were 
measured at a wavelength of 254 nm using a gradient machine. The 70S peaks were collected 
and subsequently pelleted for 14.5h at 43,000 rpm and 4 °C using a Ti45 rotor. The pellets 
obtained were resuspended in 300 µL buffer A and A260 was measured to determine 70S 
concentration (OD/mL).  
6.3. Biochemical Methods 
6.3.1. In vitro transcription-translation 
For coupled transcription-translation assays, the rapid translation system (RTS E. coli HY; 
biotechrabbit) expressing firefly luciferase (Fluc) from a pIVEX2.3 plasmid was employed 
and prepared according to manufacturer protocol. From a mastermix 4.5 µL reactions were 
aliquoted and mixed with 0.5 µL argyrin in varying concentrations, dissolved in DMSO. Final 
DMSO concentrations were more than 1% of whole reaction volume. Negative control was 
carried out in the presence of DMSO instead of water. The reactions were incubated for 30 
min at 30 °C at 400 rpm in a Thermomixer (Eppendorf) and stopped by adding 5 µL of 
Kanamycin (50 mg/mL) to each reaction. 5 µL of the stopped reaction were transferred to a 
black 96-well microtiter plate and mixed with 40 µL of Fluc substrate (Promega). 
Fluorescence emitted by Fluc oxidised luciferin was measured using a TECAN infinite 
200Pro plate reader. 
6.3.2. Malachite Green Phosphatase Assay 
To assess GTPase activity of EF-G in the presence of argyrins, a Malachite Green 
Phosphatase Assay Kit (BioAssay Systems) was employed. Standard curves were created 
using the kit-supplied phosphate. Where applicable, a white 96-well microtiter plate with 
transparent bottoms was pre-loaded with 0.8 µL of antibiotic in the respective concentration 
and mixed with 72 µL of mastermix, containing 30 nM 70S and 60 nM EF-G in buffer A. 
Reactions were started by addition of 8 µL 200 µM GTP (final concentration 20 µM) and 
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except for the time curve incubated for 60 minutes at room temperature. All reactions were 
carried out in independent duplicates. For colour development, the working reagent was 
prepared using room temperature reagents, 100 volumes of reagent A and 1 volume of reagent 
B. GTPase reactions were quenched by addition of 20 µL working reagent. After 15 minutes 
of colour development, the absorbance measured at a wavelength of 620 nm using a TECAN 
infinite 200Pro plate reader. Contrary to manufacturer recommendation of 30-minute colour 
development, 15 minutes were chosen as precipitations formed during longer incubation 
periods, which altered and falsified exact readings. 
6.3.3. Co-sedimentation assays 
To monitor stable interactions between EF-G and the 70S ribosome, co-sedimentation 
(binding) assays were preformed. 0.4 µM of purified E. coli 70S were mixed with 1 µM EF-G, 
500 µM of nucleotide (GTP) and 50 µM of either argyrin B or fusidic acid. Buffer A was 
added to final 150 µL and incubated at 37 °C for 15 minutes. 120 µl of reaction was 
subsequently loaded on 75 µL of a 10% (w/v) sucrose cushion in buffer A and centrifuged for 
35 minutes at 70,000 rpm in a TLA100 rotor at 4 °C. Supernatant was quickly transferred to a 
new tube and the pellet was resuspended by rinsing 20 µL buffer A thrice over it without air 
bubble formation. 1 µL pellet was diluted in 99 µL MilliQ-H2O and A260 was measured to 
determine 70S concentration (OD/mL x 0.024 = µM). 10 pmol of pellet (P), 10 µL of pre-
centrifugation reaction (R) and supernatant (S) were mixed with 4X SB and boiled at 95 °C 
for 10 minutes before being loaded on a 18% SDS-PAGE. 
6.3.4. SDS-PAGE 
For general protein analysis via SDS-PAGE after Laemmli (Laemmli, 1970), a 18% 
separating gel with 4% stacking gel were prepared and run in 1X SDS-running buffer. 
Samples were mixed according to volume with 4X SB-buffer. As a standard Color Prestained 
Protein Standard, broad range (11-230kDa) (NEB) was loaded. The gel was run at 220V until 
the running front reached the end of the gel. 
For protein detection, gels were subsequently stained with Instant Blue (Expedeon) over night 
and washed with water before image scanning. 
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6.4. Cryo-EM 
6.4.1. Data collection and single particle reconstruction 
For grid formation, 4.5 A260/ml of argyrin B–EF-G–70S complex from the co-sedimentation 
assays were used. 3.5 µl of the complex was applied to 2 nm precoated Quantifoil R3/3 holey 
carbon supported grids and vitrified using a Vitrobot Mark IV (FEI company). Data collection 
was performed using a FEI Titan Krios transmission electron microscope equipped with a 
Falcon II direct electron detector at 300 kV with a dose of 2.5 e-/Å2 per frame, using a pixel 
size of 1.084 Å and a defocus range of -0.5 to -3.5 µm, resulting in 7891 micrographs. The 
first ten frames (28e-/Å2 in total) were aligned using MotionCor2 (Zheng et al., 2017). Power 
spectra, defocus values, astigmatism and estimation of micrograph resolution were 
determined by CTFFIND4 software (Rohou & Grigorieff, 2015). A resolution cut-off of 3.5 Å 
and defocus cut-off of 30,000 were applied. Following further visual inspection of 
micrographs for thon-rings and ice quality, 3466 micrographs were used for automated 
particle picking by GAUTOMATCH (http://www.mrc-lmb.cam.ac.uk/kzhang). 610,946 
particles were extracted using RELION3 (Zivanov et al., 2018) and subjected to 2D-
classficiation using 130 classes. 557,434 particles were focus-sorted with a soft-mask around 
EF-G into four classes for 300 rounds. Class I to III showed EF-G density, whereas class IV 
constituted an empty 70S and was not further pursued. Contrast transfer function (CTF) and 
beam tilt refinement with subsequent Bayesian polishing was performed on class I to III. 
Using the gold standard criterion (Fourier shell correlation of 0.143), post-processed maps 
showed an improved resolution by roughly 0.5 Å, resulting in average resolution of 3 Å for 
class I to III. Class I was subjected multi-body refinement with three masks, consisting of 50S 
with EF-G, 30S body and platform, and 30S head. Resolutions were improved to 2.76 Å, 2.77 
Å and 3 Å, respectively, reaching 2.6 Å in the 50S core. The refined maps were sharpened by 
applying an automatically determined B factor using RELION 3.0 (Zivanov et al., 2018). 
Local resolution and maps filtered according to local resolution were computed using 
SPHIRE 1.3 (Moriya et al., 2017). 
6.4.2. Modelling 
The molecular model for the ribosome was based on a previous cryo-EM structure of the E. 
coli 70S ribosome (PDB 5mgp) (Huter et al., 2017b), where the 30S was divided into head 
and body/platform models. For EF-G, a GMPPCP trapped complex (PDB 4v9p) (Pulk & Cate, 
2013) was used as a start model. Ribosomal structures were rigid-body fit in the respective 
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locally filtered maps, using UCSF Chimera (Pettersen et al., 2004). An atomic model for 
argyrin B was generated de novo from the chemical 2D structure (PubChem CID 9940787) 
using the in Chemdraw integrated Chem3D software. Restraints for argyrin B were generated 
using PHENIX eLBOW (Moriarty et al., 2009). The molecular models were manually 
adjusted and refined using Coot (Emsley & Cowtan, 2004). The atomic models were 
combined and refined using realspace-refined with secondary structure restraints calculated 
by PHENIX 1.14 (Adams et al., 2010). 
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Abstract 
Efficient adaptation to environmental changes is pivotal to all bacterial cells. Almost 
all bacterial species depend on the conserved stringent response system to prompt 
timely transcriptional and metabolic readjustments according to stress and nutrient 
depletion. The stringent response relies on the stress dependent synthesis of the 
second messenger nucleotide (p)ppGpp that pleiotropically targets and reprograms 
processes that consume cellular resources, such as the biogenesis of ribosomes. 
Here we show how (p)ppGpp acts on the ribosome biogenesis GTPase A (RbgA). 
We demonstrate by X-ray crystallography and in vitro activity assays that (p)ppGpp 
prevents the GTPase active conformation of Staphylococcus aureus RbgA by 
sterically blocking the association of the G2 motif via the 3’-pyrophosphate moieties. 
We furthermore show by cryo-EM that RbgA induces structural destabilization at 
H67-71 of the large subunit, suggesting that H67-71 represents the interface for 
RbgA on the large subunit. Taken together, our structural and biochemical 
characterization of RbgA in context of the stringent response alarmone reveals how 
(p)ppGpp affects the function of RbgA and reprograms the GTPase to act as a 
ribosomal large subunit arresting factor.  
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Introduction 
Rapidly reproducing bacterial cells depend on an effective translational machinery to 
maintain their fast growth rate. At the heart of this machinery, ribosomes translate 
mRNA into proteins. However, functional ribosomes have to be assembled in an 
efficient manner to meet the high demand on the translational capacity during cell 
proliferation. In Escherichia coli, ribosome assembly is estimated to take 
approximately two minutes with a corresponding assembly rate of 100,000 ribosomes 
per hour 1. Bacterial ribosome biogenesis involves the initial transcription of a ∼5 kb 
primary ribosomal RNA (rRNA) transcript that is co-transcriptionally cleaved and 
modified to yield three mature rRNAs (23S, 16S and 5S) that provide a platform for 
assembly of large (50S) and small (30S) subunits. Folding of the rRNA occurs co-
transcriptionally and is accompanied by the hierarchically variable and blockwise 
incorporation of ∼50 ribosomal proteins (r-proteins) 2. The assembly process involves 
a set of approximately 100 ribosome biogenesis factors to facilitate cleaving, 
modification and chaperoning of the intermediates in both, the 50S and 30S 
biogenesis pathways 3. Therefore, ribosome biogenesis imposes a high metabolic 
load on bacterial cells and has to be precisely regulated during nutrient starvation to 
preserve cellular resources. In many bacterial species ribosome biogenesis is 
regulated by the stringent response system that senses stress stimuli and signals the 
stress level via the pleiotropically acting nucleotide messenger alarmones (p)ppGpp 
4,5. Upon stress, such as restricted nutrient availability, RSH (RelA/SpoT 
Homologue)-type proteins produce (p)ppGpp by transfer of pyrophosphate from ATP 
onto the 3′-OH moiety of GTP or GDP. Eventually, when environmental conditions 
ameliorate, (p)ppGpp is hydrolyzed by RSH-type hydrolases to retrieve GTP/GDP 
and consequently stress signaling declines. Alarmone-mediated regulation of 
ribosome biogenesis not only includes the repression of rRNA and r-protein gene 
transcription to shut down production of ribosomal components, but may also involve 
the inhibition of ribosome biogenesis factors to block the assembly of ribosomal 
subunits 4,6. In particular, the Staphylococcus aureus ribosome biogenesis 
associated GTPases RbgA, HflX, Era, RsgA and ObgE have been recently shown to 
be directly targeted by (p)ppGpp to suppress GTPase activity 6. It has been 
hypothesized that the (p)ppGpp mediated GTPase activity suppression prevents the 
final ribosome subunit maturation step and might therefore arrest subunits before 
they engage as matured subunits in 70S formation and translation 6.  
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The 50S subunit ribosome biogenesis GTPase RbgA (Ribosome biogenesis GTPase 
A, also: Ylqf) has been shown to be essential for growth in Bacillus subtilis 7. 
Depletion of RbgA leads to a reduction of 70S ribosomes resulting from an arrest of 
large subunit biogenesis at pre-mature 45S particles that lack the ribosomal proteins 
L16, L27, L28, L33, L36 and L37 and might be incompetent in 70S formation 8–12. 
RbgA homologues (YRG family – Ylqf-Related GTPase) are evolutionary widely 
distributed and can be found in all three kingdoms of life 13,14. In Saccharomyces 
cerevisiae, the eukaryotic RbgA homologue Lsg1 acts late during the final ribosomal 
large subunit maturation and was shown to be involved in the GTPase-dependent 
release of the nuclear export adapter Nmd3 upon 60S subunit completion 15–17. RbgA 
belongs to the TRAFAC (translation factor) GTPase family and comprises a N-
terminal Rossmann fold GTP binding domain (G domain) and a C-terminal alpha 
helical domain 18. The HAS-type G domain features a K-loop for K+ ion cofactor 
binding and is characterized by a circularly permuted GTPase fold (cpGTPase) in 
which the conserved G1-G2-G3-G4-G5 motif is rearranged to G4-G5-G1-G2-G3 in 
the protein sequence 18–21. It has been hypothesized that the cpGTPase fold might 
allow a nucleotide ligand-dependent movement of the C-terminal domain, which has 
also been suggested to be involved in rRNA contacts and might participate in rRNA 
remodeling 21. Crystal structures of the RbgA homologues of Thermotoga maritima 
and Bacillus subtilis are available and reveal the N-terminal GTPase fold preceded 
by a alpha helical C-terminal putative RNA binding domain (PDB-IDs 3CNN, 3CNO, 
3CNL and 1PUJ). However, the molecular details of ribosome interaction and the 
mechanism of GTPase activation for 50S maturation have remained enigmatic. 
Furthermore, the mechanism by which the stringent response alarmone (p)ppGpp 
blocks the GTPase activation of RbgA to arrest the maturation of large ribosomal 
subunits is also unknown. 
Here we present high-resolution X-ray crystal structures of S. aureus RbgA in 
presence of GDP, GMPPNP, ppGpp and pppGpp suggesting that the nucleotides do 
not change RbgA’s configuration in the ribosome-free state. We furthermore show by 
cryo electron microscopy (cryo-EM) of B. subtilis RbgA associated to 50S ribosomal 
subunits, that RbgA remodels the large ribosomal subunit in proximity to the A- and 
P-site at the 23S rRNA helices H67-H71. Comparison of ribosome-free RbgA with 
the ribosome associated GTPase active state of the eukaryotic RbgA homologue 
Lsg1 suggests how RbgA GTPase activation is triggered at the large subunit and 
	
	 4	
inhibited by (p)ppGpp. Taken together, our structural and biochemical analyses of 
RbgA for the first time reveal how the GTPase active conformation is suppressed by 
(p)ppGpp to arrest large ribosomal subunits during the stringent response. 
 
 
Results 
 
Structures of S. aureus RbgA bound to GDP and GMPPNP 
Typically, GTPases undergo conformational rearrangements upon hydrolysis of GTP 
to GDP and the subsequent release of inorganic phosphate. To delineate nucleotide 
dependent conformational changes of S. aureus RbgA, we determined its crystal 
structures bound to GDP and the non-hydrolysable GTP analogue guanosine-5'-[( 
β,γ )-imido]triphosphate (GMPPNP) at 2.15 Å and 1.93 Å resolution, respectively 
(Table 1). Both structures revealed the two-domain architecture of RbgA consisting 
of the N-terminal G-domain followed by the C-terminal α-helical putative rRNA 
interaction domain (Fig. 1A-E). Both, GDP and GMPPNP, could be unambiguously 
identified in the unbiased electron density map within the GTPase active site of RbgA 
(Fig. S1A-B). The guanine base is accommodated by stacking interactions of lysine 
88 and lysine 59 and identified by hydrogen bonding interactions of aspartate 86 and 
61, and asparagine 58 of the G5 and G4 GTPase motifs, respectively (Fig. 1D-E). 
Amino acids 129 to 134 of the G1 motif contribute to coordination of the α-, β- and γ-
phosphate moieties via hydrogen bonding and salt bridge interactions (Fig. 1D-E). 
The γ-phosphate of GMPPNP is furthermore surrounded by the non-polar sidechains 
of proline 129 and isoleucine 175 of the G1 and G3 motif and is less well defined in 
the electron density map than the α- and β-phosphate moieties (Fig. S1B). Thus, 
RbgA coordinates its GDP and GTP nucleotides in an identical fashion to other 
homologous GTPases. Despite the different nucleotide content, no significant 
structural differences between the GDP and GMPPNP-bound state could be 
observed. The root mean square deviations (r.m.s.d.) between both structures and 
the individual monomers in the unit cell were below 0.2 Å (Table S1; Fig. S2A-E). 
This observation is substantiated by the fact that both states of RgbA crystallized in 
the same space group with identical cell dimensions (Table 1). Therefore, we 
conclude that the conformational state of RgbA is not necessarily affected by the 
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nature of the nucleotide bound within its active site. However, it is important to note 
that crystal packing might impact the configuration in our structures.  
 
Structures of ppGpp- and pppGpp-bound RbgA  
The alarmones (p)ppGpp inhibit the GTPase activity of RbgA, yet the underlying 
molecular mechanism has remained unknown 6. To address this question, we 
determined the crystal structures of RbgA bound to ppGpp and pppGpp at 1.8 Å and 
1.65 Å resolution, respectively (Fig. 2A-B, Table 1). We unambiguously identified the 
alarmones ppGpp and pppGpp in the unbiased electron density map within the active 
site of the RbgA G-domain (Fig. S1C-D). The GDP and GTP moieties of ppGpp and 
pppGpp, respectively, associate to the active site in an identical fashion as their 
native nucleotide counterparts. The 3’-pyrophosphate moieties of both alarmones 
point away from the active site towards the solvent and seem to be stabilized only by 
the e-amino group of lysine 88 of the G5 motif (Fig. 2A-B). However, lysine 88 is not 
conserved among RbgA homologues arguing against a substantial role of this 
residue for the coordination of (p)ppGpp to RgbA (Fig. S3). This is further supported 
by comparable binding constants of RbgA for GDP, GTP, ppGpp and pppGpp as 
determined by MicroScale thermophoresis (Figs. 2C and S4A-D). Structural 
comparison of the alarmone-bound states of RbgA with its GDP/GMPPNP-bound 
states revealed no significant structural differences as indicated by the low r.m.s.d. (< 
0.3 Å) (Table S1; Fig. S2A-E). These findings show that the alarmones do not alter 
the conformation of ribosome free RbgA. 
 
RbgA binds nucleotides in the absence of magnesium 
Our inspection of the electron density maps of the presented structures did not show 
electron density for magnesium, although magnesium was present in the final size 
exclusion buffer at a concentration of 20 mM. The absence of magnesium is also true 
for the crystal structures observed for the T. maritima RbgA in complex with GDP, 
GTP and GMPPNP (PDB IDs: 3CNN, 3CNO and 3CNL 18). Since the Mg2+ ion 
cofactor is essential for catalysis, we reason that our structures and the previously 
reported structure of the T. maritima homologue do not represent the GTPase active 
conformation of RbgA. In canonical GTPases, binding of Mg2+ in a tetragonal 
bipyramidal coordination sphere is facilitated by the G1, G2 and G3 motifs. 
Serine/threonine of the G1 motif GxxxxGKS/T (P-loop) forms a direct contact while 
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aspartate of the G3 motif DxxG forms a water-mediated contact to the Mg2+, which is 
required for tight binding of the cofactor 22. The coordination sphere is completed by 
a contact via the conserved threonine of the G2 motif. However, our crystal 
structures revealed that although the G1 motif is in a position capable of interacting 
with a properly placed Mg2+ ion, the G2 (switch I) and G3 (switch II) motifs are 
positioned in a manner apparently not allowing interaction with the Mg2+ ion (Fig. 
3A). Comparison of our structure and the T. maritima RbgA structure with the GTP-
bound B. subtilis RbgA revealed that G3 rearrangement might coincide with GTP and 
Mg2+ cofactor binding (Fig. 3B-C). Noteworthy, the G3 motif is directly connected to 
the putative C-terminal RNA binding domain via a linker and rearrangement of the C-
terminal domain upon contact with the large subunit might allow proper positioning of 
the G3 motif and GTP and Mg2+ cofactor binding, or vice versa. Mutation of the 
conserved phenylalanine at position 180 in the G3 linker region has been shown to 
be lethal for B. subtilis RbgA underlining the importance of this region 21. In summary, 
displacement of the G2 and G3 motifs in absence of the proper RNA contact site 
might result in cofactor release and GTPase suppression. 
 
Cryo-EM structure of an RbgA-50S complex  
To analyze the interaction of RbgA with the large ribosomal subunit, we formed 
complexes of RbgA with 50S subunits in the presence of GMPPNP (Fig. S5). Since 
RbgA appears to be involved in a late step in large subunit biogenesis we formed 
complexes with mature 50S subunits, as it has been successfully performed 
previously for other bacterial ribosome biogenesis complexes (e.g. Era 23, RbfA 24 
and RsgA 25,26 on the 30S subunit and EngA 27 and ObgE 28 on the 50S subunit). 
Moreover, mature large subunits have been shown to stimulate the GTPase activity 
of RbgA 19, and Lsg1 was trapped with GMPPNP on mature 60S subunits in the 
presence of Nmd317. Therefore, the RbgA-50S-GMPPNP complex was applied to 
cryo-grids and cryo-EM data was collected on a Titan Krios (FEI) transmission 
electron microscope with a Falcon II direct electron detector. 3D classification using 
FREALIGN 29 revealed two major subpopulations of 50S particles, mature 50S 
particles (34%) and 50S-like particles (34%) that appeared to lack density for specific 
23S rRNA helices, which we termed intermediate 50S (50SInt) particles (Fig. S6). 
Both subpopulations were refined to yield cryo-EM maps of the mature 50S and 
50SInt particles (Fig 4A-B), with average resolutions of 3.6 Å and 3.7 Å, respectively 
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(Fig. S7). Fitting of molecular models for the 50S subunit immediately revealed that 
while strong density for 23S rRNA helices H67-H71 was present in the mature 50S 
subunit, this density was absent in the 50SInt (Figs. 4A-D). This suggested that 
binding of RbgA to the mature 50S subunit leads to a destabilization of rRNA helices 
H67-H71, comparable to the cryo-EM structures of RbgA-depleted 45S particles 11,12 
and also YphC-depleted 45S particles30 (Fig. S8A-D). Surprisingly, no clear density 
for RbgA was observed in the cryo-EM maps of the 50SInt, suggesting that it was not 
stably bound to the particle and/or highly flexible. Filtering of the cryo-EM map to 
lower resolutions indeed revealed a large region of density located at the intersubunit 
surface within the region of H69 (Fig. 4E). Unfortunately, the density is poorly defined 
and may therefore represent the delocalized 23S rRNA helices alone or together with 
RbgA. We noted that the yeast homology of RbgA, Lsg1, was not observed in the 
absence of Nmd3 17 and was poorly resolved in the structure of the pre-60S particle 
31. The use of 0.5% glutaraldehyde crosslinking in the 60S-Nmd3-Lsg1 localized the 
binding site of directly adjacent to H69 17, where we observe the large delocalized 
electron density (Fig. 4F). Therefore, we conclude that if RbgA is present in the 
50SInt complex, being highly flexible due to its likely interaction with the destabilized 
helices H69-H71. 
 
RbgA GTPase inhibition by (p)ppGpp 
Comparison of the crystal structure of alarmone bound S. aureus RbgA, B. subtilis 
RbgA and S. cerevisiae Lsg1 revealed that the δ- and ε-phosphates are placed in a 
position that would allow proper positioning of the G3 motif, but may also prohibit full 
association of the G2 motif and should therefore impede Mg2+ and K+ coordination for 
hydrolase activation (Fig. 5A). Hence, RbgA should not be capable of pppGpp 
hydrolysis. To test this hypothesis, we assayed RbgA GTPase for the ability to 
hydrolyze (p)ppGpp (Fig. 5B-E). Strikingly, RbgA did not hydrolyze (p)ppGpp, 
showing that the additional phosphate moieties prohibit the catalytically active 
conformation likely by blocking association of the G2 motif (Fig. 5B). We additionally 
assayed the GTPase activity of RbgA in presence 70S ribosomes and (p)ppGpp 
(Fig. 5). As expected from a previous study 6, the presence of 70S ribosomes 
stimulated the GTPase activity of RbgA. Incubation of RbgA alone and in presence of 
70S ribosomes with varying ratios of GTP:(p)ppGpp (1:1, 0.5:1 and 0.25:1) revealed 
that the GTP hydrolysis activity of RbgA is repressed only if the concentration of 
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(p)ppGpp exceeds that of GTP, arguing for a competitive inhibition (Fig. 5C-E). 
Summed up, the δ- and ε-phosphate moieties prohibit GTPase activation and might 
therefore sequester RbgA at large ribosomal subunits under stringent response 
conditions. 
 
 
Discussion 
 
(p)ppGpp blocks the GTPase active conformation of RbgA 
In this study, we revealed how the stringent response alarmone (p)ppGpp 
suppresses the GTPase activity of the evolutionary widely conserved and essential 
large ribosomal subunit biogenesis cpGTPase RbgA. Our crystal structures of S. 
aureus RbgA suggest that ribosome-free RbgA exists in a conformation not 
compatible with hydrolysis of GTP, characterized by the displaced G2 and G3 motifs 
(switch I + II) that leads to a deficiency of the active site coordination of Mg2+ and K+. 
We furthermore demonstrate by our biochemical analysis that RbgA is incapable of 
hydrolyzing (p)ppGpp, suggesting that the δ- and ε-phosphate moieties prohibit the 
active conformation by precluding full association of the G2 motif. Association of the 
G2 motif to the active site, however, has previously been noted in a biochemical 
analysis of RbgA from B. subtilis 19 to be crucial for efficient Mg2+/K+ cofactor 
coordination and hence for formation of the active configuration. From our data and 
based on a model of the RbgA switch loop (K-loop), which was derived from a 
homology modeling according to the transition state structure of the GTPase MnmE 
we also conclude, that correct association of the loop structure is required to activate 
the GTPase. We moreover provide evidence for the alarmones (p)ppGpp acting in a 
GTP competitive manner to reduce the GTPase activity of RbgA. This suggests that 
(p)ppGpp likely sequesters RbgA 45S and 50S particles due to GTPase suppression, 
which is supported by the observation that pppGpp increases the affinity of RbgA for 
mature 50S subunits 19. This, in turn, might withdraw mature 50S subunits from the 
formation of translationally active 70S ribosomes and consequently shuts down not 
only ribosome maturation but also protein production to economize cellular resources 
during starvation 6,19. Taken together, our crystal structures and biochemical 
analyses of RbgA suggest that the alarmone (p)ppGpp prohibits formation of the 
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GTPase active configuration by sterically precluding association of the G2 motif via 
the δ- and ε-phosphate moieties in a GTP competitive manner.  
 
Implications for final 50S ribosome subunit maturation  
Final maturation of the large subunit is to some extend conserved between 
prokaryotic and eukaryotic ribosomes and incorporation of uL16 coincides with 
Lsg1/RbgA GTPase activation and release 12,17. However, the process appears 
unequally more intricate in eukaryotes than in prokaryotes. In brief, delivery and 
incorporation of uL16 has been shown in S. cerevisiae to require the dedicated 
chaperone Sqt1 that shields uL16’s N-terminal domain before incorporation at the 
central protuberance close to the P-site 32. Incorporation of uL16 into mature the 
large subunit appears to be concerted with the release of Sqt1, the activation and 
dissociation of the GTPase Lsg1, and the release of large subunit export adapter 
Nmd3 15–17,32. However, it is not precisely understood if the GTPase activity of Lsg1 is 
required to assemble uL16 or if assembly of uL16 leads to activation of Lsg1 and 
Nmd3 release to signal for subunit maturation. A similar but less complex scenario 
has been observed in the prokaryotic 50S maturation. RbgA-depleted cells enrich 
uL16 deficient pre-45S particles and presence of uL16 is required for stimulation of 
the GTPase activity and release of RbgA 12. Cryo-EM of pre-45S particles from RbgA 
depleted cells revealed that four 45S subunit regions have a particular high degree of 
conformational flexibility: the central protuberance, helix 38 (A-site finger), helices 89-
93 of the PTC and helices 67-71 which are required for ribosomal intersubunit 
contacts 11,12. Interestingly, our cryo-EM analyses of RbgA-50S particles show that 
densities for helices 76-71 are absent in the 50SInt structure. Filtering of the cryo-EM 
map to lower resolution, however, revealed a large region of density within the region 
of H69. Since the binding interface of Lsg1 is located in the same region of the LSU 
and the ribosome maturation function is conserved between the homologues, we 
speculate that the RbgA binding interface on the 23S rRNA is analogously located on 
helices 67-71. Noteworthy, the distance between the putative binding site of RbgA as 
identified by cryo-EM and the incorporation site of uL16 in between helix 38 and 89 of 
the 23S rRNA are approximately 40 Å apart. Hence, RbgA might not be activated by 
a direct contact with uL16. It seems more conceivable that incorporation of uL16 
induces structural rearrangement in the 23S rRNA, which propagates towards H68-
71 of the large subunit. The mature 50S arrangement of H69-71 might then allow 
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RbgA to assume the GTPase active configuration by positioning its flexibly linked N-
terminal G-domain and C-terminal putative RNA binding domain to rearrange the G-
motifs capable of hydrolyzing GTP for RbgA release as suggested by the structural 
homology to the G-domain and RNA binding domain of Lsg1 (Fig. 6). In conclusion, 
our observation combined with the available structural data on 45S particles from 
RbgA-depleted cells suggests that RbgA associates to H68-71 of 45S particles, 
which in turn allows proper positioning of the surrounding PTC helices 89-93, helix 38 
(A-site finger) and the adjacent CP compatible with recruitment of the final r-proteins. 
Incorporation of the final r-protein set may then establish the mature configuration of 
the CP and PTC, which leads to the mature configuration of H68-71 and eventually 
the GTPase activation and release of RbgA to signal for 50S completion.    
 
 
Experimental procedures 
 
Cloning of expression constructs. S. aureus rbgA was amplified by PCR from S. 
aureus USA300 genomic DNA (gDNA) using a forward primer that contained a NcoI 
restriction site and the coding sequence for a hexa-histidine tag and a reverse 
primer, which contained a BamHI restriction site. The fragment was digested with 
NcoI and BamHI and cloned into pET24d (Novagen). The B. subtilis rbgA homologue 
was amplified from B. subtilis 168 gDNA and cloned into pET24d via the same 
strategy.   
 
Production and purification of RbgA. Constructs were transformed in E. coli 
BL21(DE3) (Novagen) for overexpression. Cells (Novagen) were inoculated into two 
liters of LB medium, supplemented with 25 g lactose and kanamycin (50 mg/l). Cells 
were incubated at 30 °C over night under rigorous shaking (180 revolutions per 
minute (rpm)). Cells were harvested by centrifugation (3,500 x g, 20 min, 4 °C) and 
resuspended in 20 ml buffer A (20 mM HEPES-Na, pH 8.0, 250 mM NaCl, 20 mM 
KCl, 20 mM MgCl2, 40 mM imidazole) before lysis in a M-110L Microfluidizer 
(Microfluidics). The lysate was cleared at 47,850 x g for 20 min at 4 °C and the 
supernatant was applied onto two 1 ml HisTrap FF columns (GE Healthcare) for Ni-
NTA affinity chromatography. After a wash step with 15 column volumes (CV) of 
buffer A, proteins were eluted with three CV of buffer B (20 mM HEPES-Na, pH 8.0, 
	
	 11	
250 mM NaCl, 20 mM KCl, 20 mM MgCl2, 500 mM imidazole). Proteins were 
concentrated to 1 ml and further purified by size exclusion chromatography (SEC) 
using a HiLoad 26/600 Superdex 75 column (GE Healthcare) equilibrated in buffer C 
(20 mM HEPES-Na, pH 7.5, 200 mM NaCl). The main peak fractions were 
concentrated to 1.5 ml and dialyzed over night at 4 °C against 200 ml buffer C 
containing 10 g HCl-activated charcoal and 1 mM EDTA to remove Mg2+ and co-
purified nucleotides. RbgA was subsequently subjected to a second SEC step using 
a HiLoad 26/600 Superdex 75 column (GE Healthcare) equilibrated in buffer D (20 
mM HEPES-Na, pH 7.5, 20 mM KCl, 20 mM MgCl2, 200 mM NaCl). The main peak 
fractions were concentrated and concentrations were determined using a NanoDrop 
Lite Spectrophotometer. 
 
Preparation of (p)ppGpp. ppGpp and pppGpp were prepared as previously 
described 33. 
 
Crystallization. Purified S. aureus RbgA was concentrated to 20 mg/ml. Nucleotides 
(GDP, GMPPNP, ppGpp or pppGpp) were added at a final concentration of 5 mM 
and RbgA was subsequently subjected to crystallization by sitting drop vapor-
diffusion at 20 °C. Block shaped crystals grew within two days in drops containing: 1 
µl RbgA-GDP and 1 µl crystallization buffer (0.2 M Lithium sulfate, 0.1 M MES pH 
6.0, 35% (v/v) MPD); 1 µl RbgA-GMPPNP and 1 µl crystallization buffer (0.2 M 
Potassium fluoride, 0.1 M MES pH 6.0, 20% PEG 3350);  1 µl RbgA-ppGpp and 1 µl 
crystallization buffer (0.2 M Potassium sulfate, 20% PEG 3350); 1 µl RbgA-pppGpp 
and 1 µl crystallization buffer (0.2 M Potassium fluoride, 0.1 M MES pH 6.0, 20% 
PEG 3350). Crystals were transferred into crystallization buffer containing 20% (v/v) 
glycerol as cryo-protectant, subsequently flash frozen and stored in liquid nitrogen. 
No cryo-protectant was added to the crystals of RbgA-GDP due to the presence of 
35% MPD in the crystallization buffer. 
   
Data collection and structure determination. Diffraction data were collected at 
beamlines ID-30B, ID29 and ID23-1 of the European Synchrotron Radiation Facility 
(ESRF), Grenoble, France 34. Data were processed with the XDS program package 
for data reduction 35, merging and scaling was performed using the AIMLESS 
program as implemented in the CCP4 package 36. The RbgA-GDP dataset was 
	
	 12	
solved by molecular replacement using the crystal structure of B. subtilis RbgA (PDB-
ID: 1PUJ) via the CCP4 implemented program Phaser 37. Coot 38 in combination with 
Refmac5 (CCP4 package) and phenix.refine (PHENIX package39) was used for 
iterative model building and refinement. The GMPPNP, ppGpp and pppGpp RbgA 
state datasets were subsequently solved by molecular replacement using the GDP 
cleared S. aureus RbgA crystal structure (this study) via the CCP4 implemented 
program Phaser and refined using the phenix.refine software. Figures were prepared 
in Pymol (www.pymol.org). 
 
Affinity measurements using Microscale Thermophoresis (MST). MST was 
performed on a Monolith NT.115 (NanoTemper Technologies GmbH, Munich, 
Germany) at 21°C (red LED power was set to 70% and infrared laser power to 25%) 
40. RbgA (50 µM) was labeled with the dye NT 647 according to the supplier’s 
protocol (NanoTemper Technologies). 200 nM RbgA was titrated with GTP, GDP, 
ppGpp or pppGpp starting from a concentration of 0.5 mM in Buffer C (20 mM 
HEPES-Na, pH 7.5, 200 mM NaCl). To each measurement Tween20 (Sigma) was 
added to a final concentration of 0.05 mM. At least nine independent MST 
experiments were recorded at 680 nm and processed by NanoTemper Analysis 
1.2.009. For fitting of the experimental data and Kd determination Origin8G was used. 
 
Co-sedimentation assays. 50S subunits were isolated from the B. subtilis strain 168 
as previously described 41. Binding assays were carried out as previously described 
42, with modifications. 0.4µM B. subtilis 50S were incubated with 1µM B. subtilis 
RbgA and 500µM of GMPPNP at 37 °C for 20 minutes in Binding Buffer (25mM 
HEPES-KOH, pH 7.4, 20 mM MgOAc, 100mM KOAc). The reaction was 
subsequently loaded on a 10% (w/v) sucrose cushion in Buffer A and centrifuged for 
35 minutes at 80,000 rcf in a TLA100 rotor at 4 °C. For each condition, aliquots of the 
initial reaction (R), supernatant (S) and pellet (P) after centrifugation were analyzed 
via SDS-PAGE and stained with Instant BlueTM (Expedeon). 
 
Cryo-grid preparation for the 50S-RbgA-GMPPNP complex. All following steps 
were performed in Binding Buffer (25mM HEPES-KOH, pH 7.4, 20 mM MgOAc, 
100mM KOAc). For grid preparation, 4.5 OD A260/ml of the initial reaction of co-
sedimentation assays was used. All samples were applied to 2 nm precoated 
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Quantifoil R3/3 holey carbon supported grids and vitrified using a Vitrobot Mark IV 
(FEI company). 
 
Cryo-electron microscopy and single-particle reconstructions. Data collection 
was performed using an FEI Titan Krios transmission electron microscope equipped 
with a Falcon II direct electron detector at 300 kV using a pixel size of 1.084 Å and a 
defocus range of 0.5 to 3.5µm, initially resulting in 3995 microgaphs. Ten frames 
(dose per frame of 2.5 e-/Å2) were aligned using MotionCor2 43. Power spectra, 
defocus values, astigmatism and estimation of micrograph resolution were 
determined CTFFIND4 software 44. Micrographs showing Thon rings beyond 3.5Å 
resolution were further inspected for good power spectra, resulting in 1629 
micrographs. Particles were automatically picked by Gautomatch (http://www.mrc-
lmb.cam.ac.uk/kzhang/) and single particles were extracted using RELION 1.4 45. 
Initial alignment was performed with 224,022 particles using FREALIGN 29, using the 
50S from a B. subtilis 70S ribosome 46 as a reference structure. Afterwards a 3D 
classification using the same reference was performed resulting in two major classes, 
representing the 50S and RbgA-GMPPNP-50S-complex (Figure S6). These classes 
were further refined to a final average resolution of 3.58 Å and 3.64 Å (FSC0.143) for 
(Figure S7). 3D classification and initial alignment was performed using three times 
decimated data. The local resolution of the final maps was computed using ResMap 
47 (Figure S7). The final maps were sharpened by dividing the maps by the 
modulation transfer function of the detector and by applying an automatically 
determined negative B factor to the maps using RELION 1.4. Resolution was 
estimated using the ‘‘gold standard’’ criterion (FSC = 0.143). Maps filtered according 
to local Resolution were computed using RELION 2.1 48. 
 
Ribosome preparation for RbgA GTPase assay. B. subtilis 168 was inoculated 
into 250 ml LB medium at an OD600 = 0.05 and incubated at 37 °C to an OD600 = 0.6 
under rigorous shaking (180 rpm). Cells were subsequently cooled down by 
incubation on ice for 20 min and harvested by centrifugation (3,500 x g, 20 min, 4 
°C). The cell pellet was resuspended in 20 ml buffer RI (20 mM Tris/HCl pH 7.6, 15 
mM MgOAc2, 100 mM KOAc, 0.1 mM DTT) before lysis in a M-110L Microfluidizer 
(Microfluidics). Cell debris were removed by centrifugation at 47,850 x g for 20 min 
at 4 °C. The supernatant was transferred to a 35.5 ml polypropylene tube (Beckman 
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Coulter) and combined with 15 ml cushion buffer S17.5 (20 mM Tris/HCl pH 7.6, 15 
mM MgOAc2, 100 mM KOAc, 0.1 mM DTT, 17.5% (w/v) sucrose). Ribosomes were 
pelleted by centrifugation at 200,000 x g for 2 h at 4 °C and resuspended in 400 µL 
RI buffer. 
 
GTPase activity of RbgA. GTPase activity of RbgA was monitored by high-
performance liquid chromatography (HPLC). 1 µM RbgA was incubated together with 
GTP in absence or presence of ppGpp and pppGpp as indicated in figures and text in 
20 mM HEPES-Na, pH 7.5, 20 mM MgCl2, 1 mM KCl and 200 mM NaCl. Ribosomes 
were added at a final concentration of 1 µM where indicated. After 30 minutes at 37 
°C, the reactions were stopped as described previously 49. HPLC analysis was 
carried out on an Agilent 1100 Series system (Agilent Technologies) equipped with a 
C18 column (EC 250/4.6 Nucleodur HTec 3 µM; Macherey-Nagel). Nucleotides were 
eluted from the column with a buffer containing 50 mM KH2PO4, 50 mM K2HPO4, 10 
mM tetrapentylammonium bromide and 20% (v/v) acetonitrile and detected at 260 
nm in agreement with standards. 
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Figures and tables 
 
Table 1	 SaRbgA-GDP	 SaRbgA-GMPPNP	 SaRbgA-ppGpp	 SaRbgA-pppGpp	
PDB-ID 6G0Z	 6G12	 6G14	 6G15	
Data	collection	 	 	 	 	
Space	group	 P	21	21	21	 P	21	21	21	 		P	21	21	21	 		P	21	21	21	
Cell	dimensions	 	 	 	 	
a,	b,	c	(Å)	 71.932	 71.899	 71.781	 72.084	
	 77.812	 77.71	 74.512	 78.467	
	 124.667	 124.36	 125.215	 125.022	
α, β, γ	(°)	 90.00	 90.00	 90.00	 90.00	
	 90.00	 90.00	 90.00	 90.00	
	 90.00	 90.00	 90.00	 90.00	
Energy	(Å)	 0.97625	 0.97903	 0.97625	 0.97625	
Resolution	(Å)	 48.65		-	2.15	 62.24		-	1.93	 47.93		-	1.80	 48.89		-	1.65	
	 (2.23		-	2.15)	 (2.00		-	1.93)	 (1.864		-	1.80)	 (1.71		-	1.65)	
No.	unique	
reflections	
38760	(3822)	 52769	(5238)	 62299	(6048)	 85889	(8495)	
Rmerge	 0.041	(0.277)	 0.056	(0.332)	 0.106	(0.555)	 0.035	(0.989)	
I	/	σI	 8.79	(2.45)	 6.36	(2.08)	 7.88	(1.74)	 24.70	(1.85)	
Completeness	(%)	 99.9	(99.9)	 99.2	(99.5)	 99.0	(97.5)	 100.0	(99.9)	
Redundancy	 2.0	(2.0)	 2.0	(2.0)	 		4.2	(4.2)	 7.4	(7.4)	
CC(1/2)	 1.00	(0.88)	 1.00	(0.54)	 1.00	(0.94)	 1.00	(0.81)	
	 	 	 	 	
Refinement	 	 	 	 	
Resolution	(Å)	 48.65		-	2.15	 62.24		-	1.93	 47.93		-	1.80	 48.89		-	1.65	
Rwork/	Rfree	 18.2	 22.7	 21.7	 21.8	
	 21.7	 25.6	 25.6	 24.4	
No.	atoms	 4989	 5026	 5020	 5090	
				Macromolecule	 4636	 4636	 4541	 4611	
				Ligand	 56	 64	 72	 80	
				Water	 297	 326	 407	 399	
R.m.s	deviations	 	 	 	 	
				Bond	lengths	(Å)	 0.011	 0.008	 0.009	 0.007	
				Bond	angles	(°)	 1.30	 1.12	 1.19	 1.11	
Ramachandran	(%)	 	 	 	 	
Preferred	 98	 98	 99	 97	
Allowed	 1.65	 1.65	 1	 2.82	
Outliers	 0.35	 0.35	 0	 0.18	
*Statistics	for	the	highest-resolution	shell	are	shown	in	parentheses.	
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Figure 1: Crystal structures of S. aureus RbgA bound to GDP and GTP. A: 
Amino acid sequence of RbgA illustrating the domain arrangement (N-terminal G-
domain and C-terminal RNA binding domain). G-motifs are highlighted in turquoise 
and labeled according to the identity (G1-G5). B and C: Crystal structure of RbgA 
(grey cartoon representation) in complex with GDP (B), respectively GMPPNP (C) 
(yellow stick representation) in two 180° rotated views. Secondary structure elements 
are labeled according to their identity and N and C indicate the respective termini. 
The G1-G5 motifs are colored turquoise and are labeled accordingly. D and E: 
Detailed view on the GTPase active sites with the accommodated nucleotide GDP 
(D), respectively GMPPNP (E). Coloring as in B. G-motif and adjacent site chains are 
shown in stick representation and are labeled according to their identity.  
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Figure 2: Crystal structures of S. aureus RbgA bound to ppGpp and pppGpp. A 
and B: Left: Crystal structure of RbgA (grey cartoon representation) in complex with 
ppGpp (A), respectively pppGpp (B) (yellow stick representation). Secondary 
structure elements are labeled according to their identity and N indicates the N-
terminus. The G1-G5 motifs are labeled accordingly. Right: Close-up on the GTP 
binding site. K88 (blue stick representation) of the G5 motif is in close proximity to the 
ε-phosphate moiety. C: Binding and dissociation constants for GTP, GDP, ppGpp or 
pppGpp and RbgA as determined by MicroScale Thermophoresis (MST). Error bars 
represent the standard deviation of the calculated Kd or Ka values based on the fitting 
of the respective experimental data (see supporting information fig. S4). 
 
 
 
 
	
	 22	
 
 
Figure 3: Binding of Mg2+ coincides with rearrangement of the G3 motif (switch 
II). A: Upper panel: Overview of the crystal structure of S. aureus RbgA (grey 
cartoon) in complex with GMPPNP (yellow stick representation). G-motifs that 
participate in phosphate coordination and hydrolysis are colored in turquoise and 
labeled according to their identity. Adjacent helices are labeled according to their 
identity for orientation (compare to fig. 1). Lower panel: Close-up of the GTPase 
active site. The side chains of the G-motifs G1-G3 are shown in blue stick 
representation. Magenta arrows emphasize the rearrangements that have to occur to 
locate the G2-motif (switch I; S-I) and G3-motif (switch II; S-II) in a position 
compatible GTP hydrolysis. B: Crystal structure of T. maritima RbgA (PDB-ID: 3CNN 
18). Representations as in subfigure A. C: Crystal structure of B. subtilis RbgA (PDB-
ID: 1PUJ). Representations as in subfigure A and B. In contrast to the structures of 
S. aureus and T. maritima, B. subtilis RbgA assumes a configuration in which the G3 
motif is repositioned to allow for Mg2+ (green sphere) coordination. 
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Figure 4: Cryo EM structure of Bacillus subtilis RbgA 50S complex. (A) Cryo-
EM maps of mature 50S, and (B) RbgA-50S intermediate with the 50S of PDB-ID 
3J9W fitted; the stalks L1 and L7/12 have been edited out for clarity. (C and D) 
showing the displaced densities for H67-71 (H67 – green; H68 – blue; H69 – yellow; 
H71 - red) in the mature 50S and RbgA-50S complex, respectively. (E and F) Low 
pass filtered maps of the 50S-RbgA complex, with extra density coloured in orange; 
(F) Lsg1, shown in a green cartoon representation (PDB-ID 5T62 17), superimposed 
in the respective binding site. 
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Figure 5: RbgA GTPase inhibition by (p)ppGpp. A: Comparison of the three 
different GTPase G1-, G2- and G3-motif (turquoise) configurations observed in the 
crystal structures of S. aureus RbgA (left panel; this study), B. subtilis RbgA (middle 
panel; PDB-ID: 1PUJ) and cryo-EM structure of S. cerevisiae Lsg1 (right panel; PDB-
ID: 5T62 17). RbgA/Lsg1 is shown in a grey cartoon representation in a close-up view 
on the GTPase active site. The associated nucleotides are shown in a yellow stick 
representation and the coordinated Mg2+ ion is shown as a green sphere. 
Rearrangements of switch I and II required for GTPase activation are indicated by 
magenta arrows. The δ- and ε-phosphate moiety of (p)ppGpp sterically blocks the 
association of the G2 motif as suggested by the G-motif configuration observed in the 
Lsg1 homologue (indicated as orange circle). B: GTP and (p)ppGpp hydrolytic 
activity of B. subtilis RbgA in presence (+70S, grey bars) or absence (-70S, black 
bars) of B. subtilis 70S ribosomes. C, D and E: GTPase activity of RbgA in presence 
(+70S) or absence of 70S (-70S) ribosomes and in dependence of the GTP:(p)ppGpp 
ratio (C: 1 mM : 1 mM; D: 0.5 mM : 1 mM and E: 0.25 mM : 1 mM). 
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Figure 6:  Configuration control of YRG-type GTPase G-motifs by the relative 
arrangement of H69/H71 of the large subunit. Shown are the crystal structures of 
S. aureus (yellow, this study) and B. subtilis (green, PDB-ID: 1PUJ) aligned to the 
G1-motif of the cryo-EM structure of S. cerevisiae Lsg1 (blue, PDB-ID: 5T62 17). The 
relative position of the flexibly connected N-terminal G-domain and C-terminal RNA 
binding domain of the YRG-type GTPases depends on the configuration of H69/H71. 
The mature configuration of H69/H71 might eventually signal for LSU completion to 
allow for GTPase activation by proper positioning of the G-motifs (G1-G5) and 
subsequent GTPase release.  
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Figure S1: Nucleotide omit maps. RbgA is shown in ribbon representation and the 
nucleotides are shown in stick representation. Omit difference maps (green: positive 
density; red: negative density) were calculated from the final models after removing 
the nucleotide ligands and contoured at 3.6 σ. The respective RbgA chain is 
indicated in the upper left and the nucleotides are labeled according to their identity. 
A: RbgA-GDP; B: RbgA-GMPPNP; C: RbgA-ppGpp; D: RbgA-pppGpp. The figure 
was prepared in Coot 1.  
 
Table S1: r.m.s.d.s of RbgA structural alignment  
structure chain target chain r.m.s.d. # atoms 
RbgA-GDP A RbgA-GDP B 0.130 235 
RbgA-GMPPNP A RbgA-GMPPNP B 0.139 254 
RbgA-GMPPNP A RbgA-GDP A 0.164 259 
RbgA-GMPPNP B RbgA-GDP A 0.125 257 
RbgA-GMPPNP A RbgA-GDP B 0.123 243 
RbgA-GMPPNP B RbgA-GDP B 0.169 239 
RbgA-pppGpp A RbgA-GMPPNP A 0.190 255 
RbgA-pppGpp A RbgA-GMPPNP B 0.137 250 
RbgA-pppGpp B RbgA-GMPPNP A 0.154 274 
RbgA-pppGpp B RbgA-GMPPNP B 0.212 264 
RbgA-ppGpp A RbgA-GDP A 0.139 234 
RbgA-ppGpp A RbgA-GDP B 0.150 228 
RbgA-ppGpp B RbgA-GDP A 0.309 262 
RbgA-ppGpp B RbgA-GDP B 0.234 261 
Structures were aligned in PyMOL (pymol.org) 
 
 
	 S-3	
 
 
Figure S2: Superimposition of the of S. aureus RbgA nucleotide states 
observed in this study. A: Superimposition of all monomers observed in the crystal 
structures of RbgA (cartoon) in complex with the nucleotides (stick representation) 
GDP (yellow), GMPPNP (light blue), ppGpp (red) and pppGpp (dark blue). The G-
domain and RNA binding domain of RbgA are indicated and the G-motifs are labeled 
G1-G5. B: Superimposition of chain A and B of RbgA-GDP. C: Superimposition of 
chain A and B of RbgA-GMPPNP. D: Superimposition of chain A and B of RbgA-
ppGpp. E: Superimposition of chain A and B of RbgA-pppGpp. 
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Figure S3: Sequence alignment of RbgA. Shown is the protein sequence 
alignment of RbgA from T. maritima, B. subtilis and S. aureus, illustrating the non-
conserved and alarmone contacting residue lysine 88 (blue label) of S. aureus RbgA. 
The alignment was generated using the MUSCLE online tool (https://www.ebi.ac.uk 
/Tools/msa/muscle/). 
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Figure S4: Quantitative determination of the interaction between RbgA and 
GTP, GDP, ppGpp or pppGpp. RbgA (200 nM) was titrated with increasing amounts 
of GTP (A), GDP (B), ppGpp (C) and pppGpp (D) starting from 0.5 mM. Fitting (solid 
line) of the experimental data (black circles) was achieved using the Origin8G 
software. Residuals (dashed line) represent the deviation of the fitting. Error bars of 
experimental data show the standard deviation (SD) of 9 independent 
measurements.   
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Figure S5: Co-sedimentation assay of RbgA with the mature 50S. Of each 
sedimentation assay, original reaction (R) before centrifugation and supernatant (SN) 
and pellet (P) after centrifugation were applied to an SDS-PAGE and stained with 
Instantblue. RbgA did not pellet without ribosomes, while it can be found in the pellet 
in the reaction with ribosomes, showing binding to the 50S, as previously reported 2. 
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Figure S6: In Silico Sorting scheme for the RbgA-50S complex. 
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Figure S7: Fourier Shell Correlation (FSC) curves of the 50SInt (A) and 50S (B), the 
line at FSC = 0.143 indicates average resolution of the volumes. Filtered by local 
resolution maps coloured according to resolution for the 50SInt complex (C, E) and 
50S (D, F) calculated with RELION. (G) Low-pass filtered map for RbgA-50S 
complex, displaying extra density in proximity to H67. 
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Figure S8: Comparison of 50S-RbgA complex with 45S particles. (A) filtered 50S-
RbgA complex, showing missing density for H68-71 (B and C) Class Ia and IIa of 
RbgA depleted 45S particle 3 showing missing densities for H68-71 and ribosomal 
Proteins (e.g. L16) (B) and displaced H38 and CP (C). (D) YphC depleted 45S 
particle 4 showing missing densities for H68-71, ribosomal Proteins as well as the 
CP. 
 
Supporting references: 
1. Emsley, P. & Cowtan, K. Coot : model-building tools for molecular graphics. 
Acta Crystallogr. Sect. D 2126–2132 (2004).  
2. Achila, D., Gulati, M., Jain, N. & Britton, R. A. Biochemical characterization of 
ribosome assembly gtpase RbgA in Bacillus subtilis. J. Biol. Chem. 287, 8417–
8423 (2012). 
3. Li, N. et al. Cryo-EM structures of the late-stage assembly intermediates of the 
bacterial 50S ribosomal subunit. 41, 7073–7083 (2013). 
4. Ni, X. et al. YphC and YsxC GTPases assist the maturation of the central 
protuberance , GTPase associated region and functional core of the 50S 
ribosomal subunit. Nucleic Acids Res. 44, 8442–8455 (2016). 
 
	 1	
Structural	 basis	 for	 the	 (p)ppGpp-dependent	 control	 of	 the	 translation	
elongation	factor	EF-Tu		
Wieland	Steinchen1,5,6,	Mohamad	Majkini1,5,	Maximiliane	Wieland2,	Anita	Dornes1,	Pietro	 I.	
Giammarinaro1,	 Alexander	 Lepak1,	 Benjamin	 J.	 Burnett3,	 Scott	 C.	 Blanchard3,4,	 Daniel	 N.	
Wilson2	and	Gert	Bange1,6	
	
1Philipps-University	Marburg,	Center	for	Synthetic	Microbiology	(SYNMIKRO)	&	Department	
of	Chemistry,	Hans-Meerwein-Straße,	35043	Marburg,	Germany	
2Institute	for	Biochemistry	and	Molecular	Biology,	University	of	Hamburg,	Germany.	
3Weill	Cornell	Medicine,	Department	of	Physiology	and	Biophysics,	New	York,	NY	10065	
4Present	 address:	 St.	 Jude	 Children’s	 Research	Hospital,	 Department	 of	 Structural	 Biology,	
MS	312,	Room	D1007D,	262	Danny	Thomas	Place,	Memphis,	TN,	USA	
5These	authors	contributed	equally	to	this	work.	
6Correspondence:	
wieland.steinchen@synmikro.uni-marburg.de	
gert.bange@synmikro.uni-marburg.de	
		
ABSTRACT	
Bacteria	have	to	continuously	adapt	to	their	environment	and	cope	with	stress	conditions.	
The	 second	messengers	ppGpp	and	pppGpp	 (also:	 (p)ppGpp)	 regulate	 a	 variety	of	 cellular	
processes	including	protein	biosynthesis.	Here	we	show	that	(p)ppGpp	can	inhibit	translation	
through	binding	to	the	elongation	factor	GTPase	EF-Tu,	which	delivers	amino-acylated	tRNA	
(aa-tRNA)	 to	 the	 A-site	 of	 the	 translating	 ribosome.	 Our	 structural	 analysis	 shows	 that	
(p)ppGpp	locks	the	elongation	factor	into	the	‘inactive’	GDP-bound	conformation	unable	to	
accommodate	 aa-tRNAs.	Moreover,	 binding	of	 the	 alarmone	 leads	 to	 a	 disordering	of	 the	
switch	 I	 region	of	 EF-Tu,	which	 further	 restricts	 the	 functionality	of	 the	EF-Tu	GTPase	and	
might	 affect	 EF-Tu‘s	 phosphorylation	 state.	 The	 guanosine	 exchange	 factor	 EF-Ts	 removes	
ppGpp	 from	EF-Tu,	which	might	be	 important	 to	 ‘reset’	 EF-Tu	once	 stress	 conditions	 fade	
away.	Our	study	further	shows	that	EF-Tu	acts	as	hydrolase	converting	pppGpp	into	ppGpp	
thus	 partaking	 in	 metabolism	 of	 (p)ppGpp.	 Taken	 together,	 these	 findings	 provides	 a	
mechanistic	framework	that	helps	explain	how	(p)ppGpp	controls	protein	biosynthesis	at	the	
level	of	translation	elongation	via	EF-Tu.		
	 2	
INTRODUCTION	
Protein	biosynthesis	by	ribosomes,	translation,	is	central	to	all	living	organisms.	The	process	
of	 translation	 is	 divided	 into	 the	 steps	 of	 initiation,	 elongation	 and	 termination,	 where	
elongation	 represents	 the	 synthesis	phase	 in	which	amino	acids	 are	added	 to	 the	nascent	
polypeptide.	 Elongation	 critically	 relies	 on	 the	 delivery	 of	 cognate	 transfer	 RNA	 (tRNA)	
charged	with	a	specific	amino	acid	(aa-tRNA)	to	a	ribosome	programmed	with	a	messenger	
RNA	(mRNA).	The	delivery	of	aa-tRNAs	to	the	ribosomal	A-site	is	achieved	by	the	elongation	
factor	 GTPase	 EF-Tu,	 which	 in	 its	 GTP-bound	 state	 forms	 a	 ternary	 complex	 with	 the	 aa-
tRNA.	Upon	recognition	of	cognate	codon-anticodon	interactions	at	the	ribosomal	A-site,	the	
GTPase	activity	of	EF-Tu	is	stimulated,	which	ultimately	leads	to	the	dissociation	of	EF-Tu	and	
accommodation	of	the	aa-tRNA	into	the	ribosome	followed	by	peptide	bond	formation.	The	
elongation	 factor	 EF-Ts	 serves	 as	 a	 guanosine	 exchange	 factor	 (GEF)	 for	 EF-Tu,	 which	
promotes	the	GDP	to	GTP	exchange	(1)	and	ternary	complex	formation	(2).	
EF-Tu	consists	of	the	N-terminal	Ras-like	GTPase	domain	(domain	I),	which	is	followed	by	the	
two	β-barrel	 domains	 II	 and	 III	 involved	 in	 the	 interaction	with	 aa-tRNA	 (3).	 Like	 in	many	
other	G-proteins,	domain	I	contains	the	characteristic	G-protein	elements	G1	to	G5	required	
for	 guanosine	 nucleotide	 binding	 and	 magnesium	 ion	 coordination	 (4).	 The	 G2	 and	 G3	
elements	 are	 part	 of	 the	 switch	 regions	 I	 and	 II,	 respectively.	 Switch	 I	 and	 switch	 II	 (in	
Escherichia	 coli	 EF-Tu	 amino	 acids	 40-62	 and	 83-100,	 respectively)	 undergo	 large	
conformational	rearrangements	during	ternary	complex	formation	and	aa-tRNA	selection	on	
the	ribosome,	which	depend	on	the	presence	of	the	magnesium	ion	and	the	γ-phosphate	of	
GTP	 (5,	 6).	 Thus,	 GTP	 binding	 to	 EF-Tu	 induces	 large	 conformational	 rearrangements	 of	
domains	II	and	III	relative	to	domain	I,	enforced	by	the	nucleotide-specific	configurations	of	
both	switch	regions	(7,	8).	The	GTP-dependent	movement	of	switches	I	and	II	causes	domain	
III	 to	 pack	 against	 switch	 II,	 opening	 a	 cleft	 between	 domains	 I	 and	 II	 into	 to	 which	 the	
acceptor	end	of	 the	aa-tRNA	binds.	Domain	 III	 provides	 the	binding	 site	 for	 the	T	 stem	of	
tRNA	(3).		
Protein	biosynthesis	 is	 inhibited	during	conditions	of	amino	acid	 limitation.	 In	bacteria,	the	
response	to	amino	acid	limitation	is	mediated,	 in	part,	by	the	production	of	the	nutritional	
alarmones	 ppGpp	 and	 pppGpp	 (collectively:	 (p)ppGpp	 or	 alarmones)	 (9,	 10).	 Synthesis	 of	
(p)ppGpp	is	carried	out	by	enzymes	of	the	RelA/SpoT	homology	(RSH)	family	(11),	which	bind	
to	 ribosomes	 along	 with	 deacylated	 tRNA	 within	 the	 A-site	 to	 catalyze	 the	 transfer	 of	
pyrophosphate	 (β-	 and	 γ-phosphates)	 from	 ATP	 to	 the	 ribose	 3’-OH	 of	 GDP	 or	 GTP	 to	
synthesize	 ppGpp	 or	 pppGpp,	 respectively.	 The	 (p)ppGpp	 alarmones	 affect	 a	 plethora	 of	
cellular	processes	 rendering	 the	cellular	metabolism	more	 robust	 to	amino	acid	 starvation	
(10,	12,	13).	ppGpp	can	inhibit	translation	(14)	by	binding	IF2	(15,	16),	EF-G	(14,	15)	and	EF-
Tu	 (14,	17).	While,	 there	exists	a	concrete	structural	understanding	of	how	ppGpp	 inhibits	
IF2	(16)	the	molecular	basis	of	how	(p)ppGpp	affects	EF-Tu	has	yet	to	be	revealed.	
To	fill	this	knowledge	gap,	we	examined	the	molecular	mechanism	underlying	the	(p)ppGpp-
dependent	control	of	EF-Tu.	Our	study	shows	that	ppGpp	and	pppGpp	 interact	with	EF-Tu	
with	similar	affinities	as	their	counterparts	GDP	and	GTP,	respectively.	We	determined	the	
crystal	 structure	 of	 EF-Tu	 bound	 to	 ppGpp/Mg2+	 showing	 that	 the	 alarmone	 ‘locks’	 the	
elongation	 factor	 in	 an	 ‘inactive’	 conformation	 consistent	with	GDP-bound	 structures	 and	
furthermore	provokes	repulsion	of	the	switch	 I	 region	due	to	 its	3’-pyrophosphate	moiety.	
Our	biochemical	analysis	reveals	that	ppGpp	disables	the	binding	of	EF-Tu	to	aa-tRNAs	and	
that	ppGpp	 can	be	discharged	 from	EF-Tu	by	 the	nucleotide	exchange	 factor	 EF-Ts.	 These	
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findings	collectively	suggest	that	(p)ppGpp	inhibits	translation	by	reducing	ternary	complex	
concentrations	 in	 the	 cell,	 which	 may	 enhance	 the	 nutrient	 limitation-induced	 stress	
response	by	further	increasing	RelA-mediated	alarmone	synthesis.	
	
RESULTS	
(p)ppGpp	competitively	inhibits	GTP	and	GDP	binding	to	EF-Tu.	Already	30	years	ago,	it	was	
suggested	that	(p)ppGpp	can	inhibit	the	elongation	factor	EF-Tu	(14).	To	recapitulate	these	
early	 findings	based	on	ppGpp	purified	from	E.	coli	 ‘magic	spot’,	we	re-analyzed	the	effect	
with	enzymatically	synthesized	and	purified	ppGpp	and	pppGpp	(18)	on	E.	coli	translation	in	
vitro	 using	 enhanced	 green	 fluorescent	 protein	 (eGFP)	 as	 a	 reporter.	 These	 experiments	
show	that	the	both	alarmones,	ppGpp	and	pppGpp,	inhibit	translation	in	a	dose-dependent	
manner	(Fig.	1A).	
Next,	 we	 wanted	 to	 determine	 the	 binding	 affinity	 between	 (p)ppGpp	 and	 EF-Tu.	 The	
elongation	factor	was	recombinantly	produced	in	E.	coli	and	 initially	purified	by	a	two-step	
protocol	consisting	of	a	Ni-ion	affinity	followed	by	size-exclusion	chromatography.	However,	
most	 EF-Tu	 purified	 in	 this	 fashion	 was	 in	 a	 GDP-bound	 state,	 likely	 owing	 to	 its	 strong	
interaction	with	 the	nucleotide.	We,	 therefore,	purified	EF-Tu	 in	 the	absence	of	Mg2+,	 and	
additionally	added	EDTA,	to	strip-off	residual	Mg2+	and	nucleotide	from	EF-Tu	(19,	20)	(Fig.	
S1).	With	 nucleotide-free	 EF-Tu	 in	 hand,	 we	 next	 probed	 the	 binding	 of	 a	 fluorescently	
labeled	GTP	(i.e.	Mant-GTP)	to	EF-Tu,	which	yielded	a	dissociation	constant	(Kd)	of	1.6	±	0.4	
µM	 (Fig.	 1B).	 The	 binding	 of	 alarmones	 was	 probed	 indirectly	 through	 competition	 with	
Mant-GTP	binding	to	EF-Tu.	Hereby	ppGpp	displayed	a	similar	inhibitory	constant	(Ki)	value	
as	GDP	(i.e.	0.5	±	1.2	µM	and	0.4	±	1.3	µM,	respectively),	while	the	Ki	value	for	pppGpp	was	
closer	to	GTP	(i.e.	1.8	±	1.2	µM	and	1.4	±	1.1	µM,	respectively;	Figs.	1C	and	D).	Hence,	the	Ki	
values	 for	 the	 5’-diphosphate	 nucleotides	 GDP	 and	 ppGpp	 are	 approximately	 3-	 to	 4-fold	
lower	than	for	the	5’-triphosphates	GTP	and	pppGpp,	indicative	of	higher	affinity	binding	to	
EF-Tu.	
In	 order	 to	 clarify	 of	 whether	 the	 (p)ppGpp	 is	 specific	 to	 EF-Tu	 from	 the	 Gram-negative	
model	 bacterium	 E.	 coli,	 or	 if	 such	 findings	 also	 extend	 to	 other	 bacteria,	 we	 analyzed	
(p)ppGpp	 interactions	with	EF-Tu	 from	 the	Gram-positive	model	organism	Bacillus	 subtilis.	
Here,	similar	values	as	described	above	for	E.	coli	EF-Tu	were	observed,	suggesting	that	the	
(p)ppGpp-dependent	 regulation	 of	 EF-Tu	 is	 a	 conserved	 feature	 among	 evolutionarily	
divergent	bacterial	species	(Fig.	S2).		
Crystal	structure	of	EF-Tu	bound	to	ppGpp/Mg.	To	gain	insights	into	the	molecular	basis	of	
(p)ppGpp-mediated	inhibition	of	EF-Tu,	we	determined	the	crystal	structure	of	E.	coli	EF-Tu	
in	the	presence	of	pppGpp	to	a	resolution	of	2.0	Å	(Table	S1).	The	majority	of	EF-Tu	could	be	
built	with	the	exception	of	amino	acid	residues	40-60	containing	the	switch	I	region	(Fig.	2A).	
The	 structure	 showed	 the	 typical	 appearance	of	 EF-Tu	with	 its	N-terminal	GTPase	domain	
(domain	I)	followed	by	the	two	β-barrel	domains	II	and	III	(Fig.	2A).	The	relative	arrangement	
of	 the	domains	 I-III	 to	each	other	was	highly	 reminiscent	 to	 the	GDP-bound	state	of	EF-Tu	
with	a	root	mean	square	deviation	(r.m.s.d.)	of	0.474	Å	over	2011	atoms	(Fig.	2B;	Fig.	S3).	
Moreover,	 the	 conformation	 of	 our	 EF-Tu	 structure	 clearly	 differed	 from	 those	 previously	
observed	in	presence	of	the	GTP	analog,	GMPPNP	(Fig.	2C;	Fig.	S3).	Inspection	of	the	active	
site	revealed	an	electron	density	that	could	be	unambiguously	assigned	to,	and	refined	with,	
ppGpp	and	a	single	magnesium	ion	(Mg2+)	(Fig.	S4).		
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The	binding	of	ppGpp	to	EF-Tu	is	achieved	in	the	same	manner	as	for	GDP	(Fig.	2D	and	ref.	
(21)).	 The	 guanine	 base	 is	 sandwiched	 between	 the	 side	 chains	 of	 K136	 and	 L175.	 K136	
furthermore	 interacts	 with	 its	 ε-amino	 group	 with	 O1	 of	 the	 ribose.	 Hydrogen-bonding	
interactions	with	the	guanine	base	of	ppGpp	are	established	between	N135	and	nitrogen	7,	
D138	and	the	6’-oxo	group	and	S173	and	the	nitrogen	1	and	the	2’-amino	group	of	the	base,	
respectively.	The	α-	and	β-	phosphate	moieties	at	the	5’	end	of	the	ribose	are	coordinated	
mainly	 through	 the	 backbone	 amides	 of	 D21,	 G23,	 K24,	 T25	 and	 T26	 and	 additionally	
through	 the	 side	 chains	 of	 K24	 and	 T25	 (Fig.	 2D).	 Four	 water	 molecules	 along	 with	 the	
hydroxyl	group	of	T25	and	the	β-phosphate	of	ppGpp	coordinate	the	magnesium	ion.	The	δ-	
and	ε-	phosphate	moieties	of	ppGpp	are	not	further	coordinated	and	point	away	from	the	
active	site	towards	the	switch	I	region	(Fig.	2D).	
The	disordered	conformation	of	the	switch	I	region	in	our	ppGpp-bound	EF-Tu	structure	(Fig.	
2E)	is	in	contrast	to	its	conformation	in	the	GDP-bound	state	of	EF-Tu	in	which	the	switch	I	
region	 forms	 a	 short	 α-helical	 segment	 followed	 by	 an	 anti-parallel β−ribbon	 (Fig.	 2F).	
Superposition	of	 the	ppGpp-	and	GDP-bound	structures	shows	that	 the	positions	of	 the	δ-
 and	 ε-	 phosphate	 moieties	 of	 ppGpp	 and	 the	 switch	 I	 region	 are	 incompatible,	 mainly	
through	electrostatic	clashes	of	the	pyrophosphate	with	the	switch	I	residues	F46	and	D50	
(Fig.	2F).	The	same	residues	would	also	provoke	clashes	with	ppGpp	in	the	aa-tRNA-bound	
closed	conformation	of	EF-Tu	(Fig.	2G).	We	thus	conclude	that	(p)ppGpp	inhibits	the	function	
of	EF-Tu	by	interfering	with	the	conformational	rearrangements	of	the	switch	I	region	of	the	
elongation	factor.	
(p)ppGpp	 inhibits	 EF-Tu	 ternary	 complex	 formation.	 The	 structure	 and	 conformational	
rearrangements	 of	 switch	 I	 are	 crucial	 for	 the	 nucleotide-dependent	 traversing	 of	 EF-Tu	
between	its	‘open’,	GDP-bound	and	‘closed’,	GTP-bound	conformations,	the	latter	one	being	
able	to	interact	with	aa-tRNA	(3).	These	observations	suggested	to	us	that	(p)ppGpp	should	
destabilize	 the	 EF-Tu•GTP•aa-tRNA	 ternary	 complex.	 To	 test	 this	 hypothesis,	 we	 initially	
performed	 electrophoretic	 mobility	 shift	 assay	 (EMSA)	 experiments.	 In	 this	 assay,	 the	
binding	 of	 Lys-tRNALys	 to	 EF-Tu	 in	 presence	 of	 GTP	 is	 evidenced	 by	 an	 altered	 migration	
behavior	 of	 the	 tRNA	 compared	 to	 the	 absence	 of	 GTP	 (Fig.	 3A).	 Addition	 of	 ppGpp	 or	
pppGpp	 with	 increasing	 concentrations	 (ratios	 of	 1:5,	 1:1	 and	 5:1	 (p)ppGpp	 to	 GTP)	
diminished	 the	 observed	 difference	 in	 band	 migration,	 indicating	 a	 disruption	 of	 the	 EF-
Tu•GTP•Lys-tRNALys	 ternary	 complex	 (Fig.	 3A).	 To	 further	 probe	 this	 assessment,	 we	
performed	 an	 ensemble	 fluorescence	 investigation	 in	 which	 ppGpp	 was	 added	 to	 pre-
formed	ternary	complex	(Fig.	3B).	 In	the	absence	of	EF-Ts	we	observed	approximately	50%	
dissociation	of	 ternary	complex	when	ppGpp	was	added	 (100	µM;	10,000-fold	excess	over	
GTP).	Remaining	ternary	complex	was	efficiently	dissociated	by	addition	of	GDP	(100	µM).	In	
presence	of	EF-Ts,	 the	observed	rate	of	 ternary	complex	turnover	was	markedly	enhanced	
while	 the	overall	extent	of	 ternary	complex	dissociation	was	unchanged.	These	 finding	are	
consistent	 with	 both	 dissociation	 processes	 taking	 place	 via	 nucleotide	 exchange	 on	 the	
intact	 ternary	 complex	 (2,	 22).	 Taken	 together,	 these	 findings	 show	 that	 alarmones	
destabilize	aa-tRNA	binding	to	EF-Tu,	and	as	such	prohibit	productive	transfer	of	aa-tRNAs	to	
a	translating	ribosome.		
EF-Tu	is	able	to	hydrolyze	pppGpp	into	ppGpp.	While	we	crystallized	EF-Tu	in	the	presence	
of	 pppGpp,	 we	 observed	 ppGpp	 in	 the	 determined	 structure.	 This	 observation	 could	 be	
explained	 by	 non-enzymatic	 pppGpp	 hydrolysis	 or	 contaminating	 ppGpp	 in	 our	 pppGpp	
preparation,	upon	which	the	higher	affine	ppGpp	would	preferentially	bind	to	EF-Tu	instead	
of	pppGpp	(Figs.	 1C	and	D).	However,	 it	could	also	 indicate	 the	ability	of	EF-Tu	to	actively	
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remove	the	γ-phosphate	moiety	of	pppGpp	in	order	to	generate	ppGpp.	Consistent	with	the	
latter	 model,	 we	 found	 that	 the	 incubation	 EF-Tu	 with	 pppGpp	 degraded	 pppGpp	 into	
ppGpp	 in	 a	 dose-dependent	manner	 by	 removal	 of	 the	 5’	 γ-phosphate	 (Fig.	 4)	 suggesting	
that	EF-Tu	functions	as	a	pppGpp	hydrolase.		
Removal	 of	 (p)ppGpp	 by	 EF-Ts.	 During	 the	 normal	 cycle	 of	 EF-Tu	 its	 GTPase	 activity	 is	
stimulated	 in	 codon-dependent	manner	 by	 the	 translating	 ribosome,	 ultimately	 triggering	
aa-tRNA	accommodation	and	release	of	EF-Tu•GDP	 from	the	 ribosome.	Recycling	of	EF-Tu	
from	 the	GDP-bound	 state	 is	 facilitated	by	 EF-Ts,	 a	GEF	 that	 binds	 EF-Tu	 to	 facilitate	GDP	
release	 and	 GTP	 binding,	 followed	 by	 EF-Ts	 dissociation	 (1,	 19).	 To	 probe	 whether	 EF-Ts	
would	 similarly	 act	 as	 a	 GEF	 on	 EF-Tu•(p)ppGpp,	 we	 performed	 pull-down	 experiments	
where	we	pre-incubated	EF-Tu	with	an	excess	of	nucleotides	and,	after	 incubation	with	or	
without	 EF-Ts	 followed	 by	 removal	 of	 unbound	 (or	 released)	 nucleotides	 by	 extensive	
washing,	 analyzed	 EF-Tu’s	 nucleotide	 content	 by	 HPLC.	 In	 the	 absence	 of	 EF-Ts,	 EF-Tu	
retained	an	approximately	equimolar	amount	of	GDP,	ppGpp	and	pppGpp	nucleotides	while	
addition	of	EF-Ts	resulted	in	the	loss	of	nucleotide	coordination	by	EF-Tu	(Fig.	5A).	We	also	
probed	 EF-Ts-dependent	 nucleotide	 coordination	 by	 EF-Tu	 with	 size-exclusion	
chromatography	again	evidencing	that	EF-Ts	weakens	the	interaction	of	(p)ppGpp	with	EF-Tu	
resulting	 in	 release	 of	 the	 nucleotides	 (Fig.	 5B).	 These	 data	 suggest	 that	 EF-Ts	 is	 able	 to	
remove	(p)ppGpp	from	the	EF-Tu•(p)ppGpp	complex.		
	
DISCUSSION	
When	microorganisms	 encounter	 amino	 acid	 limitation,	 productive	 protein	 biosynthesis	 is	
hindered	 because	 less	 aminoacylated	 tRNAs	 are	 available	 for	 translation.	 The	 stringent	
factor	RelA	(aka	Rel)	binds	to	uncharged	tRNAs	(23,	24)	and	its	(p)ppGpp	synthetic	activity	is	
massively	stimulated	when	the	tRNA/RelA	complex	binds	to	the	A-site	of	ribosome	 lacking	
cognate	aa-tRNAs	 (25-28)	 (Fig.	 6,	 I).	By	 this	mechanism,	 the	 intracellular	concentrations	of	
(p)ppGpp	 can	 rise	 up	 to	 1	 mM	 (10).	 Inhibition	 of	 translation	 through	 ppGpp	 via	 the	
translational	 GTPase	 EF-Tu	 had	 been	 identified	 early	 on	 (14,	 17).	 However,	 the	 precise	
molecular	mechanism	by	which	(p)ppGpp	acted	on	EF-Tu	was	unclear.		
Our	structural	analysis	now	shows	that	ppGpp	and	pppGpp	interact	with	EF-Tu	in	the	same	
way	 (and	 with	 similar	 affinities)	 as	 their	 counterparts	 GDP	 and	 GTP,	 respectively.	 Thus,	
ppGpp	and	pppGpp	are	competitive	inhibitors	of	GTP-binding	to	EF-Tu	in	the	context	of	the	
cell.	Our	structure	of	EF-Tu	bound	to	ppGpp	shows	that	the	protein	adopts	a	conformation	
highly	similar	to	the	EF-Tu•GDP	complex,	which	is	unable	to	interact	with	aa-tRNA	(Fig.	6,	II).	
Additionally,	the	δ-	and	ε-phosphate	moieties	ppGpp	enforces	a	disordering	of	the	switch	I	
region	 because	 of	 steric	 clashing.	 This	 observation	 adds	 another	mechanistic	 level	 to	 the	
ppGpp-dependent	inhibition	of	aa-tRNA	binding	to	EF-Tu,	because	the	switch	I	region	needs	
to	undergo	a	distinct	and	GTP-dependent	conformational	change	in	order	to	allow	binding	of	
acceptor	end	of	the	aa-tRNA	into	a	cleft	formed	between	domains	I	and	II.	Thus,	our	study	
explains	how	(p)ppGpp	inhibits	EF-Tu	by	hindering	the	formation	of	the	EF-Tu•GTP•aa-tRNA	
ternary	complex	(Fig.	6,	II).		
Our	study	also	showed	that	EF-Ts	is	able	to	remove	(p)ppGpp	from	EF-Tu,	which	is	likely	to	
be	 important	 to	 ‘reset’	 the	elongation	 factor	once	stringent	 response	conditions	 fade,	and	
contribute	to	the	steady-state	equilibrium	between	GDP,	GTP	and	(p)ppGpp	during	‘relaxed’	
conditions,	where	the	basal	level	of	(p)ppGpp	is	approximately	10	to	20	µM	(Fig.	6,	III).		
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To	our	surprise,	we	also	 found	that	EF-Tu	contains	a	hydrolase	activity,	which	can	remove	
the	γ-phosphate	moiety	from	pppGpp	in	order	to	generate	ppGpp	(Fig.	6,	IV).	So	far,	only	the	
E.	 coli	 GppA	 protein	 was	 thought	 to	 contain	 such	 a	 functionality	 (29).	 This	 finding	 could	
suggest	 that	 EF-Tu	 and	 some	 other	 GTPases	 might	 also	 contribute	 to	 the	 conversion	 of	
pppGpp	 to	 ppGpp	 inside	 cells.	 In	 contrast	 to	 EF-Tu,	 however,	 the	 GTPase	 RbgA	 from	
B.	subtilis,	which	is	involved	in	the	biogenesis	of	50S	ribosomal	subunits,	does	not	hydrolyze	
pppGpp	(30)	and	thus	further	studies	are	required	to	elaborate	on	this	idea.	
We	further	noticed	that	the	disordering	of	the	switch	I	region	by	ppGpp	could	have	further	
consequences	on	EF-Tu.	Specifically,	regulation	of	EF-Tu	 is	known	to	occur	through	several	
phosphorylation	 sites	 (31-33)	 including	 a	 highly	 conserved	 threonine	 within	 the	 switch	 I	
region	(e.g.	T61	(E.	coli),	T63	(B.	subtilis)	or	T64	(Mycobacterium	tuberculosis)).	As	noted	by	
Talavera	et	al.,	however,	T61	(E.	coli	EF-Tu)	is	‘hidden’	within	the	nucleotide-binding	pocket	
in	 both	 the	GDP-	 and	GTP-bound	 states	 (34),	making	 it	 not	 intuitively	 clear	 how	 a	 kinase	
could	 gain	 access	 to	 this	 non–surface-exposed	 residue	 (Fig.	 6,	 V).	 Through	 the	 (p)ppGpp-
induced	disordering	of	the	switch	I,	however,	this	threonine	would	readily	become	surface-
exposed	 (Fig.	 S5)	 and	 thus	 more	 amenable	 to	 phosphorylation.	 This	 mechanism	 would	
provide	 an	 elegant	way	 of	 coupling	 the	 stress-dependent	 cellular	 (p)ppGpp	 pool	with	 the	
phosphorylation	state	of	EF-Tu	to	enable	an	overall	 inhibition	of	bacterial	protein	synthesis	
at	e.g.	the	onset	of	(endo-)spore	formation	(35)	or	dormancy	(36).	
	
MATERIALS	&	METHODS	
Cloning	and	mutagenesis.	E.	coli	EF-Tu	and	EF-Ts	were	amplified	from	E.	coli	K-12	MG1655	
and	B.	subtilis	EF-Tu	from	B.	subtilis	strain	3610	genomic	DNA	by	polymerase	chain	reaction	
(PCR)	with	the	primers	listed	in	Table	S2	using	Phusion	High-Fidelity	DNA	polymerase	(NEB)	
according	to	the	manufacturer’s	manual.	The	resulting	PCR	fragments	were	introduced	into	
pET24d	(E.	coli	and	B.	subtilis	EF-Tu)	or	pET16b	(E.	coli	EF-Ts)	vectors	(Novagen)	and	encoded	
hexahistidine-tags	in	frame	with	their	DNA	sequences	(Table	S2).		 	
Protein	Production	and	Purification.	Proteins	were	overproduced	in	E.	coli	BL21	(DE3)	(NEB)	
carrying	 the	 respective	 plasmids.	 Cells	 were	 grown	 in	 lysogeny	 broth	 (LB)-medium	
supplemented	 with	 50	 µg/ml	 kanamycin	 or	 100	 µg/ml	 and	 12.5	 g/l	 D(+)-lactose-
monohydrate	for	20	h	at	30	°C	and	harvested	by	centrifugation	(3,500	x	g,	20	min,	4	°C).	For	
purification	of	E.	coli	EF-Tu,	the	cells	were	resuspended	in	lysis	buffer	(20	mM	of	HEPES-Na	
pH	8.0,	 20	mM	KCl,	 250	mM	NaCl	 and	40	mM	 imidazole)	 and	 lysed	by	 French	Press	 (SLM	
Aminco)	at	1,000	psi	pressure.	After	centrifugation	of	the	lysate	(47,850	x	g,	20	min,	4	°C),	
the	supernatant	was	loaded	on	a	5-ml	HisTrap	column	(GE	Healthcare)	equilibrated	with	10	
column	volumes	(CV)	lysis	buffer.	After	washing	with	10	CV	of	lysis	buffer,	EF-Tu	was	eluted	
with	5	CV	elution	buffer	(lysis	buffer	containing	500	mM	imidazole).	50	mM	EDTA-Na	pH	8.0	
were	 added	 to	 the	 eluate	 and	 incubated	 for	 30	minutes	 at	 4	 °C.	 EF-Tu	was	 concentrated	
(Amicon	Ultracel-10K	 (Millipore))	and	applied	 to	 size-exclusion	chromatography	 (SEC)	on	a	
HiLoad	 26/600	 Superdex	 200	 pg	 column	 (GE	Healthcare)	 equilibrated	with	 SEC	 buffer	 (20	
mM	of	HEPES-Na,	pH	7.5,	20	mM	KCl	and	200	mM	NaCl).	Fractions	containing	nucleotide-
free	EF-Tu	as	estimated	by	HPLC	(see	below)	were	pooled,	concentrated	(Amicon	Ultracel-
10K	(Millipore)),	deep-frozen	 in	 liquid	nitrogen	and	stored	at	 -80	°C.	Protein	concentration	
was	 determined	 by	 a	 spectrophotometer	 (NanoDrop	 Lite,	 Thermo	 Scientific).	E.	 coli	 EF-Ts	
was	purified	by	similar	procedure	but	no	EDTA	added	 to	 the	protein.	B.	 subtilis	EF-Tu	was	
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purified	by	the	same	procedure	as	E.	coli	EF-Tu	but	all	buffers	contained	500	mM	NaCl	and	
5%		(v/v)	glycerol.		
Preparation	 of	 ppGpp	 and	 pppGpp.	 (p)ppGpp	was	produced	as	described	previously	with	
the	(p)ppGpp	synthetase	RelQ	from	B.	subtilis	(18).		
In	vitro	translation	assays.	The	synthesis	of	enhanced	green	fluorescent	protein	(eGFP)	was	
assayed	 with	 a	 coupled	 transcription/translation	 system	 (RTS	 100	 E.	 coli	 HY	 Kit,	
Biotechrabbit).	 Reactions	 of	 50	 µl	 contained	 12	 µl	E.	 coli	 lysate,	 10	 µl	 reaction	mix,	 12	 µl	
amino	acid	solution,	1	µl	of	methionine,	5	µl	 reconstitution	buffer	and	1	µg	of	 the	control	
vector	containing	eGFP.	ppGpp	or	pppGpp	were	added	with	final	concentrations	of	10,	100	
or	1,000	µM.	The	reaction	was	allowed	to	proceed	for	4	h	at	30	°C	and	afterwards	kept	at	4	
°C	 for	24	h	 for	 full	maturation	of	eGFP.	eGFP	production	was	determined	by	 fluorescence	
measurement	(λEx/λEm	=	395/509	nm)	with	a	spectramax	M4	multi-mode	microplate	reader	
(Molecular	Devices).	
Inhibitory	constants	of	(p)ppGpp	binding	to	EF-Tu.	Inhibitory	constants	were	determined	by	
fluorescence	 spectroscopy	carried	out	with	a	FP-6300	Spectrofluorometer	 (Jasco)	with	 the	
following	 settings:	 excitation	 355	 ±	 2.5	 nm,	 emission	 450	 ±	 10	 nm,	 response	 time	 0.5	 s,	
sensitivity	med	and	data	pitch	of	 0.5	 s.	 Spectra	were	evaluated	with	 Spectra	Manager	 for	
Windows	1.05.03	[Build	1].	Further	data	analysis	was	done	in	GraphPad	Prism	version	6.04	
for	Windows	(GraphPad	Software,	San	Diego,	California,	USA).	The	dissociation	constant	(Kd)	
of	Mant-GTP	was	determined	by	titrating	1	µM	Mant-GTP	in	SEC	buffer	(supplemented	with	
20	 mM	 MgCl2)	 with	 0.5	 µM	 EF-Tu	 per	 injection	 and	 calculated	 with	 the	 equation	
ΔFluorescence	=	Bmax	*	[EF-Tu]	/	(Kd	+	[EF-Tu]).		Inhibitory	constants	(Ki)	for	GDP,	GTP,	ppGpp	
and	pppGpp	were	obtained	by	titrating	a	mixture	of	1	µM	Mant-GTP	and	5	µM	EF-Tu	in	SEC	
buffer	(supplemented	with	20	mM	MgCl2)	with	GDP,	GTP,	ppGpp	or	pppGpp	and	calculated	
with	the	‘One	site	-	inhibitory	constant’	model	using	equations	Fluorescence=Bottom	+	(Top-
Bottom)/(1+10^(log[Nucleotide]-logEC50))	and	logEC50=log(10^logKi*(1+1000/1600)).	
Crystallization	 and	 structure	 determination.	 Prior	 crystallization,	 1	mM	 E.	 coli	 EF-Tu	was	
supplemented	with	10	mM	pppGpp	and	10	mM	MgCl2	and	incubated	for	30	minutes	at	room	
temperature.	 Crystallization	 was	 carried	 out	 at	 room	 temperature	 by	 sitting	 drop	 vapor	
diffusion	method	in	SWISSCI	MRC	2-well	plates	(Jena	Bioscience)	with	a	reservoir	volume	of	
50	 µl.	 Screens	were	 set	 up	 by	mixing	 0.5	 µl	 of	 protein	 solution	with	 the	 same	 volume	 of	
crystallization	solution.	Crystals	of	ppGpp/Mg-bound	E.	coli	EF-Tu	were	obtained	after	2	days	
from	0.1	M	HEPES	pH	7,	0.1	M	MgCl2,	and	15%	(w/v)	PEG4000.	For	crystals	harvest,	0.5	µl	of	
a	 cryo-protecting	 solution	 containing	mother	 liquor	 supplemented	with	 20%	 (v/v)	 glycerol	
was	added	to	the	drop,	crystals	looped	and	flash-frozen	in	liquid	nitrogen.	Diffraction	data	of	
crystals	 were	 collected	 at	 the	 European	 Synchrotron	 Radiation	 Facility	 (ESRF)	 Grenoble,	
France,	 at	 beamline	 ID29	 under	 laminar	 nitrogen	 flow	 at	 100K	 (Oxford	 Cryostream	 700	
Series)	with	a	DECTRIS	PILATUS	6M	F	detector	at	1.07234	Å.	Data	were	processed	with	XDS	
(37)	 and	 CCP4-implemented	 AIMLESS	 (38).	 The	 structure	was	 determined	with	 the	 CCP4-
implemented	 program	 PHASER	 (39)	 using	 GDP-bound	 E.	 coli	 EF-Tu	 (PDB:	 1EFC	 (21))	 as	 a	
search	model	for	molecular	replacement.	The	structure	was	manually	built	in	Coot	(40)	and	
refined	with	REFMAC5	(41).	Figures	were	prepared	with	PyMOL	(www.pymol.org).	
Determination	 of	 EF-Tu	 nucleotide	 content	 and	 activity.	 The	nucleotide	 content	of	EF-Tu	
was	 determined	 high-performance	 liquid	 chromatography	 (HPLC).	 200	 µM	 of	 EF-Tu	 were	
denaturated	by	adding	two	volume	parts	chloroform	followed	by	15	s	vigorous	mixing,	15	s	
heat	 treatment	at	95	°C	and	 flash-freezing	 in	 liquid	nitrogen.	This	mixture	was	centrifuged	
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(17,300	x	g,	30	min,	4	°C)	and	while	thawing	the	aqueous	phase	removed.	The	sample	was	
diluted	1:5	with	double-distilled	water	and	analyzed	for	its	nucleotide	contents	by	HPLC	on	
an	 Agilent	 1260	 Infinity	 system	 equipped	 with	 Metrosep	 A	 Supp	 5	 -	 150/4.0	 column.	
Nucleotides	were	eluted	isocratically	with	a	flow	rate	of	0.7	ml/min	of	100	mM	(NH4)2CO3	at	
pH	9.25	and	detected	at	260	nm	wavelength	in	agreement	with	standards.		
Determination	of	EF-Tu	activity	towards	pppGpp.	Hydrolysis	of	pppGpp	by	E.	coli	EF-Tu	was	
probed	 by	 incubating	 1/2.5/5/10/25	 µM	 EF-Tu	 together	 with	 1	 mM	 pppGpp	 for	
1/6/30/90/150	min	at	37	°C	in	SEC	buffer	supplemented	with	20	mM	MgCl2.	Reactions	were	
stopped	 and	 analyzed	 as	 described	 above.	 Non-enzymatic	 hydrolysis	 of	 pppGpp	 was	
determined	from	reactions	carried	out	without	EF-Tu.	All	measurements	were	performed	in	
triplicates.	
Determination	of	ternary	complex	formation	by	fluorescence	spectroscopy.	Labeled	EF-Tu	
was	 constructed	and	purified	using	 the	expression	 system	described	 for	native	EF-Tu	with	
the	 modification	 of	 a	 C-terminal	 acyl-carrier	 protein	 recognition	 epitope	 (CT-AcpS),	 as	
previously	 described	 (22).	 Briefly,	 labeling	was	 achieved	 by	 incubating	 purified	 EF-Tu	 (CT-
AcpS)	 with	 a	 10-fold	 excess	 of	 CoA-linked	 Cy5Q	 and	 a	 5-fold	 excess	 of	 AcpS	
phosphopantetheinyl	 transferase	 enzyme	 in	 buffer	 A	 (50	 mM	 HEPES	 pH	 7.5,	 10	 mM	
Mg(OAc)2)	for	2	h.	Wild-type	E.	coli	tRNAPhe	was	expressed	and	purified	from	strain	MRE600	
as	described	previously	(42).	tRNAPhe	was	site-specifically	labeled	with	Cy3B	via	the	naturally	
occurring	modified	nucleotide	acp3U	at	position	47,	and	purified	by	hydrophobic	interaction	
chromatography	 (HIC)	 on	 a	 Phenyl-5PW	 column	 (TOSOH)	 by	 applying	 a	 shallow	 gradient	
from	buffer	C	(10	mM	NH4(OAc)	pH	5.8,	1.7	M	(NH4)2SO4)	to	buffer	D	(10	mM	NH4(OAc)	pH	
5.8,	10%	(v/v)	methanol)	over	20	column	volumes.	tRNAPhe	was	aminoacylated	by	adding	a	
0.1x	molar	ratio	of	tRNA	synthetase	and	a	1,000-fold	excess	of	phenylalanine	in	a	volume	of	
10	μL	in	buffer	E	(50	mM	Tris-HCl	pH	8,	20	mM	KCl,	100	mM	NH4Cl,	1	mM	DTT,	2.5	mM	ATP,	
0.5	 mM	 EDTA,	 10	 mM	 MgCl2)	 and	 incubating	 at	 37	 °C	 for	 20	 min.	 The	 extent	 of	
aminoacylation	was	verified	by	analytical	HIC.	GDP	and	GTP	were	purchased	from	Sigma	and	
further	purified	on	a	Tricorn	Mono	Q	5/50	GL	ion	exchange	column	as	previously	described	
(2).	
Fluorescence	 measurements	 were	 performed	 using	 a	 Photon	 Technology	 International	
fluorescence	 spectrometer	 with	 a	 532	 nm	 long-pass	 emission	 filter	 (LP03-532RS-25	
RazorEdge	by	Semrock).	Reactions	were	analyzed	in	buffer	F	(100	mM	HEPES	pH	7,	20	mM	
KCl,	100	mM	NH4Cl,	1	mM	DTT,	0.5	mM	EDTA,	2.5	mM	MgCl2)	in	a	3	mL	quartz	cuvette	with	
constant	mixing	at	room	temperature	while	exciting	at	532	nm	and	monitoring	the	emission	
at	 565	 nm.	 Ternary	 complex	 was	 pre-formed	 in	 situ	 by	 manually	 adding	 400	 nM	 Cy5Q-
labeled	EF-Tu,	or	Cy5Q-labeled	EF-Tu	in	a	1:1	complex	with	EF-Ts,	to	a	reaction	containing	5	
nM	Cy3B-labeled	Phe-tRNAPhe	and	10	μM	GTP	in	buffer	F	at	room	temperature	with	constant	
mixing.	
Determination	 of	 ternary	 complex	 formation	 by	 electrophoretic	 mobility	 shift	 assay.	
Ternary	complex	was	preformed	by	mixing	100	µM	EF-Tu,	250	µM	GTP	and	5	µM	Lys-tRNALys	
in	 SEC	 buffer	 supplemented	 with	 20	mM	 MgCl2.	 (p)ppGpp	 was	 added	 with	 final	
concentrations	of	50	µM,	250	µM	or	1	mM.	Reactions	were	incubated	at	room	temperature	
for	 10	 min	 and	 directly	 subjected	 to	 gel	 electrophoresis	 employing	 10%	 polyacrylamide	
(19:1)	gel	and	TB	buffer	(90	mM	Tris-Borate,	pH	8.3),	both	supplemented	with	1	mM	MgCl2.	
Gels	were	stained	for	15	min	with	GelRed	Nucleic	Acid	Stain	(Biotium)	and	imaged	using	UV	
light	of	312	nm	wavelength.	
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Nucleotide	 removal	 from	 EF-Tu	 by	 EF-Ts.	 In	 pull-down	 experiments,	 EF-Tu	 (100	 µM)	was	
incubated	in	SEC	buffer	supplemented	with	1	mM	MgCl2	with	nucleotides	(1	mM)	in	absence	
or	presence	of	EF-Ts	(100	µM)	for	5	min	at	room	temperature.	Subsequently,	100	µl	of	Ni-
NTA	beads	 (Macherey	Nagel)	were	 added,	 transferred	 into	 spin	 columns	 and	washed	 five	
times	with	500	µl	SEC	buffer	+	40	mM	imidazole	before	elution	with	SEC	buffer	+	500	mM	
imidazole.	EF-Tu	was	dentaturated	with	chloroform	and	 its	nucleotide	content	analyzed	as	
described	above.	In	analytical	SEC	experiments,	EF-Tu	(100	µM)	was	incubated	in	SEC	buffer	
supplemented	with	1	mM	MgCl2	with	nucleotides	(200	µM)	in	absence	or	presence	of	EF-Ts	
(100	 µM)	 for	 5	 min	 at	 room	 temperature	 and	 1	 ml	 of	 this	 mixture	 applied	 to	 SEC	 on	 a	
Superdex	 200	 Increase	 10/300	 GL	 column	 (GE	 Healthcare)	 equilibrated	 with	 SEC	 buffer	
supplemented	with	1	mM	MgCl2.		
	
DATA	AVAILABILITY	
Atomic	coordinates	and	structure	 factors	 for	ppGpp-bound	E.	coli	EF-Tu	were	deposited	 in	
the	Protein	Data	Bank	(PDB)	under	accession	code	6Z0N.		
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FIGURES	
	
	
Fig.	 1.	 Binding	 of	 (p)ppGpp	 to	 EF-Tu.	 A.	 Inhibition	 of	 translation	 in	 vitro	 by	 ppGpp	 and	
pppGpp.	Translation	activity	was	determined	by	quantifying	the	amount	of	eGFP.	Activity	in	
absence	of	(p)ppGpp	was	set	to	100%.	B.	Binding	of	Mant-GTP	to	EF-Tu.	1	µM	of	Mant-GTP	
was	titrated	with	EF-Tu	and	the	change	in	Mant-GTP	fluorescence	quantified.	Data	represent	
mean	±	 SD	of	n=6	 technical	 replicates.	C-D.	 Competition	of	unlabeled	GDP	and	ppGpp	 (C)	
and	GTP	and	pppGpp	(D)	for	binding	to	Mant-GTP/EF-Tu.	A	mixture	of	1	µM	Mant-GTP	and	5	
µM	 EF-Tu	 was	 titrated	 with	 unlabeled	 nucleotides.	 Data	 represent	 mean	 ±	 SD	 of	 n=2	
technical	replicates.		
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Fig.	 2.	 Crystal	 structure	 of	 ppGpp/Mg2+-bound	 EF-Tu.	A-C.	 Cartoon	 representation	of	 the	
crystal	structures	of	EF-Tu	in	complex	with	ppGpp/Mg	(A),	GDP/Mg	(B,	PDB:	1EFC	(21))	and	
GMPPNP/Mg,	Phe-tRNAPhe	and	kirromycin	(C,	PDB:	1OB2).	All	structures	are	rainbow-colored	
from	 their	 N-	 to	 C-termini.	 Roman	 numbers	 denote	 the	 domains	 I-III	 of	 EF-Tu.	 The	
nucleotides	are	shown	in	sticks	and	the	magnesium	ions	as	green	spheres.	A	red	dashed	line	
indicates	the	amino	acids	40-60	of	ppGpp/Mg-bound	EF-Tu	(A)	too	flexible	to	be	modeled.	D.	
Coordination	of	ppGpp/Mg	by	EF-Tu.	Atoms	are	colored	in	grey	(carbon),	orange	(phosphor),	
blue	 (nitrogen)	 and	 red	 (oxygen).	 Hydrogen-bonding	 interactions	 are	 indicated	 by	 black	
dotted	lines.	E-G.	Cartoon	representation	of	the	GTPase	domains	of	EF-Tu	 in	complex	with	
ppGpp/Mg	(E),	GDP/Mg	(F,	PDB:	1EFC	 (21))	and	GMPPNP/Mg,	Phe-tRNAPhe	and	kirromycin	
(G,	 PDB:	 1OB2).	 The	 switch	 I	 and	 switch	 II	 regions	 are	 colored	 in	 orange	 and	 yellow,	
respectively.	The	ligand	ppGpp	was	placed	into	all	structures	based	on	superpositions	with	
ppGpp/Mg-bound	EF-Tu	(see	also	Fig.	S3).			
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Fig.	3.	(p)ppGpp	interferes	with	ternary	complexes.	A.	Inhibition	of	EF-Tu•GTP•Lys-tRNALys	
ternary	 complex	 formation	 by	 (p)ppGpp	 in	 electrophoretic	mobility	 shift	 assay.	B.	 ppGpp-
mediated	dissociation	of	EF-Tu•GTP•Phe-tRNAPhe	ternary	complexes	pre-formed	with	Cy5Q-
labeled	EF-Tu	 in	 absence	 (grey)	or	presence	 (red)	of	 EF-Ts.	Arrows	denote	 the	addition	of	
ppGpp	 (at	 200	 sec)	 and	GDP	 (at	 750	 sec),	 both	with	 100	µM	 final	 concentration	 equaling	
10,000-fold	excess	over	GTP.		
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Fig.	4.	EF-Tu	degrades	pppGpp	to	ppGpp.	A.	Representative	chromatograms	depicting	the	
ability	of	EF-Tu	 to	degrade	pppGpp	 into	ppGpp	 through	 removal	of	 the	5’	γ-phosphate.	B.	
Variable	 concentrations	 of	 EF-Tu	were	 incubated	with	 pppGpp	 and	 the	 amount	 of	 ppGpp	
and	pppGpp	quantified	by	HPLC.	Data	represent	mean	±	SD	of	n=3	technical	replicates.	The	
inset	depicts	the	slope	of	the	linear	regressions	versus	the	concentration	of	EF-Tu.			
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Fig.	5.	Removal	of	(p)ppGpp	from	EF-Tu	by	EF-Ts.	A.	EF-Tu	(100	µM)	was	pre-incubated	with	
nucleotides	(1	mM)	as	indicated	either	in	absence	(blue)	or	presence	(red)	of	EF-Ts	(100	µM).	
Nucleotides	bound	to	EF-Tu	were	determined	by	HPLC.	B.	EF-Tu	(100	µM)	was	pre-incubated	
with	nucleotides	 (200	µM)	as	 indicated	either	 in	absence	 (blue)	or	presence	 (red)	of	EF-Ts	
(100	µM)	and	subjected	to	size-exclusion	chromatography.	EF-Ts-dependent	increase	in	peak	
size	of	free	nucleotides	indicates	nucleotide	removal	by	EF-Ts.		
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Fig.	6.		Framework	of	(p)ppGpp	and	EF-Tu.	RelA	(purple)	and	EF-Tu	(turquoise)	interact	with	
uncharged	tRNA	(red)	and	aa-tRNA	(green),	respectively.	Both	complexes	can	bind	to	the	A-
site	of	translating	ribosomes.	The	alarmones	(p)ppGpp	are	produced	when	tRNA/RelA	binds	
to	ribosome,	and	can	inhibit	formation	of	the	EF-Tu•GTP•aa-tRNA	ternary	complex	through	
competitive	binding	into	the	GTP-binding	site	of	EF-Tu.	EF-Tu	is	able	to	degrade	pppGpp	into	
ppGpp,	 both	 of	 which	 can	 be	 released	 by	 EF-Ts.	 The	 tRNAs	 at	 the	 P-	 and	 E-sites	 of	 the	
ribosome	 are	 in	 yellow.	 The	 large	 (50S)	 and	 small	 (30S)	 ribosomal	 units	 are	 in	 grey	 and	
ochre,	respectively.	Further	descriptions	are	given	in	the	discussion.		 	
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Fig.	S1.	Removal	of	GDP	during	purification	of	EF-Tu.	UV	traces	of	EF-Tu	before	(red)	and	
after	treatment	with	EDTA	(blue).	GDP	(black)	was	used	as	a	standard.		
	
	
	
Fig.	S2.	Binding	of	(p)ppGpp	to	B.	subtilis	EF-Tu.	A.	Binding	of	Mant-GTP	to	B.	subtilis	EF-Tu.	
1	 µM	 of	 Mant-GTP	 was	 titrated	 with	 EF-Tu	 and	 the	 change	 in	 Mant-GTP	 fluorescence	
quantified.	 Data	 represent	 mean	 ±	 SD	 of	 n=6	 technical	 replicates.	 B-C.	 Competition	 of	
unlabeled	GDP	and	ppGpp	 (B)	 and	GTP	and	pppGpp	 (C)	 for	binding	 to	Mant-GTP/EF-Tu.	A	
mixture	of	1	µM	Mant-GTP	and	5	µM	EF-Tu	was	 titrated	with	unlabeled	nucleotides.	Data	
represent	mean	±	SD	of	n=2	technical	replicates.		
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Fig.	 S3.	 Superimposition	 of	 ppGpp/Mg-bound	 EF-Tu	 colored	 in	 rainbow	 from	 N-	 to	 C-
terminus	with	GDP/Mg-bound	EF-Tu	 (A,	 PDB:	 1EFC	 (Song,	 Parsons	 et	 al.	 1999))	 and	 EF-Tu	
bound	to	GMPPNP/Mg•Phe-tRNAPhe	and	kirromycin	(B,	PDB:	1OB2).	Roman	numbers	denote	
the	domains	I-III	of	EF-Tu.		
	
	
	
Fig.	 S4.	 Electron	 density	 for	 ppGpp/Mg.	 A.	 The	 unbiased	 Fobs–Fcalc	 difference	 electron	
density	of	AMPCPP	contoured	at	2.5	σ	is	shown	as	green	mesh.	Note:	The	ppGpp	molecule	
(sticks)	and	magnesium	(green	sphere)	were	not	present	during	refinement	and	are	placed	
only	 for	 reasons	 of	 illustration.	 B.	 The	 2Fobs–Fcalc	 electron	 density	 of	 ppGpp	 (sticks)	 and	
magnesium	 (green	sphere)	after	 final	 refinement	 is	 contoured	at	2.5	σ	and	shown	as	blue	
mesh.	Yellow	ribbons	indicate	the	backbone	of	EF-Tu.	Figures	were	generated	with	PyMOL.	
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Fig.	S5.	Accessibility	of	threonine	61	in	different	conformational	states	of	EF-Tu.	A-C.	The	
crystal	 structure	 of	E.	 coli	 EF-Tu	 in	 presence	 of	 ppGpp	 (A,	 this	 study),	 GDP	 (B,	 PDB:	 1EFC	
(Song,	 Parsons	 et	 al.	 1999))	GMPPNP/Mg/Phe-tRNAPhe	 (C,	 PDB:	 1OB2)	 is	 shown	 in	 surface	
representation.	Roman	numbers	denote	the	domains	 I-III	of	EF-Tu	colored	 in	pale	green	(I,	
residues	 1-205),	 orange	 (II,	 residues	 206-300),	 teal	 (III,	 residues	 300-393).	 The	 switch	 I	
region,	threonine	61	and	the	tRNA	are	colored	in	forest,	red	and	white,	respectively.	
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Table	S1.	Crystallographic	data	collection	and	refinement	statistics.	 	
 
 E.	coli	EF-Tu	ppGpp/Mg 
Data collection  
Space group P43212 
Cell dimensions    
    a, b, c (Å) 68.991, 68.991, 158.853 
    a, b, g  (°)  90, 90, 90 
Wavelength (Å) 1.07234 
Resolution (Å) 48.83  - 2.0 (2.052  - 2.0) 
 
Rmerge 0.1633 (1.733) 
I / σI 13.17 (1.48) 
Completeness (%) 99.99 (100.00) 
Redundancy 25.1 (26.0) 
CC1/2 
 
0.998 (0.742) 
Refinement  
Resolution (Å) 48.83  - 2.0 
No. reflections 25416 (1926) 
Rwork / Rfree 0.2053/0.2624 
No. atoms 2981 
    Protein 2835 
    Ligand/ion 37 
    Water 109 
B-factors 37.74 
    Protein 37.84 
    Ligand/ion 32.92 
    Water 37.41 
R.m.s. deviations  
    Bond lengths (Å) 0.007 
    Bond angles (°) 1.64 
*Values in parentheses are for highest-resolution shell. 
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Table	S2.	Oligonucleotides.	
	
Primer Sequence Purpose 
EcEF-Tu_NcoI_F TTAACCATGGGCTCTAAAGAAAAATTTGAACGTACAAAACCGCACG Cloning of C-terminal 
His6-tagged E. coli 
EF-Tu into pET24d EcEF-Tu_XhoI_6H_R TTAACTCGAGTTAGTGGTGATGGTGATGATGGCCCAGAACTTTAGCAACAACGCC 
EcEF-Ts_NdeI_F TTAACATATGGCTGAAATTACCGCATC Cloning of N-terminal 
His6-tagged E. coli 
EF-Ts into pET16b EcEF-Ts_BamHI_R TTAAGGATCCTTAAGACTGCTTGGACATC 
BsEF-Tu_PciI_6H_F TTAAACATGTCACATCACCATCACCATCACGCTAAAGAAAAATTCGACCGTTCCAAATC 
Cloning of N-terminal 
His6-tagged B. subtilis 
EF-Tu into pET24d BsEF-Tu_XhoI_R TTAACTCGAGTTACTCAGTGATTGTAGAAACAACG 
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Aromatic polyketides represent a large and diverse fam-ily of natural products synthesized by the nonribosomal type II polyketide synthases1. Well-characterized aromatic 
polyketides include tetracycline (Tet) and the anthracycline doxoru-
bicin (Dox), which despite their structural similarity (Fig. 1a,b) have 
completely distinct modes of action. Tet binds to the small subunit 
of the ribosome and inhibits protein synthesis by interfering with 
the delivery of aminoacyl-transfer RNAs to the A-site2. By contrast, 
Dox intercalates with DNA and thereby inhibits DNA replication 
and RNA transcription by interfering with topoisomerase II func-
tion3. While tetracyclines are an important source of clinically used 
antibiotics2, anthracyclines, such as Dox, display cytotoxic activity 
and represent one of the most effective anticancer treatments ever 
developed3–5. Thus, characterization of new aromatic polyketides 
may result in the discovery of new lead compounds for the develop-
ment of improved antimicrobial and anticancer agents.
In this context, one of the lesser-characterized families of aro-
matic polyketides is the tetracenomycins (Tcms). Tcm members 
contain a tetracyclic naphthacenequinone chromophore (Fig. 1c) 
and thus have structural similarity to the tetracycline and anthracy-
cline families (Fig. 1a,b). The founding member of the Tcm family 
is tetracenomycin C (TcmC), which was originally isolated from the 
soil-actinomycete Streptomyces glaucescens and shown to have anti-
microbial activity against a variety of Actinomyces and Streptomyces 
species6. A 12a-O-methyl ester of TcmC, termed TcmX, is also pro-
duced by Nocardia mediterranei7 and has also been recently identi-
fied from the marine-derived actinomycete Saccharothrix sp. 10-10 
(refs. 8,9). In addition, Streptomyces olivaceus produces Elloramycin, 
an anthracycline antibiotic closely related to Tcm, but bearing an 
additional l-rhamnose attached to the tetracyclic chromophore10.
While tetracenomycins generally display moderate antibacterial 
activity against some Gram-positive bacteria, these compounds are 
reported to have some cytotoxic activity against various human cell 
lines8–12. The mechanism of action of tetracenomycins has not been 
determined, but is assumed to be analogous to the anthracycline 
Dox10,11,13. This assumption is based primarily on the observation 
that the tetracyclic chromophore of Tcm is flat, resembling Dox, 
and is therefore optimal for intercalating between the basepairs of 
DNA. By contrast, the tetracyclic chromophore of Tet is not planar, 
preventing DNA intercalation. We note also that the original paper 
reporting the discovery of TcmC demonstrated that TcmC does 
not inhibit in vitro synthesis of poly(U)-dependent poly(Phe)6, 
which may have reinforced the notion that tetracenomycins are 
not translation inhibitors.
Here we show that tetracenomycins, such as TcmX, do not 
induce DNA damage as observed for Dox, but rather bind to 
the ribosome and inhibit protein synthesis. However, unlike 
the structurally similar compound tetracycline, TcmX does not 
Tetracenomycin X inhibits translation by binding 
within the ribosomal exit tunnel
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The increase in multi-drug resistant pathogenic bacteria is making our current arsenal of clinically used antibiotics obsolete, 
highlighting the urgent need for new lead compounds with distinct target binding sites to avoid cross-resistance. Here we 
report that the aromatic polyketide antibiotic tetracenomycin (TcmX) is a potent inhibitor of protein synthesis, and does not 
induce DNA damage as previously thought. Despite the structural similarity to the well-known translation inhibitor tetracy-
cline, we show that TcmX does not interact with the small ribosomal subunit, but rather binds to the large subunit, within the 
polypeptide exit tunnel. This previously unappreciated binding site is located adjacent to the macrolide-binding site, where 
TcmX stacks on the noncanonical basepair formed by U1782 and U2586 of the 23S ribosomal RNA. Although the binding site is 
distinct from the macrolide antibiotics, our results indicate that like macrolides, TcmX allows translation of short oligopeptides 
before further translation is blocked.
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bind to the small ribosomal subunit, but rather to the large sub-
unit. Cryo-electron microscopy (cryo-EM) structures reveal that 
TcmX binds to a unique site inside the polypeptide exit tunnel of 
both bacterial (Escherichia coli) and mammalian (human) ribo-
somes. In this binding site, TcmX appears to inhibit translation 
by preventing the prolongation of the nascent polypeptide chain, 
analogous to the macrolide class of antibiotics. Our biochemical 
and structural insights into TcmX interaction with the ribosome 
pave the way for the development of tetracenomycins as antibac-
terial and/or anticancer agents.
Results
Identification of TcmX from Amycolatopsis sp. A23. In an ongoing 
high-throughput screen of synthetic and natural products14, we have 
identified the presence of a translation inhibitor in the culture media 
of the unclassified Amycolatopsis sp. A23. The active compound was 
purified and analyzed using ultraviolet (UV) and mass spectrom-
etry, as well as nuclear magnetic resonance (NMR) spectroscopy 
(Supplementary Notes 1–3). The UV spectrum, molecular weight 
(486 Da) (Supplementary Note 1) and NMR data (Supplementary 
Notes 2 and 3 and Supplementary Table 1) indicate that the active 
compound is identical to TcmX. To validate that TcmX is indeed 
produced by the Amycolatopsis sp. A23, we sequenced the com-
plete genome and identified the presence of the gene cluster for 
TcmX biosynthesis, which is similar to the previously identified 
TcmC cluster present in the genome of S. glaucescens15 (Fig. 1d). 
Bioinformatic analysis indicates that similar gene clusters are found 
in S. caatingaensis, A. rifamycinica and A. balhimycina strains 
(Supplementary Table 2), suggesting that these species also pro-
duce a Tcm compound. Our bioinformatic analysis also identified 
a second smaller paralogous gene cluster in Amycolatopsis sp. A23, 
which we also identify in S. glaucescens GLA.O as well as a number 
of other Streptomyces and Amycolatopsis species that do not contain 
the Tcm gene cluster (Supplementary Tables 2–4). Collectively, our 
biochemical and bioinformatic findings suggest that the active com-
pound produced by Amycolatopsis sp. A23 is TcmX.
TcmX inhibits protein synthesis and not DNA metabolism. 
Because tetracenomycins are assumed to intercalate with DNA 
and interfere with DNA metabolism10,11,13, as described for the 
anthracyclines such as Dox3, we were surprised to identify TcmX 
in a high-throughput screen designed to specifically detect protein 
synthesis inhibitors. To reassess the mode of action of TcmX, we 
employed an in vivo dual-reporter assay that is designed to distin-
guish between compounds that inhibit translation and/or induce 
DNA damage14,16 (Fig. 1e). The basis for the reporter is that com-
pounds inhibiting translation induce ribosome stalling within a 
modified tryptophan operon leader sequence (trpL-2Ala), which 
in turn induces expression of the downstream Katushka2S (far-red 
fluorescent) protein, shown in red. By contrast, compounds that 
induce DNA damage evoke the SOS response and derepress the 
LexA-repressed sulA promoter, thereby leading to the expression 
of red fluorescent protein (RFP) (shown in green pseudo-color). 
TcmX, along with the known translation inhibitors Tet and the mac-
rolide erythromycin (Ery) as well as the DNA replication inhibi-
tors Dox and levofloxacin (Lev) were spotted onto agar plates where 
the growth and fluorescence of the E. coli strain JW5503ΔtolC 
strain bearing the pDualrep2 reporter plasmid were monitored 
(Fig. 1e). Unlike Dox and Lev, but similar to Tet and Ery, TcmX 
led to the appearance of red fluorescence induced by expression of 
Katushka2S and not of the pseudo-green fluorescence due to RFP 
expression (Fig. 1e), thus indicating that TcmX indeed inhibits 
protein synthesis and does not induce DNA damage. To substan-
tiate the results from the dual-reporter assay, we also monitored 
the incorporation of radiolabeled [14C]-valine into proteins as well 
as [3H]-thymidine incorporation into DNA during growth of the 
E. coli, in the presence of increasing concentrations of TcmX, Tet or 
Dox (Fig. 1f,g). The results demonstrated that at concentrations ten-
fold higher than the minimal inhibitory concentration (MIC), both 
TcmX and Tet led to a dramatic (80%) reduction in protein synthesis, 
whereas at the same fold-concentration Dox had little effect (Fig. 1f). 
By contrast, Dox was an excellent inhibitor of DNA synthesis, 
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Fig. 1 | TcmX inhibits protein synthesis and not DNA metabolism. 
 a–c, Chemical structures of Tet (a), Dox (b) and TcmC and TcmX (c).  
d, Chromosomal arrangement of the tetracenomycin biosynthesis gene 
cluster in Amycolatopsis sp. A23 and S. glaucescens GLA.O (see also 
Supplementary Tables 2–4). Orthologous genes are shown with matching 
colors and letters. e, The induction of a two-color dual-reporter system 
sensitive to inhibitors of ribosome progression or of DNA replication. 
Spots of Tet (0.5!µg), Dox (2!µg), erythromycin (Ery, 2!µg), levofloxacin 
(Lev, 0.05!µg) and TcmX (2!µg) were placed on the surface of an agar plate 
containing E. coli ΔtolC cells transformed with the pDualrep2 plasmid. 
Induction of the expression of Katushka2S (red) is triggered by translation 
inhibitors, whereas RFP expression (green) is induced on DNA damage. 
f, Relative inhibition of protein synthesis with [14C]-valine incorporation 
used for detection protein synthesis. TcmX, Dox and Tet were added in 
accordance with their MIC (1–30-fold MIC; MIC, TcmX 2!µg!ml−1, Dox 
1.3!µg!ml−1 and Tet 0.3!µg!ml−1). g, Relative inhibition of DNA metabolism  
by TcmX, Dox or Tet determined by macromolecular synthesis inhibition  
via [3H]-thymidine incorporation (with concentrations the same as in f).  
h, Protein synthesis inhibition with increasing concentrations of TcmX (blue), 
Tet (yellow) and Dox (green) using an in vitro cell-free translation system.  
In f–h, the error bars represent the s.e.m. for three independent experiments.
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yielding near complete inhibition of [3H]-thymidine incorporation 
into DNA at fivefold MIC, whereas TcmX had little to no effect on 
[3H]-thymidine incorporation, even at 30-fold MIC (Fig. 1g). We 
observed an inhibitory effect (50%) of Tet on thymidine incorpora-
tion but only at 10× MIC, which is likely to be indirect and due to 
alteration of membrane integrity as previously reported17. We think 
it is unlikely that Tet directly effects DNA replication by DNA inter-
calation since we observe no SOS response in our reporter system 
with Tet (Fig. 1e). To directly assess the ability of TcmX to inhibit 
protein synthesis, we also employed an in vitro cell-free translation 
system to investigate the influence of increasing concentrations of 
TcmX on the expression of firefly luciferase (Fluc) by monitoring 
Fluc luminescence (Fig. 1h). Consistent with our in vivo results, we 
found that TcmX (and Tet) was an efficient inhibitor of protein syn-
thesis, blocking production of Fluc with a half-maximal inhibitory 
concentration (IC50) of 1.5 μM, whereas Dox had no effect, even at 
40 μM (Fig. 1h). Collectively, our results suggest that TcmX, like 
Tet, is a potent inhibitor of protein synthesis, and unlike Dox, does 
not intercalate with DNA to induce DNA damage, as previously 
assumed10,11,13. Superimposing TcmX onto the Dox-DNA complex 
structure18 on the basis of the tetracyclic chromophores reveals 
severe clashes with the methoxy groups of ring A of TcmX with the 
DNA base (Extended Data Fig. 1a–c), consistent with our findings 
that TcmX does not intercalate with DNA. Based on the structural 
similarity of TcmX with other tetracenomycins, such as TcmC and 
elloramycins, we would expect that generally tetracenomycins can-
not intercalate with DNA.
Ribosomal mutations conferring TcmX resistance. To ascertain 
whether TcmX inhibits translation by targeting the ribosome, we 
employed an E. coli SQ110DTC strain to select for TcmX resis-
tance mutations. Unlike wild-type E. coli strains that contain seven 
rRNA operons, the E. coli SQ110DTC strain contains only a single 
rRNA operon (rrlE), thus making selection of antibiotic resistance 
via rRNA mutations much easier19. Additionally, the DTC (delta 
TolC/ΔtolC) strain lacks the outer membrane component TolC 
of efflux pumps that allows lower antibiotic (TcmX) concentra-
tions to be used during the selection procedure, as evident from 
the 32-fold decrease (>64 to 2 μg ml−1) in MIC for TcmX (Table 1). 
The selection procedure yielded several strains exhibiting MICs 
that were 8–16-fold higher than the wild-type strain (Table 1). 
The MIC increase of these strains was specific for TcmX since 
no increase in MIC was observed for Ery in comparison with the 
wild-type strain (Table 1). Sequencing of the entire rRNA operon of 
the TcmX resistant strains revealed single nucleotide substitutions 
U2586A, U2586G or U2609G in the 23S rRNA (Table 1). To vali-
date that these nucleotide positions were responsible for the TcmX 
resistance phenotype, we generated all three possible base substi-
tutions at these positions in the rrnB operon located on plasmid 
pAM552. The plasmids were then introduced into the SQ171DTC 
strain lacking all seven rRNA operons, so that the plasmid-borne 
mutated rrnB operons served as the sole source of ribosomes fol-
lowing loss of the wild-type rRNA containing pCSacB plasmid. As 
expected, the presence of U2586G, U2586A or U2609G mutations 
in the rrnB operon led to an 8–16-fold increase in MIC (Table 1), 
consistent with the spontaneously selected strains. In addition, we 
could demonstrate that the U2586C mutation also resulted in an 
eightfold MIC increase (Table 1). Although increased resistance 
was also observed for the U2609A and U2609C substitutions, the 
MIC fold-increases were less dramatic (2–4-fold). As controls, 
A2058G and A2059G substitutions conferred high level Ery resis-
tance (>64-fold), as shown previously20, but had no effect on the 
TcmX MIC (Table 1). On the basis of these results, we conclude that 
TcmX interacts with the large ribosomal subunit, which is distinct 
from the binding site of the related antibiotic Tet on the small sub-
unit. Superimposing TcmX onto the Tet-70S complexes2,21 on the 
basis of the tetracyclic chromophores (Extended Data Fig. 1d,e) 
supports our finding that TcmX cannot bind similarly to Tet since 
TcmX would fail to establish a number of interactions that Tet forms 
with the 16S rRNA (Extended Data Fig. 2) and would additionally 
result in clashes between TcmX and nucleotides (G1054, U1196 and 
G1197) of the 16S rRNA (Extended Data Fig. 1e,f).
TcmX binds to the E. coli large ribosomal subunit. To determine 
the binding site of TcmX on the bacterial ribosome, we incubated 
TcmX with E. coli 70S ribosomes (Eco70S) and analyzed the result-
ing complex using cryo-EM. After sorting and refinement (Extended 
Data Fig. 3a), the final cryo-EM map of the TcmX-Eco70S complex 
had an average resolution of 2.9 Å (Extended Data Fig. 3b), with 
local resolutions extending toward 2.75 Å inside the core of the 
large subunit (Extended Data Fig. 3c,d and Supplementary Table 5). 
Examination of the cryo-EM map revealed a single additional den-
sity present within the polypeptide exit tunnel of the large subunit 
(Fig. 2a) consistent with the chemical structure of TcmX (Extended 
Data Fig. 3e–g). Within the binding site, the planar rings C and D 
of the tetracyclic chromophore of TcmX stack on the bases of 23S 
rRNA nucleotides U1782 and U2586, which form a noncanonical 
U–U basepair with each other (Fig. 2b and Extended Data Fig. 2). 
Due to space restrictions, we predict that the U2586A and U2586G 
substitutions would break the basepair (Extended Data Fig. 4) and 
result in nonplanar conformations that would prevent TcmX bind-
ing, consistent with the TcmX resistance observed by these muta-
tions (Table 1). Nevertheless, we cannot exclude that the mutated 
bases can shift to accommodate base-pairing and that TcmX binding 
is therefore destabilized for another reason. We note that both the 
U2586C and U1782C substitutions also led to high level (8–16-fold 
MIC increase) TcmX resistance (Table 1). Since a shift in one of the 
bases is necessary to maintain nonisosteric C–U or U–C basepairs, 
we expect that these mutations also result in nonplanar conforma-
tions that prevent TcmX binding. By contrast, we observed that 
U2609G/A/C mutations confer moderate levels of TcmX resistance 
Table 1 | TcmX MICs in different strains and rRNA resistance 
mutants
E. coli strain MIC TcmX 
µg"ml−1
MIC Ery 
µg"ml−1
BW25113 >64 >64
BW25113 ΔtolC 2 2
SQ110DTC WT 1 2
SQ110DTC U2586G 16 2
SQ110DTC U2586A 16 2
SQ110DTC U2609G 8 2
SQ171DTC WT 1 2
SQ171DTC U2586Ga 16 2
SQ171DTC U2586Aa 16 2
SQ171DTC U2586Ca 8 2
SQ171DTC U1782Cb 16 2
SQ171DTC U2609Ga 8 2
SQ171DTC U2609Aa 4 2
SQ171DTC U2609Ca 2 2
SQ171DTC A2059Ga 1 >64
SQ171DTC A2058Ga 1 >64
SQ171DTC U1782C/U2586Cb 4 2
aPlasmid with mutated rRNA operon on the basis of pLK35. bPlasmid with mutated rRNA operon on 
the basis of pAM552.
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(Table 1), despite the fact that TcmX does not interact with U2609 
(Fig. 2c,d). Since U2609 basepairs with A752 (Fig. 2c), one possible 
explanation for TcmX resistance in these cases is that the U2609 
mutations disrupt base-pairing with A752 (Extended Data Fig. 4), 
which could in turn lead to a conformation that encroach on the 
TcmX binding site. Aside from the stacking interactions, most of the 
other TcmX-ribosome contacts are mediated via two ions, which we 
assume are magnesium (Mg) ions based on the presence and simi-
larity of coordinated Mg ions in the tetracycline-ribosome struc-
ture21,22. Mg1 and Mg2 coordinate interaction of TcmX with the 
phosphate-oxygen backbone of U2441, and the ribose and nucleo-
base of A2587, respectively (Fig. 2b–d and Extended Data Fig. 2). 
Although A2062 comes into close proximity of TcmX, the density 
for this base is poorly resolved (Extended Data Fig. 3g), suggesting 
that it does not establish a stable interaction. Since the only differ-
ence between TcmX and TcmC is the 12a-O-methyl group (Fig. 1c), 
which does not establish interactions with the ribosome (Extended 
Data Fig. 2), we predict that TcmC would bind in an identical fashion 
to the ribosome as TcmX. Similarly, molecular modeling suggests 
that the elloramycins can also be accommodated at the TcmX bind-
ing site, despite the presence of the 2,3,4-tri-O-methyl-l-rhamnose 
moiety, which is absent in TcmX (Extended Data Fig. 1g,h).
Conservation of the TcmX binding site on the ribosome. Since the 
stacking interaction between TcmX and the U1782–U2586 basepair 
within the 23S rRNA appears to be a chief determinant for TcmX 
binding, we investigated the extent to which these two nucleotides 
are conserved across different organisms. Based on available data 
from the comparative RNA web (CRW) site23, 37% of bacteria (236 
sequences) contain a U–U basepair at the equivalent position, simi-
lar to that of E. coli. In addition to E. coli, this includes Streptomyces 
species that are reported to be susceptible to tetracenomycins6,8, 
as well as many clinically important pathogens, such as Neisseria 
gonorrhoeae, Pseudomonas aeruginosa, Vibrio cholerae and Yersinia 
pestis (Extended Data Fig. 4k). Most (63%) bacteria contain the C–C 
basepair at the equivalent position, which is observed, for example, 
in the crystal structures of Thermus thermophilus 70S ribosomes21. 
Since our initial attempts to determine the crystal structure of TcmX 
in complex with the T. thermophilus 70S ribosome failed, this led us 
to wonder whether the C–C basepair confers resistance to TcmX. 
To investigate this, we generated a U1782C–U2586C disubstituted 
rrnB SQ171DTC strain and analyzed the MIC in the presence of 
TcmX and Ery. As expected, the double mutation did not influence 
the MIC for Ery, whereas a fourfold increase in MIC was observed 
for TcmX (Table 1). This finding suggests that the ribosomes from 
bacteria containing C–C basepair at the equivalent position to the 
E. coli U1782–U2586 basepair are naturally more resistant to TcmX 
than bacteria containing the U–U basepair. The CRW site23 also 
revealed that in contrast to bacteria, this U–U basepair appears to 
be universally conserved in eukaryotic ribosomes (135 sequences), 
suggesting that TcmX may also bind analogously to human 80S 
ribosome, which may be the cause of the observed cytotoxicity8–12.
TcmX binds to the large subunit of the human ribosome. To 
determine the binding site of TcmX on the human ribosome, we 
incubated TcmX with H. sapiens 80S ribosomes and analyzed the 
resulting complex using cryo-EM. After sorting and refinement 
(Extended Data Fig. 5a), the final cryo-EM map of the TcmX-Hsa80S 
complex had an average resolution of 2.8 Å (Extended Data 
Fig. 5b), with local resolutions extending toward 2.5 Å within the core 
of the large subunit (Extended Data Fig. 5c,d). Examination of the 
cryo-EM map revealed a single additional density for TcmX located 
within the polypeptide exit tunnel of the large subunit (Fig. 2e,f  
and Extended Data Fig. 5d) at the equivalent site observed in the 
TcmX-Eco70S ribosome structure (Extended Data Fig. 5e,f). On 
the human 80S ribosome, TcmX stacks on nucleotides U3644 
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Fig. 2 | Binding site of TcmX on the bacterial and human ribosomes. a, Transverse section of the cryo-EM map of the 70S ribosome (30S, yellow; 50S, 
gray) showing the TcmX (blue) binding site within the large subunit. b, Electron density for TcmX with putative Mg ions (green). c,d, TcmX interactions on 
the E. coli ribosome. e, Transverse section of the cryo-EM map of the human 80S ribosome (40S, yellow; 60S, gray) with TcmX (blue). f, Electron density 
for TcmX, Mg1 and Mg2 on the human 80S ribosome. g, Interaction of TcmX with the human 80S ribosome. h, Comparison of TcmX binding site on E. coli 
(Eco, gray) and H. sapiens (Hsa, wheat) aligned on the basis of the large subunit rRNA nucleotides, E. coli numbering is used.
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(EcU1782) and U4532 (EcU2586), which also form a noncanoni-
cal U–U basepair (Fig. 2g), analogous to that observed in the 
TcmX-Eco70S structure. A similar network of interactions via two 
coordinated (putative) Mg ions is observed between TcmX and 28S 
rRNA nucleotides U4387 (EcU2441) and A4533 (EcA2587), respec-
tively. A3908 (EcA2062) is better resolved in the TcmX-Hsa80S 
structure, where the N3 appears to contribute to the coordination of 
Mg1 (Fig. 2g and Extended Data Fig. 5d). Overall, the binding site 
and interactions of TcmX on the E. coli 70S and H. sapiens 80S ribo-
some are very similar with a root mean square deviation (r.m.s.d.) 
of <1 Å. We note that the binding site of TcmX on the human 80S 
ribosome is in close proximity to one of the putative binding sites 
of Tet analogs on the large subunit (Extended Data Fig. 5e,f), as 
determined by crosslinking24, although we note that none of the 
cross-linked nucleotides are directly involved in establishing inter-
actions with TcmX (Extended Data Fig. 5e,f).
TcmX inhibits translation on the human ribosome. Since the 
cryo-EM structure of the TcmX-80S complex used human ribo-
somes from human embryonic kidney 293T (HEK293T) cells, we 
were first interested in assessing whether TcmX also displays cyto-
toxicity against these cells, as reported for other human cell lines, 
such as HepG2, MCF-7 and K562 (refs. 8–12). As seen in Fig. 3a, 
increasing concentrations of TcmX led to a complete loss in 
HEK293T cell viability, with a calculated cytotoxicity concentra-
tion that inhibits 50% viability (CC50) of 2.5 μM, similar to that 
(5.4–10.9 μM) reported previously against the other human cell 
lines8–12. By comparison, Dox exhibited a much higher cytotoxic 
activity against HEK293T cells, with an CC50 of 0.006 μM (6 nM), 
which was more than two orders of magnitude lower than for 
TcmX. Having established that TcmX exhibits cytotoxicity against 
HEK293T cells, we were interested in assessing whether TcmX can 
inhibit translation in vivo (Fig. 3b) and in vitro (Fig. 3c). To test 
the inhibition of translation in vivo, we transfected HEK293T cells 
with a Fluc reporter construct and monitored Fluc luminescence25 
in the presence of increasing concentrations of TcmX, as well as 
the control Dox (Fig. 3b). TcmX inhibited Fluc luminescence with 
an IC50 of 2.5 μM (Fig. 3b), comparable with the CC50 observed 
for cytotoxicity, which was also 2.5 μM (Fig. 3a). The identical 
CC50 and IC50 values suggested to us that the cytotoxicity caused 
by TcmX on HEK293T cells is probably due to a direct inhibi-
tion of translation. By contrast, Dox inhibited Fluc luminescence 
with an IC50 (of 1.5 μM), which was 250-fold higher than the CC50 
observed for cytotoxicity (Fig. 3a) and thus likely reflects an indi-
rect effect of Dox on translation, presumably via inhibition of DNA 
replication and transcription in cells. To confirm that TcmX can 
directly inhibit translation on human 80S ribosomes, we prepared 
whole-cell extracts from cultured HEK293T cells and monitored 
in vitro translation of Fluc26 in the presence of increasing concen-
trations of TcmX (Fig. 3c). Using this in vitro translation system, 
TcmX exhibited a dose-dependent inhibition of Fluc translation 
with an IC50 of 10 μM, which is in a similar range to that observed 
for cytotoxicity and in vivo translation inhibition. Nevertheless, 
we cannot completely exclude the possibility that TcmX also has 
another target within the mammalian cell, which could account 
for the slight differences in IC50 values in vitro and in vivo. Unlike 
TcmX, Dox did not inhibit in vitro translation of Fluc, even at the 
highest concentration (50 μM) tested (Fig. 3c).
TcmX inhibits translation elongation. To ascertain the mecha-
nism of action of TcmX during translation, we performed toeprint-
ing assays to monitor the position of the ribosome on the trpL-2Ala 
mRNA using reverse transcription (Fig. 4a). The reactions were 
performed in the absence of antibiotics as well as presence of TcmX 
and control antibiotics Ery, Tet and thiostrepton (Ths). As expected, 
multiple bands were observed in the absence of antibiotic, cor-
responding to translating ribosomes spread over the entire open 
reading frame (ORF). By contrast, the addition of Ths led to a loss 
of the bands within the ORF and the appearance of a strong band 
corresponding to ribosomes that initiated on the AUG start codon, 
but could not progress into the elongation phase, as observed pre-
viously22,27. Similarly, in the presence of Tet, most ribosomes also 
became trapped at the start codon; however, some translation of 
the downstream ORF was evident. By contrast, in the presence of 
Ery, the majority of ribosomes translated the first seven codons of 
the mRNA, but then became stuck with the seventh (Leu, L) codon 
located in the P-site and the eighth codon (Lys, K) in the A-site. 
This is consistent with mode of inhibition of macrolides, such as 
Ery, to permit synthesis of short oligopeptides, but to prevent fur-
ther prolongation of the nascent polypeptide chain by occluding the 
ribosomal tunnel28. The toeprinting results in the presence of TcmX 
resemble closely those observed for Ery, suggesting that TcmX has 
a similar mechanism of action, allowing synthesis of short oligo-
peptides before preventing further translation elongation. We also 
0
0 0 00.1 1 10 1050 500.001 0.01
Antibiotic (µM) Antibiotic (µM) Antibiotic (µM)
0.1 1 10 100
20
TcmX
Dox
TcmX
Dox
TcmX
Dox
40
60
80
100
a b c
C
el
l v
ia
bi
lit
y 
(%
)
0
20
40
60
80
100
R
el
at
iv
e 
lu
m
in
es
ce
nc
e 
(%
)
0
20
40
60
80
100
R
el
at
iv
e 
lu
m
in
es
ce
nc
e 
(%
)
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performed toeprinting using another template, namely, the ErmBL 
mRNA (Fig. 4b). As observed previously, Ery induced translational 
arrest of ErmBL with the tenth (Asp, D) codon located in the P 
site29,30. While TcmX also induced translational arrest of the ErmBL 
template, ribosome stalling was not observed at the tenth codon, 
but rather with the 16th (Leu, L) codon (Fig. 4b). This suggests that 
analogous to macrolides, the translational arrest mediated by TcmX 
is also nascent polypeptide chain-dependent, but that TcmX exhib-
its a different sequence-specificity compared with macrolides such 
as erythromycin. Our finding that TcmX does not inhibit transla-
tion initiation, but rather blocks an early elongation step (Fig. 4a,b), 
analogous to the mechanism of action of macrolides such as Ery28, is 
consistent with the binding position of TcmX (Fig. 4c). TcmX does 
not overlap with A- or P-site tRNA (Fig. 4d), but is instead located 
deeper within the exit tunnel, analogous to Ery (Fig. 4e), where it 
could interfere with the prolongation of nascent polypeptide chains 
(Fig. 4f). Although TcmX binds on the opposite side of the tunnel 
with respect to Ery, we note that the extent of tunnel blockage is not 
complete and that the remaining space may also allow some transla-
tion of nascent chains in the presence of the drug (Fig. 4g).
Discussion
The antimicrobial and cytotoxic activity of tetracenomycins has 
been assumed to result from the ability of this family of compounds 
to intercalate with DNA and thereby induce DNA damage10,11,13. 
This assumption was also reinforced by the similarity of tetraceno-
mycins with Dox (Fig. 1a), as well as the report that tetracenomy-
cins do not inhibit in vitro poly(U)-dependent poly(Phe) synthesis6. 
Here we challenge these assumptions by showing that (1) TcmX 
does not evoke the SOS response due to DNA damage, as observed 
for Dox (Fig. 1e) and (2) TcmX, unlike Dox, does not inhibit thy-
mine incorporation into DNA in living cells (Fig. 1g), but rather (3) 
TcmX, like Tet, inhibits valine incorporation into proteins (Fig. 1f) 
and (4) TcmX, like Tet21, inhibits in vitro cell-free protein synthesis 
A
T
G
T
T
G
G
T
A
T
T
C
C
A
A
A
T
G
C
G
T
A
A
T
G
T
A
G
A
T
A
A
A
A
C
A
T
C
T
A
C
T
A
T
T
T
T
G
A
A
A
T
A
A
M
L
V
F
Q
M
R
N
V
D
K
T
S
T
I
L
K
*
A C G U
ErmBL
– T
cm
X
E
ry
T
et
T
hs
TnaC
TcmX
Ery
TcmX
TcmX
P-Site tRNA
A-Site tRNA
TcmX
ErmBL
50S30S TcmX
A
T
G
A
A
A
G
C
A
A
T
T
T
T
C
G
T
A
C
T
G
A
A
A
G
G
T
G
C
G
G
C
G
C
G
C
A
C
T
T
C
C
T
G
A
M
K
A
I
F
V
L
K
G
A
A
R
T
S
*
A
a b c
d
e
f
g
C G U – T
cm
X
E
ry
T
et
T
hs
TrpL_2Ala
Fig. 4 | TcmX inhibits translation elongation in a template-dependent fashion. a,b, Toeprinting assay of TrpL-2Ala (a) and ErmBL template (b) in the 
presence or absence (−) of TcmX and control antibiotics erythromycin (Ery), tetracycline (Tet) and thiostrepton (Ths). Ths and Tet inhibit initiation (green 
arrow), while TcmX and Ery lead to stalling during elongation, at the seventh codon for TrpL_2Ala in a or the tenth and 16th codons, respectively, for the 
ErmBL template in b. The no antibiotic control translates to the stop codon at the end (purple arrow). Codons in P site are marked by color circles; note 
that owing to the large size of the ribosome, the reverse transcriptase stops are at nucleotide +16 relative to the codon located in the P site. c–g, Transverse 
section of the cryo-EM map of the TcmX-Eco70S showing the TcmX binding site in the exit tunnel (c), with zooms (d–g) showing the relative location of 
TcmX (blue) compared to A-site Phe-tRNA (yellow) (d) and P site fMet-tRNA (green) (PDB 1VY4)33, erythromycin (red, PDB 5JTE) (e)30, ErmBL nascent 
chain (gold, PDB 5JTE) (f)30 and TnaC nascent peptide chain (green, PDB 4UY8) (g)34. Experiments were repeated twice independently with similar results. 
NATURE CHEMICAL BIOLOGY | www.nature.com/naturechemicalbiology
ARTICLESNATURE CHEMICAL BIOLOGY
in bacteria (Fig. 1h) as well as in human lysates (Fig. 3c). Moreover, 
we demonstrate that in bacteria the ribosome and protein synthesis 
are the physiological target for TcmX by showing that single point 
mutations within the 23S rRNA confer TcmX resistance (Table 1).
The tetracyclic chromophore of TcmX stacks on the nonca-
nonical basepair formed between U2586 and U1782. We note 
that the producers of tetracenomycins, such as S. glaucescens and 
Amycolatopsis sp. A23 also contain a U–U basepair (Extended Data 
Fig. 4), suggesting that their ribosomes should be susceptible to the 
antibiotics they produce. In these organisms, resistance is instead 
conferred by the presence of an inducible tcmA gene, which encodes 
the TcmA metabolite transporter responsible for pumping TcmC out 
of the cell31. Consistent with the conservation of the U–U basepair 
in all eukaryotes, we could demonstrate using cryo-EM that TcmX 
binds to the same site within the exit tunnel (Fig. 2e–h) and inhibits 
translation on human 80S ribosomes in vivo and in vitro (Fig. 3b,c). 
Thus, we suggest that inhibition of protein synthesis, rather than 
intercalation with DNA, is a likely reason for the observed cytotox-
icity of tetracenomycins observed here for HEK293T cells (Fig. 3a) 
and reported against other human cell lines8–12.
Compared to the macrolide antibiotics, such as Ery, the TcmX 
binding site is on the opposite surface of the ribosomal tunnel 
(Fig. 4d). The distinct binding sites of TcmX and Ery is consistent 
with our findings that the A2058G mutation within the 23S rRNA 
confers erythromycin but not TcmX resistance, whereas mutations 
in U2586 or U1782 that confer TcmX resistance, do not confer 
Ery resistance (Table 1). The lack of cross-resistance to TcmX by 
A2058G is important since mutation or modification (methylation) 
of A2058 represents one of the main determinants for clinical resis-
tance to macrolides, lincosamides and streptogramin B (MLSB) anti-
biotics32. Nevertheless, the mechanism of action of TcmX appears 
to resemble that of macrolides to stall translation in a nascent 
polypeptide-dependent manner28; however, the sequence-specificity 
of stalling for TcmX appears to be distinct. Thus, it will be interest-
ing in the future to analyze in a translatome-wide manner to see 
whether there is also a sequence-specificity of the inhibition of 
TcmX and if so, how this specificity compares with the sequence 
motifs identified for macrolide antibiotics28.
Collectively, our findings that the binding mode and mechanism 
of action of TcmX, as well as the lack of cross-resistance with other 
antibiotics, is likely to be conserved for most, if not all, tetraceno-
mycins, making members of this family potentially attractive lead 
compounds for future development of new antimicrobial agents.
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Methods
Genome sequencing and data analysis. Library Preparation Nanopore long-read 
sequencing: DNA samples were prepared for long-read Oxford Nanopore 
Technologies sequencing using the Nanopore Rapid Barcoding genomic DNA 
Sequencing kit SQK-RBK004 Oxford Nanopore Technologies according to the 
manufacturer’s protocol and sequenced in-house using MinION and flow cell 
FLO-MIN106. Illumina short read sequencing: DNA samples were prepared for 
sequencing using NEBNext Ultra II FS DNA Library Prep Kit for Illumina modules 
E7810L and E7595L (New England BioLabs (NEB)) following the manufacturer’s 
protocol for use with inputs ≥100 ng with modifications to eliminate 
PCR-amplification steps. IDT for Illumina TruSeq DNA UD Indexes 20022370 
(Integrated DNA Technologies) were used in place of NEBNext adaptors. The 
USER addition and incubation were skipped for this reason, and the volume was 
replaced instead with water to reach the necessary sample volume for size selection 
steps. Library size selection and clean up were performed using AMPure XP beads 
(Beckman Coulter) following the NEB protocol. Prepared libraries were quantified 
using NEBNext Library Quant Kit for Illumina E7630L (NEB) and pooled with 
volumes adjusted to normalize concentrations. Library size and quality were 
analyzed with the 2100 Bioanalyzer Instrument (Agilent). Pooled DNA libraries 
were sequenced by Novogene Co., Ltd. Hybrid assembly: adapter sequences 
in Illumina paired reads were cut with trimmomatic v.0.36 (ref. 35). Nanopore 
basecalling and demultiplexing was performed by Albacore v.2.3.4 available from 
ONT community web site (community.nanoporetech.com). To obtain more 
coverage with long reads we performed secondary demultiplexing of unclassified 
reads with Porechop v.0.2.4 (https://github.com/rrwick/Porechop). Adapter 
sequences were cut with the same program. Hybrid assembly was performed with 
MaSuRCA v.3.2.8 (ref. 36). Assembly quality was assessed with Quast v.5.0.2 (ref. 37). 
Phylogeny construction: the phylogeny of Amycolatopsis species was built using 
16S–23S rRNA concatenate. Genomes for the analysis were downloaded from 
the PATRIC database38. Sequences of rRNAs were extracted using barrnap v.0.9 
(https://github.com/tseemann/barrnap) and aligned with MAFFT39. Assembly 
results: achieved assembly of total length 10,560,374 nucleotides has six contigs 
with a mean coverage of 58×, N50 of 3,441,384 with largest contig of 4,455,037-nt 
length. The genome of Amycolatopsis sp. A23 was fully annotated using the RAST 
automated annotation pipeline40. The TcmX cluster was analyzed in detailed using 
a subsystems-based comparative genomic approach implemented in SEED41.
Detection of the translation inhibitors with pDualrep2 reporter. Reporter strain 
JW5503 ΔtolC (BW25113) pDualrep2 was used as previously described42. Tested 
antibiotic solutions (Spots of Tet (0.5 μg), Dox (2 μg), erythromycin (Ery, 2 μg)), 
levofloxacin (Lev, 0.05 μg) and TcmX (2 μg)) were applied to an agar plate that 
already contained a lawn of the reporter strain. After being incubated overnight at 
37 °C, the plate was scanned by ChemiDoc (Bio-Rad) in the modes ‘Cy3-blot’ for 
RFP and ‘Cy5-blot’ for Katushka2S.
TcmX purification and structure determination. Amycolatopsis sp. A23 strain 
was grown in 50 ml of Org79 medium42 for 2 d at 28 °C, and 5 ml of the preculture 
was used to inoculate seven flasks containing 150 ml of Org79 medium. The 
cultures were then incubated at 28 °C for 21 d without shaking. Then 1 l was 
used for gravity-force reverse-phase chromatography on LPS500H sorbent 
(polyvinylbenzene, pore size 50–1,000 Å) with elution by 10, 25, 50 and 75% 
acetonitrile solutions. The pDualrep2 reporter system was used to analyze the 
activity in the fractions14. The fraction eluted by 50% acetonitrile demonstrated 
the highest inhibitory activity and induced Katushka2S expression, indicating 
presence of protein synthesis inhibitor. This fraction was subjected to further 
purification by means of high-performance liquid chromatography (HPLC) 
(Agilent 1260, isocratic elution 42% of MeCN, 0.05% TFA) using a Phenomenex 
HPLC column (Luna 5 μm C18 (2) 100 Å), collected fraction were again analyzed 
by means pDualrep2 reporter and individual peak with antibacterial activity was 
collected and lyophilized. As a result, 11 mg of yellow powder was obtained. The 
chemical structure of the active compound was revealed by combination of mass 
spectrometry and NMR analysis.
Determination of the chemical structure of TcmX. NMR spectra of 
tetracenomycin X were recorded on a Bruker AVANCE spectrometer operating at a 
proton frequency of 600 MHz, at 298 K in DMSO-d6. Concentration of the sample 
was ~100 μM. NMR spectra were processed and analyzed similarly as before42. UV 
and mass spectra were made by means of ultra-efficient liquid chromatography/
mass spectrometry on a Waters Acquity ultra-HPLC–tandem mass spectrometry 
liquid chromatography system (Waters) supplied with TQD (ESI, MS1 mode) and 
PDA detectors, using an analytical column Acquity UPLC BEH C18 (50 × 2.1 mm2, 
1.7 μm) by gradient elution 5–100% MeCN (3 min) in the presence 20 mM 
formic acid (35 °C, 0.5 ml min−1, injection vol. 2 μl). The structure of the isolated 
compound was established using the mass-spectroscopy data (molecular weight, 
486; Supplementary Note 1) and information from NMR spectra. 1H spectrum 
recorded in DMSO-d6 (Supplementary Notes 2 and 3) contains 12 singlets, 
including five signals of methyl groups (with chemical shifts in the range between 
2.7 and 4.0 ppm), four C–H signals (4.7–8.8 ppm) and three broader signals 
from exchangeable protons (O–H). This scant information derived from the 1H 
spectrum is substantially extended by the use of 13C data (Supplementary Note 3).  
The two-dimensional 13C-1H HMBC spectrum shows correlations between 1H 
signals and more than twenty 13C resonances (Supplementary Note 3) and allows 
to suggest a topology of the studied compound. The suggested topology was 
found to be identical to the topology of TcmX. Comparison of the measured 1H 
and 13C chemical shifts and NMR parameters published for TcmX8 shows high 
level of identity (Supplementary Table 1) and proves the structure of the isolated 
compound. The low field shift of the signal of O–H (ref. 11) (13.8 ppm) indicates 
the formation of a strong intramolecular hydrogen bond.
Determination of MIC and in vivo testing of TcmX. MIC values were 
determined by monitoring growth in 96-well plates of E. coli cultures exposed 
to TcmX serial dilutions. Specifically, overnight E. coli cultures were diluted 
in 96-well plates to an OD600 of 0.01 in LB medium. The wells were then 
supplemented with antibiotic at concentrations of 64, 32, 16, 8, 4, 2, 1 and 
0.5 µg ml−1. After antibiotic addition, the plates were incubated, with shaking 
(200 r.p.m.) overnight at 37 °C and cell growth was assessed by scanning each well 
with a VictorX5 reader. For protein synthesis inhibition experiments, JW5503 
ΔtolC was grown in M9 media, supplemented with all amino acids (40 mg l−1 each), 
except valine, until the optical density (OD of 600 nm) reached 0.2. TcmX, Dox 
and Tet (30×, 10×, 5×, 1× MIC, MIC: TcmX 2 µg ml−1, Dox 1.3 µg ml−1 and Tet 
0.3 µg ml−1) were added to 200 µl of cell culture and incubated for 5 min at 37 °C 
before adding of 0.5 μCi of l-[14C]-valine (Perkin Elmer), cells were incubated for 
a further 5 min at 37 °C, centrifuged and suspended in urea-containing protein 
loading dye. The reaction products were analyzed by SDS–PAGE followed by 
autoradiography, results were quantified with the Image Lab software (Bio-Rad). 
For DNA synthesis inhibition experiments, JW5503 ΔtolC was grown in M9 
media, supplemented with all amino acids (40 mg l−1 each) overnight, until the 
optical density (OD600 nm) reached 0.4. TcmX, Dox and Tet (30×, 10×, 5×, 1× MIC) 
were added to 1,000 μl of cell culture and incubated for 5 min at 37 °C before 
addition of 1 μl 500 µM (2.2 μCi per nmol) of [3H]-thymidine (Perkin Elmer), cells 
were incubated for 15 mins more at 37 °C with shaking at 200 r.p.m., centrifuged, 
washed in 100 μl of 0.9% NaCl, centrifuged and suspended in 7 M Urea 10% SDS 
buffer and analyzed by a scintillation counter (Perkin Elmer).
Selection of TcmX resistance mutants. The single rrnE allele, ΔtolC E. coli strain 
SQ110DTC19 was grown overnight in LB medium supplemented with 50 µg ml−1 
of kanamycin, then cells were plated on LB agar plates containing 50 µg ml−1 
kanamycin and different concentrations of TcmX (from 1–10 µg ml−1). Several 
colonies appeared on plates with 2.5 and 5 µg ml−1 after 24 h of incubation, which 
were cultivated and the MIC of TcmX was determined. Ribosomal DNA was 
PCR amplified from five colonies and sequenced with the set oligonucleotides as 
described previously27.
Testing TcmX resistance mutations. Plasmids pAM552 and pLK35 with 1,782, 
2,058, 2,059, 2,586 and 2,609 mutations in rRNA operon were kindly provided 
by A. Mankin (Chicago, USA), double mutant 1782/2586 was made in this 
work, by site-directed mutagenesis of 2586C mutant plasmid with following 
oligonucleotides:
1782C_F CAAAAACACAGCACTGTGC; 1782C_R ATAAACAGTTG 
CAGCCAGC.
SQ171ΔtolC (SQ171DTC) strain was transformed by mutant plasmids, and the 
cells were then cured of the wild-type plasmid pCSacB by plating onto an LB agar 
plates supplemented with 50 μg ml−1 ampicillin and 5% sucrose43. MIC values of the 
engineered mutants were tested by serial dilutions as described before.
Cryo-EM maps of E. coli and H. sapiens TcmX-ribosome complexes. For 
the human 80S-TcmX sample, HEK293T cells were collected by scraping from 
seven culture dishes (15 cm) at a confluency of ~50%. The cells were lysed by 
incubation for 30 min on ice in buffer containing 20 mM HEPES 7.4, 100 mM 
KOAc, 10 mM Mg(OAc)2, 100 mM sucrose, 1 mM DTT, 0.5% NP-40 substitute 
and Complete protease inhibitor (Sigma Aldrich). The lysate was layered on top 
of a sucrose density gradient (10–50% sucrose in 20 mM HEPES 7.4, 100 mM 
KOAc, 10 mM Mg(OAc)2, 1 mM DTT) and centrifuged at 125,755g for 3 h at 4 °C 
in an SW40 rotor (Beckman Coulter). The gradient was fractionated from top 
to bottom using a Gradient Master (BioComp). The 80S fraction was collected 
and centrifuged 356,000g for 1 h at 4 °C in a TLA120.2 rotor (Beckman Coulter). 
The pelleted ribosomes were resuspended in buffer containing 20 mM HEPES 
7.4, 100 mM KOAc, 10 mM MgOAc2 and 1 mM DTT. For the E. coli 70S-TcmX 
sample, E. coli 70S ribosomes were prepared from E. coli BW25112 ΔyfiA strain, 
as previously described44.
To prepare complexes of TcmX bound to the E. coli (TcmX-Eco70S complex) 
or H. sapiens (TcmX-Hsa80S complex), 50 and 100 µM of TcmX was incubated 
with 4 OD A260/ml 70S or 80S ribosomes, respectively. Subsequently, 3.5 µl of the 
TcmX-ribosome complexes were applied to 2 nm precoated Quantifoil R3/3 holey 
carbon supported grids and vitrified using a Vitrobot Mark IV (FEI company). 
Data collection was performed on a Titan Krios operated at 300 kV, equipped with 
a Falcon II direct electron detector. Data were collected at a nominal magnification 
of ×75,000, resulting in a pixel size of 1.084 Å, over a defocus range of −0.5 to 
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−3.5 μm. Ten frames (dose per frame of 2.5 e− Å–2) were aligned using MotionCor2 
(ref. 45). Power spectra, defocus values, astigmatism and estimation of micrograph 
resolution were determined using CTFFIND4.1.10 (ref. 46).
For the TcmX-Eco70S complex, 6,495 micrographs were initially collected. 
After applying a resolution cut-off of 3.5 Å as well as removal of bad micrographs 
during manual inspection, the remaining 4,941 micrographs were used for 
particle picking using Gautomatch (http://www.mrc-lmb.cam.ac.uk/kzhang/). 
The resulting 818,287 particles were then extracted using RELION 3.0 (ref. 47) 
and subjected to two-dimensional classification. The selected two-dimensional 
classes contained a total of 548,675 particles, which were used for initial 
alignment and three-dimensional classification, which were performed using 
three times decimated data. After 300 rounds of sorting into eight classes, one 
well-resolved 70S class with 161,915 was extracted for further high-resolution 
refinement. Contrast transfer function (CTF) and beam tilt refinement with 
subsequent Bayesian polishing was performed47 and improved the resolution 
from 3.9 to 2.86 Å. The resolution was estimated using the gold standard criterion 
(Fourier shell correlation of 0.143)48,49. The refined maps were corrected using 
the modulation transfer function of the detector and sharpened by applying an 
automatically determined negative B factor using RELION 3.0 (ref. 47). Local 
Resolution and maps filtered according to local resolution were computed using 
SPHIRE50. A sorting scheme and a visualization of the local-resolution distribution 
is provided in Extended Data Fig. 3.
For the TcmX-Hsa80S complex, 7,672 micrographs remained after visual 
inspection and were used for particle picking using Gautomatch (http://www.
mrc-lmb.cam.ac.uk/kzhang/). This resulted in 836,588 initial particles, of which 
461,131 were used for further processing after two-dimensional classification 
using RELION 3.0 (ref. 47). Three-dimensional classification yielded four classes 
of 80S ribosomes. One low-resolution class was discarded and the remaining 
well-resolved classes, which differed in eEF2 occupation and 40S subunit 
conformation were joined (302,737 particles) and refined to 3.7 Å. There was 
no extra density visible at the canonical tetracycline binding site on the 40S 
subunit. CTF-refinement, focused refinement with a mask on the 60S subunit 
and postprocessing in RELION 3.0 resulted in a resolution of 2.76 Å (Fourier 
shell correlation, 0.143). The final density map was filtered according to local 
resolution as determined by RELION 3.0, applying a B factor of −100 Å2. 
A sorting scheme and a visualization of the local-resolution distribution is 
provided in Extended Data Fig. 5.
Molecular modeling of the E. coli and H. sapiens TcmX-ribosome complexes. 
The molecular model for the TcmX-Eco70S complex was based on a previous 
cryo-EM structure of the E. coli 70S ribosome (Protein Data Bank (PDB) 
6H4N)44. The molecular model for the TcmX-Hsa60S complex was based on 
previous cryo-EM structure of the H. sapiens 80S ribosome (PDB 6EK0)51. The 
rRNA domains and ribosomal proteins were rigid-body fitted into the respective 
cryo-EM maps using Chimera52. An atomic model for TcmX was generated from 
the chemical structure (PubChem CID 129395) using the PRODRG software53. 
Restraints for TcmX were generated using PHENIX eLBOW54. The molecular 
models were manually adjusted and refined using Coot55. The complete atomic 
model of the respective complexes were subsequently refined into the locally 
filtered maps using phenix.real_space_refine with secondary structure restraints 
calculated by PHENIX 1.16 (ref. 56). The statistics of the refined models were 
obtained using MolProbity57 and are presented in Supplementary Table 5 for the 
TcmX-Eco70S and TcmX-Hsa80S complexes, respectively.
MTT assay. Cytotoxicity was measured using the MTT by Mosman58 in 
HEK293T cell line. Then 2,500 cells per well were seeded in a 96-well plate in 
DMEM/F12 media. The cells were growth for 18 h. The next day, the antibiotic of 
interest in 10% DMSO was added. Cells were incubated with compounds for 48 or 
72 h. Each experiment was done in triplicate. After incubation, MTT was added up 
to 0.5 mg ml−1 to the media and cells were incubated for an additional 2 h. Then the 
media was changed to DMSO and solution was measured spectrophotometrically at 
565 nm (VictorX5, Perkin Elmer). The cytotoxicity concentration that inhibits 50% 
viability (CC50) of the tested compounds was calculated from the dose-response 
dependencies with GraphPad Prism software (GraphPad Software, Inc.).
Mammalian cell growth and mRNA transfection. For experiments in mammalian 
systems, capped and polyadenylated mRNAs were prepared essentially as described 
previously25. In short, a T7 promoter-containing, 50A-tailed PCR products were 
obtained from the plasmid pActin-Fluc, purified by agarose gel electrophoresis, 
and used as a template for in vitro transcription. RNA synthesis was performed 
using the RiboMAX kit (Promega), followed by capping by Vaccinia Capping 
System (NEB). The transcripts were purified by LiCl precipitation and checked for 
integrity by denaturing urea PAGE.
For mRNA transfection, HEK293T cells were grown in DMEM (Gibco) 
supplemented with 10% FBS (HyClone) in the presence of penicillin and 
streptomycin (Paneco) in a humidified 5% CO2 atmosphere at 37 °C. One day 
before transfection, cells were transferred into the white FB/HB 96-well plates 
(Grenier no. 655074) in 75 μl medium per well. Next day, cell culture at ~70% 
confluency was supplemented with antibiotic or solvent, as indicated, and 
immediately after that transfected with the reporter mRNA. For this, 30 ng of 
mRNA in 20 μl Gibco Opti-MEM (per one well) were mixed with a solution of 
0.06 μl of Unifectin-56 (Unifect Group) in 3 μl Opti-MEM (per well), incubated 
for 15 min, then supplied with 0.4 μl 100 mM d-luciferin (Promega) per well and 
then 23 μl of the mixture were added to cells in the plate. During these steps, 
all manipulations were performed as described in the regular fleeting mRNA 
transfection technique protocol25, providing a rapid and nonstressful transfection 
procedure. Real-time luminescence measurements were carried out overnight in 
the CLARIOstar plate reader (BMG Labtech) equipped with Atmospheric Control 
Unit to maintain 5% CO2, at 37 °C (light integration time, 5 s). Light intensities at 
the time point 4 h after transfection were taken as luciferase activity values. All the 
experiments were repeated at least three times (including ones with different cell 
passages), the mean value ± s.d. were calculated.
Mammalian cell-free systems and in vitro translation assays. For in vitro 
translation, the whole-cell extract prepared from cultured HEK293T cell 
was used26. Translation reactions were performed in a total volume of 10 μl, 
which contained 5.5 μl of the HEK293T extract, 1× Translation Buffer (20 mM 
Hepes-KOH pH 7.6, 1 mM DTT, 0.5 mM spermidine-HCl, 0.8 mM Mg(OAc)2, 
8 mM creatine phosphate, 1 mM ATP, 0.2 mM GTP, 120 mM KOAc and 25 μM of 
each amino acid), 2 U of RiboLock RNase inhibitor (Thermo Scientific), 0.5 mM 
d-luciferin (Promega), 1 μl of either antibiotic solution or solvent (water or 10% 
DMSO), as indicated and 100 ng mRNA (the latter was added as 1 μl water solution 
after the reaction mixture supplemented with antibiotic was pre-incubated for 
5 min at 30 °C). After mRNA addition, the mixtures were transferred into the 
pre-heated white FB/NB 384-well plate (Grenier no. 781904), covered by a PCR 
plate seal and incubated in the CLARIOstar plate reader (BMG Labtech) at 30 °C 
with continuous measurement of the luciferase activity, essentially as described25,59. 
Light intensities at 30 min were taken as luciferase activity values.
In vitro translation and toeprinting analysis. In vitro translation reactions were 
made in PURExpress system (NEB), each reaction in 5 μl, supplied with 200 ng 
of Fluc mRNA and 0.1 mM of d-luciferin. Chemiluminescence was detected by 
VictorX5 multi-reader. Toeprinting was done according to the described protocol19 
using tryptophan operon leader mRNA obtained by T7 transcription from the 
linear DNA template. DNA template was obtained by amplification of TrpL-2Ala 
peptide sequence from pDualrep2 plasmid with primers F:
T GT AA TA CG AC TC AC TA TA GG GA AT TT TT CT GT AT AA TA GC CG CG GA-
AG TT CACGTAAAAAGGGTATCGACAATGAAA
R: GCGTTAAGGCTATGTACGGGTATCTGATTGCTTTACG and GCGTT 
AAGGCTATGTAC was used for reverse transcription. The ErmBL template was 
generated by PCR with two partially self-complimented oligonucleotides  
F: TAATACGACTCACTATAGGGAGTTTTATAAGGAGGAAAAAATATGTT 
GGTATTCCAAATGCGTAATGTAGATAAAACATCTAC R:
G GT TATAATGAATTTTGCTTATTAACGATAGAATTCTATCACTTTTTT
TATTATTATTATTTCAAAATAGTAGATGTTTTATCTACAT as a template and 
F: TAATACGACTCACTATAGGG R: GGTTATAATGAATTTTGCTTATTAAC 
as a pair for PCR. GGTTATAATGAATTTTGCTTATTAAC was used for reverse 
transcription. The concentration of all drugs in toeprint was 50 μM and 1% DMSO 
for no antibiotic sample.
Figure preparation. Figures showing cryo-EM densities were created using 
ChimeraX60. Figures showing atomic models with or without electron densities, 
and in silico RNA mutagenesis were generated using PyMol (PyMol Molecular 
Graphics System, v.2.4.a, Schrödinger). For large subunit rRNA alignment 
presentation, primary alignments of rRNAs from the CRW Site23 were shortened 
to the desired regions, using CLC Workbench (CLC bio). For alignment 
figure generation, Jalview v.2.11 was used. Plots displaying Fluc inhibition and 
incorporation assays were generated using QtiPlot (http://soft.proindependent.
com/qtiplot.html). Figures were assembled using Adobe Illustrator.
Reporting Summary. Further information on research design is available in the 
Nature Research Reporting Summary linked to this article.
Data availability
The cryo-EM and associated molecular models for the TcmX-Eco70S and 
TcmX-Hsa80S ribosome complexes are available from the EMDB (EMD-10705 
and EMD-10709) and PDB (ID 6Y69 and PDB 6Y6X), respectively. The complete 
genome sequence of Amycolatopsis sp. A23 has been deposited in the European 
Nucleotide Archive with the accession number GCA_902497555.1. Source data are 
provided with this paper.
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Extended Data Fig. 1 | Modeling of TcmX into DNA and onto the 30S subunit. a, Structure of doxorubicin (Dox, green) intercalating with dsDNA (PDB 
1D12). b,c, Alignment of TcmX (blue) onto Dox (green) based on the planar rings C-D illustrates that the methoxy groups attached to ring A of TcmX 
would clash with the base−pairs and prevent efficient intercalation with DNA. d, Transverse section of reconstructed map of Thermus thermophilus 70!S 
(30!S, yellow; 50!S, grey) with the Tet (green) binding site at the decoding site relative to P-site tRNA (orange) (PDB 4V9A)21. e, Alignment of TcmX (blue) 
onto Tet (green) (PDB 4V9A)21 based on rings C and D. f, Based on the alignments from (e), TcmX clashes with G1054 (top panel) and the backbone of 
U1196-G1198 (bottom panel). g,h, Two views showing the tetracyclic antibiotic elloramycin (cyan) aligned onto the TcmX (blue) binding site of the Eco70S 
based on rings A-D.
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Extended Data Fig. 2 | Interaction schemes of Tetracenomycin X and Tetracycline. a,b, Interaction scheme of Tetracenomycin X (TcmX) on the  
large subunit of the E. coli and H. sapiens ribosomes, respectively. c, Interaction scheme of Tetracycline (Tet) on decoding site of the small subunit  
of the T. thermophilus 70!S ribosome21, with red crosses marking interactions that TcmX cannot form when docked into the Tet binding site.
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Extended Data Fig. 3 | Cryo-EM structure of the TcmX-Eco70S complex. a, Sorting scheme for cryo-EM data; after initial picking, 818,287 particles were 
subjected to 2D-Classification, of which 548,675 particles were used for 3D-classification. Particles were sorted into five distinctive classes: non-aligning, 
50!S, 100!S, 70!S with 100S-substoichiometric density, and clean 70!S particles. The latter were picked for further refinement (29.34%, 161,915 particles). 
After CTF-refinement and Bayesian Polishing, a final overall resolution of 2.89!Å was achieved. b, Fourier-Shell-Correlation (FSC 0.143) curve of the 
final reconstruction, with the resolution at FSC!=!0.143 indicated with a dashed line. c, Overview and (d) transverse section of cryo-EM map filtered and 
coloured according to local resolution. e,f, Electron density for TcmX with Mg1 and Mg2 and (g) the interacting nucleotides of the 23!S rRNA.
NATURE CHEMICAL BIOLOGY | www.nature.com/naturechemicalbiology
ARTICLES NATURE CHEMICAL BIOLOGY
Extended Data Fig. 4 | Conservation of the TcmC binding site. a, In wild-type U2609 basepairs with A752; (b-d) in silico mutations of TcmX resistant 
mutations (U2609G, U2609C and U2609A) which can no longer basepair with A752 and due to possible clashing have to adopt a different conformation. 
e, In wild-type U1752 base-pairs with U2586, while in the resistance mutations (f-i) the previously base-paired nucleotides will have to adapt a different 
conformation to avoid clashing, possibly obstructing the TcmX binding site. j, In E. coli (grey) TcmX stacks upon a U–U basepair U1782-U2586; in T. 
thermophilus (light blue) (PDB 4V9A)21 it is a C–C base-pair C 1814:C2599. k, Bacterial 23!S (above) and eukaryotic 28!S (below) rRNA alignments of select 
organisms within the vicinity of the U1782 and U2586 (E. coli numbering) in eubacteria and U3644 and U4532 (H. sapiens numbering).
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Extended Data Fig. 5 | Processing and analysis of H. sapiens-TcmX cryo-EM structure. a, Sorting scheme for cryo-EM data; after Initial picking, 836,588 
particles were subjected to 2D-Classification, of which 461,131 particles were used for 3D-classification. Particles were sorted into four classes: low resolution 
particles, 80!S with E-Site, and two distinct 80!S with E-Site and eEF2. All but low-resolution particles were picked for further refinement (65.7%, 302,737 
particles). After CTF-refinement and focused refinement using a 60!S mask, a final overall resolution of 2.76!Å was achieved. b, Fourier-Shell-Correlation (FSC 
0.143) of the final reconstruction, with the resolution at FSC!=!0.143 indicated with a dashed line. c, Overview and transverse section of cryo-EM map filtered 
and coloured according to local resolution. d, Electron density (mesh) and molecular model for the TcmX (blue) binding site on the human 80!S ribosome 
(28!S rRNA nucleotides shown in grey sticks Mg1 and Mg2 as blue spheres). e, Overview of the putative Tet-analog binding sites on the Hsa80S ribosome 
at the terminal loop of H89 (binding site 1, red) and within the exit tunnel (binding site 2, pink)24 relative to the binding site of TcmX (blue). f, Zoom of the 
relative location of TcmX (blue) to 28!S rRNA nucleotides identified in binding site 2 (magenta).
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